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The CD1 family is a family ofmolecules with structural homology to MHC class I and low but
significant sequence homology to both MHC class I and MHC class II. A key feature of the CD1
family is restricted tissue distribution. This distribution varies with isotype but includes cortical
thymocytes, antigen presenting cells and intestinal epithelial cells. It has recently been shown that
CD1 can present mycobacterial lipid antigens to T cells (Beckman et al. 1994, Sieling et al. 1995).
Another major feature of CD1 is limited polymorphism which is in contrast to the extensive
polymorphism associated with MHC molecules.
In humans, five CD1 genes exist (CD1A-E) which encode four CD1 molecules (CDla-d). CD1 genes
have also been described in mice, rats, rabbits and sheep. Studies in cattle and pigs have been at the
protein level using anti-CD 1 mAbs. Studies on ovine CD1 were initially carried out using mAbs to
study expression in cells and tissues. More recently, four ovine CD1 cDNA clones (SCD1A25,
SCD1B42, SCD1B52 and SCD1T10) have been isolated all of which have closest homology to
human CD IB (Ferguson et al. 1996). SCD1B52 contains a precise deletion of exon 4 which encodes
the oc3 domain. Southern hybridization has indicated the existence of up to seven ovine CD1 genes.
The aim of the work carried out in this thesis was to further investigate the ovine CD1 family and
clarify the existing information at the cellular and molecular level. Initial studies utilised existing
anti-CD 1 mAbs to clarify the pattern of tissue expression of ovine CD1. Two distinct clusters of
mAbs were shown to exist - the majority recognise a molecule with tissue distribution similar to
CD lb whilst three mAbs, SBU-T6, CC43 and CC118 demonstrate staining of tissue macrophages, the
majority of B cells and monocytes in addition to thymocytes and dendritic cells. NH2-terminal
sequencing was subsequently used to establish the antigens recognised by the mAbs SBU-T6 and
CC14. This technique demonstrated that the CC14 antigen was consistent with the predicted sequence
of the SCD1B42 cDNA clone whereas the SBU-T6 antigen had closest homology to the predicted
amino-acid sequence of the human CD IE gene. This is particularly noteworthy as no protein product
of the CD IE gene has yet been described in any species.
Subsequent work attempted to isolate the gene encoding the molecule recognised by SBU-T6 using a
transient expression system in which COS cells were transfected with a lymph node cDNA library
contained within the vector pcDNA3. This was unsuccessful, however a sheep CD ID-like sequence
was isolated from this library utilising primers based on the NH2-terminal sequence of the SBU-T6
antigen. Expression of the SCD1D gene was investigated using in situ hybridization and RT-PCR.
SCD1D transcripts were demonstrated in thymus, liver, intestine, lymph node and PBLs. A further
experiment investigated the expression of the SCD1B52 gene (which contains a precise deletion of
exon 4). These studies have extended the knowledge of the ovine CD1 family and establish it as one
of the most complex described to date. This work has demonstrated that sheep clearly express
multiple CD1 isotypes as in man and rabbits in addition to the multiple CD IB-like genes reported
previously.
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The CD1 family represents a group of genes and molecules with homology to both
MHC class I and class II. Five CD1 genes exist in man (CD1A-E) for which four
protein products have been described (CDla-d). Sequence analysis of these genes
has allowed division into group 1 (CD1A-C) and group 2 (CDID) (Calabi et al.
1989c). No protein product of the CD IE gene has yet been described but on the basis
of sequence, the gene has been placed in an intermediate position between the group
1 and group 2 families (Calabi et al. 1989c). CD1 genes have also been described in
mice, rats and sheep whilst monoclonal antibodies (mAbs) have additionally
identified CD1 molecules in cattle and pigs.
A key feature of CD1 expression is its presence on cells with integral functions in the
immune response. Recent functional studies have shown that CD lb presents
mycobacterial mycolic acid and lipoarabinomannan (LAM) to T cells (Beckman et
al. 1994, Sieling et al. 1995) implying that CD1 molecules represent an additional
arm of the immune response capable of presenting non-protein antigens such that the
range of antigens which can be presented and subsequently recognised by T cells is
increased.
There is marked interspecies variation in the CD1 family, notably rodents possess
only members of the CD Id group. The CD1 family in sheep is particularly
interesting as mAb studies have shown two distinct patterns of CD1 expression, one
consistent with human CD lb, the other resembling human CDlc (Dutia and
Elopkins, 1991; Elopkins and Dutia, 1991). More recent studies at the molecular level
have identified four ovine CD1 clones all of which have closest homology to the
CD IB (Ferguson et al. 1996). The work described in this thesis was undertaken to
further analyse the nature of the ovine CD1 family using both immunochemical and
molecular techniques.
The following introduction includes sections on cells and molecules involved in the
immune response as a necessary prelude to the specific sections on the CD1 genes
and molecules themselves. Section A deals with the MHC and cells of the immune
system and is followed by Section B which more specifically deals with
non-classical class I molecules and the CD1 family.
SECTION A
1A.1 The Major Histocompatibility Complex (MHC)
Inherent in the survival of an organism is the need to distinguish between self and
non-self such that foreign antigens can be rapidly recognised and eliminated whilst
maintaining tolerance to self antigens. That such a system of distinguishing between
self and non-self existed was first shown in mammals by the phenomenon of skin
graft rejection (Gorer, 1936). Subsequently, the highly polymorphic antigens
responsible for this rejection were characterized and named major histocompatibility
complex (MHC) antigens.
Three classes ofMHC antigens exist in mouse and man - MHC class I, MHC class II
and MHC class III. MHC class I and class II antigens present peptides to CD8+ T
cells and CD4+ T cells respectively although there are exceptions to this general rule.
MHC class III genes encode a variety of products including complement components
but are not involved in antigen presentation and therefore will not be discussed
further.
Early reports on the CD1 family identified the fact that these molecules structurally
resembled MHC class I antigens although the CD 1 genes were shown not to map to
the MHC (Van de Rijn et al. 1983, Kahn-Perles et al. 1985, Calabi and Milstein,
1986). Since it is now generally accepted that CD1 molecules are related to both
MHC class I and class II molecules, the MHC will be discussed in detail as
important comparisons will subsequently be made between the two families in terms
of both structure and function.
1A.1.1 MHC class I genes and molecules
MHC genes and antigens have been best characterized in man and in mouse. In man,
the class I genes map to chromosome 6 and are termed HLA (Human Leucocyte
Antigen) -A, HLA -B and HLA-C. In mice, the class I genes map to chromosome 17
and are termed H-2K, H-2D and H-2L. Many other class I genes also exist, however
these genes do not demonstrate the characteristic genetic polymorphism and
widespread tissue expression of classical class I molecules and as such are termed
'non-classical class I' genes (See Section 1B.1).
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Structure
MHC class I molecules consist of a 45kd a (heavy) chain which associates
non-covalently with (^microglobulin ((W)- The heavy chain consists of three
extracellular regions (al, a2 and a3), a transmembrane region and a cytoplasmic
tail.
X-ray crystallography has shown that the the al and a2 domains combine to form
the antigen binding groove which consists of a P pleated sheet flanked by two a
helices (Bjorkman et al. 1987a). This groove accommodates a short peptide (usually
8-9 amino-acids long) and this combination allows recognition of the peptide in an
MHC restricted fashion. The allelic polymorphisms which are characteristic of the
MHC occur mainly in residues in and around the groove allowing altered specificity
of the MHC class I molecules (Bjorkman et al. 1987b). p2m makes contact with all
three of the extracellular domains of the a chain (Bjorkman et al. 1987a) hence the
conformation of the a chain is dependant on this interaction with P2m (York and
Rock, 1986).
MHC class I processing and presentation
The function of MHC class I molecules is to sample peptides from within the cell
and present them to T cells such that foreign peptides can be identified and the
appropriate immune response generated. Endogenous antigens (e.g. viral proteins)
are degraded within the cytoplasm and processed into peptides capable of associating
with MHC class I. Protein degradation is carried out by a particle called the
proteasome which hydrolyses the protein to oligopeptides (Rechsteiner et al. 1993).
Proteins are marked for degradation by ubiquitination (Hilt and Wolf, 1996) then the
degraded peptides are transported into the rough endoplasmic reticulum via the TAP
transporter. This peptide transporter is a heterodimer formed by polypeptides
encoded by the TAPJ and TAP2 genes which are located within the MHC class II
region. Once within the RER, these short peptides are then free to form associations
with MHC class I and (^-microglobulin. This stable complex can then be transported
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via the Golgi to the cell surface. The molecular chaperone, calnexin, prevents the cell
surface expression of class I molecules which are not fully assembled (Rajgopalan
and Brenner, 1994).
Although this is the general dogma for class I presentation, exceptions to this do
exist such that exogenous antigens can be presented by MHC class I antigens e.g.
Pfeifer and colleagues (1993) demonstrate the existence of an alternative class I
pathway for phagocytic processing of bacterial antigens.
The optimal length for peptide binding to MHC class I molecules is 8-9 amino acids
as non polymorphic amino acids at the ends of the groove form hydrogen bonds with
the amino and carboxy termini of the peptide thus restricting the length of peptide
that can be bound (Bleek and Nathenson, 1993). Although this is optimal, longer
peptides have also been shown to bind such that the carboxyl terminal residue is
positioned outside the peptide binding site (Collins et al. 1994).
1A.1.2 MHC class II genes and molecules
MHC class II genes are again best characterized in man and mouse. In man, both a
and P chains are encoded by genes within the HLA-D region (DP, DQ and DR). In
the mouse, class II genes are in the H-2I region (IA and IE)
MHC class II molecules are found on antigen presenting cells i.e. B cells,
macrophages and dendritic cells. In addition, following cytokine or inflammatory
stimulation there is induction of MHC class II molecules on a variety of endothelial
and epithelial cells. One example of this is the class II induction which occurs on
keratinocytes in response to IFN-y (Griffiths et al. 1989). Class II molecules consist
of an a chain and a P chain and typically bind peptides of 12-15 amino acids in
length.
The recently described MHC class II molecule HLA-DM is almost as closely related
to class I molecules as class II molecules and has been shown to play a key role in
antigen presentation (Morris et al. 1994, Fling et al. 1994). The functional role of
HLA-DM is described below.
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Structure
Each MHC class II molecule consists of a 33kd a chain and a 28kd P chain which
associate non-covalently to form a heterodimer. The a and [3 chains each possess
extracellular al and a2, and [31 and [32, domains respectively. The antigen binding
groove is formed by the al and pi domains with the class II pi domain
corresponding to the class I a2 domain (Brown et al. 1993). X-ray crystallography
has been used to determine the three dimensional structure for MHC class II
molecules which resembles MHC class I (Brown et al. 1993). As for MHC class I,
the peptide binding groove is composed of a p pleated sheet flanked by two a
helices. The antigen binding groove is open ended allowing binding of longer
peptides - typically 15-24mers.
MHC class II processing and presentation
Exogenous antigens are internalized into an endosomal compartment in which
association with class II molecules occurs. The compartment in which MHC class
II/peptide complexes are assembled has been referred to as the MIIC (For MHC
Class II Compartment - Amigorena et al. 1994). Class II a and P chains associate
with the invariant chain (Ii) within the RER. A region of the invariant chain called
CLIP associates with class II and inhibits peptide binding. The MHC class II
molecule HLA-DM (which accumulates in the MIIC - Sanderson et al. 1994) is then
responsible for facilitating the release of CLIP and allowing peptide to bind to the
class II molecule (Sherman et al. 1995 and reviewed by Roche, 1995). Once free of
invariant chain, the class II molecule can associate with exogenous antigen which
has been internalized and degraded.
1A.2 Antigen Presenting Cells
The major 'professional' antigen presenting cells are dendritic cells, B cells,
monocytes and macrophages which process and present antigen to T cells in
association with MHC class II molecules. Certain endothelial and epithelial cells can
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also express class II upon activation and are therefore be considered 'non¬
professional' APCs.
The dendritic cell is of particular interest as it expresses high levels of CD1 and is
the most potent immunostimulatory cell known. The key role of dendritic cells in
antigen presentation is well recognised. These cells have several features which
contribute to their ability to stimulate the proliferation of resting T cells including
high levels ofMHC class II expression and the presence of cell surface adhesion and
co-stimulatory molecules. Dendritic cells in the periphery exist in two stages of
maturation - immature DCs which monitor non-lymphoid organs and process antigen
prior to maturing into immunostimulatory cells which lose the ability to process
antigen but acquire surface molecules to aid their function in initiating the T cell
response (Sallusto and Lanzavecchia, 1994). Langerhans cells also express
significant levels of CD1 and several reports have demonstrated that epidermal
Langerhans cells mature into dendritic cells under the influence of the cytokines
GM-CSF and IL-1 (Heufler et al. 1988, Koch et al. 1990).
1A.3. T Cell Ontogeny
Since MHC molecules function to present antigen to T cells, it is relevant to discuss
mechanisms of T cell development and, in particular, the means whereby the T cell
repertoire is generated.
T cells development begins in the embryo with haemopoietic stem cells seeding the
thymus. Immature thymocytes reside in the thymic cortex where they undergo the
processes of positive and negative selection and migrate to the medulla as mature
thymocytes. The critical feature of thymocyte development and maturation is in
educating the host to delete any cells which have the potential to generate
autoreactive responses (negative selection) whilst maintaining the ability to
recognise antigen in the context of selfMHC molecules (positive selection).
1A.3.1 Positive and negative selection
The maturation of T lymphocytes depends on the interaction of the TCR on the
immature thymocyte with MHC/peptide complex within the thymus. This process
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results in the generation of CD4 T cells which are restricted by MHC class II and
CD8 T cells which are restricted by MHC class I (minor exceptions to this general
rule do exist). That peptide is involved in the selection process has been shown using
TAP1 mutant mice. The empty class I molecules which appear on the cell surface in
these mice can be loaded and stabilized with peptide (in the presence of (32m) such
that the effects of different peptides on selection can be studied. Using this model
with cultured foetal thymi, it was shown that only some peptides promoted positive
selection (Ashton-Rickardt et al. 1994).
Two models to explain the process of positive and negative selection have been
proposed. The first is the qualitative model which depends on conformational
changes in the TCR or associated molecules modulating signal transduction. The
second is the quantitative model where selection depends on alterations in the
affinity or avidity of TCR binding. Current evidence suggests that the quantitative
model is likely to be the most accurate. This conclusion comes from recent work by
Alam and colleagues (1996) in which surface plasmon resonance was used to
measure the kinetics of TCR interactions with ligands capable of inducing positive or
negative selection. The results showed that the affinity of binding correlated directly
to the outcome of selection i.e. lower affinity (within a 'window') resulted in positive
selection and higher affinity in negative selection.
Studies in (32m deficient mice have shown that not all y8 T cells require (32m
dependent proteins for positive selection (Correa et al. 1992). However selection of
y8 T cells by non-classical class I molecules (H-2T region products) has been
demonstrated (Dent et al. 1990, Wells et al. 1991).
1A.3.2 Extrathymic T cell development
In addition to thymic T cell development, a significant number of T cells develop
extrathymically as proven by the capacity of both a(3 and y8 T cells to develop in the
absence of a thymus. The major organ involved in extrathymic T cell development is
the intestine which supports the development of two T cell subsets which are unique
to this area - CD4+CD8aa+ and CD4"CD8aa+ (Reviewed in Poussier and Julius,
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1994). The developmental pathways and selection processes which govern the
repertoire of these gut derived cells are still uncertain, however it is known that they
do not develop through the CD4+CD8+ pathway as is the case for the thymus derived
and selected cells. As a result of this 'unconventional' selection process, this cell
population contains some autoreactive cells which are thought to have a role in the
maintenance of epithelial integrity by destroying altered epithelial cells (Rocha et al.
1992). Experiments using (52m knockout mice have shown that in the absence of
(52m, CD8+ y8 IEL developed normally in contrast to CD8+ a(5 IEL which showed
minimal development (Fujiura et al. 1996). Further, CD8aa and CD8a(5 a(5 IEL
were dependant on MHC molecules for development whereas CD8aa y5 IEL were
not.
1A.4 T Cell Subsets
As described in the previous section, T cells function to recognise antigen in the
context of self-MHC molecules. The T cell interacts with MFIC molecules via the T
cell receptor which consists of either a and (5 subunits (a[5 T cells) or y and 5
subunits (y8 T cells). The T cell receptor (TCR) can be considered as a 'multiprotein
signalling machine' (reviewed in Janeway, 1992). The components of this 'machine'
include the coreceptors CD4 and CD8 each of which associate with a tyrosine kinase
(p56lck) and CD45 (a transmembrane tyrosine phosphatase). These molecules
combine to generate optimal signals following T cell antigen recognition. In addition
to recognition by the TCR of MHC plus peptide, co-stimulatory signals are also
required in most cases to initiate T cell responses. These co-stimulatory signals arise
from the interaction of members of the CD28 family on T cells with members of the
B7 family on the APC (Reviewed in June et al. 1994).
1A.4.1 Structure of the TCR
The basic structure of the a(5 TCR was originally established by Saito and colleagues
(1984) following analysis of cDNA sequences. The receptor is made up of an a and
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(3 chain each with two extracellular Ig like domains, an amino terminal variable and
carboxy terminal constant domain. X-ray crystallography of the (3 chain shows
structural homology to immunoglobulins (Bentley et al. 1995). Functional TCR
genes arise following rearrangement of V and J segments in a and y chains and V, D
and J segments in |3 and 5 chains. As is the case for immunoglobulin genes, diversity
in the receptor arises as a result of the combination of multiple germ line segments,
combinatorial joining, junctional flexibility, N-region nucleotide addition and
somatic mutation (Davis and Bjorkman, 1988). Although the y and 5 genes contain
fewer germ line gene segments than a and [3 genes, the actual potential diversity of
the y8 receptor is greater than the a(3 receptor as a result of alternative joining of D
gene segments.
The proposed site of antigen contact within this receptor is the V-(D)-J junctional
region of the TCR which corresponds to the CDR3 region of Ig molecules with the
CDR1 and CDR2 regions contacting the a helices of the MHC (Hedrick et al. 1988;
Davis and Bjorkman, 1988).
A.4.2 y8 T cells
Several reports have demonstrated the ability of yS Tcells to restrict non-classical
class I and CD1 responses (see below). Due to the interest and speculation regarding
the possible involvement of y8 T cells with the CD1 family, this subset will be
discussed in more detail.
Man and mouse
Marked interspecies variations in the numbers, localization and repertoire of these
cells exists. In general, y8 T cells have preferential localization in epithelial tissues.
In mice, there are several populations of y8 T cells associated with epithelial sites. In
the skin, there is a population of Thyl+ dendritic epidermal cells (dEC) which are
CD47CD8" negative and express an essentially monomorphic y8 TCR (Allison and
Havran, 1991). Intestinal intraepithelial y8 T cells differ in that they express CD8 and
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as a result of considerable junctional diversity have a potentially large antigenic
repertoire. Human epithelial tissues also possess y8 T cells however they are present
in much lower numbers than in the mouse. The presence of y8 populations with
invariant TCRs would be consistent with recognition of invariant antigens. Indeed
both mouse and human y8 T cells reactive to heat-shock proteins (HSPs) have been
demonstrated (O'Brien et al. 1989, Holoshitz et al. 1989, Born et al. 1990). The HSPs
are among the most phylogenetically conserved proteins - antigens from a variety of
bacteria (notably mycobacteria) and parasites have been identified as members of
stress protein families. The mycobacterial stress proteins are among the
immunodominant targets of both cell mediated and humoral response (Young et al.
1988).
Athough they serve vital roles in the cell in the absence of stress, induction of
heat-shock/stress proteins occurs in response to a number of insults (Kauffman,
1990). Recognition by y8 T cells of these conserved antigens provides a mechanism
for removal of stressed or damaged autologous cells (Young, 1990).
Ruminants
y8 T cells exist in much larger numbers in ruminants than in man and mouse. Greater
than 50% of circulating PBMCs can be of the y8 phenotype in young ruminants
although this percentage decreases with age (Hein and Mackay, 1991). The marked
difference in numbers of y8 T cells between certain species has lead to the
description of y8 'high' (e.g. ruminants, chickens) and y8 'low' species (e.g. man and
mouse) and subsequent suggestion of possible functional redundancy within the yS
low species (Hein and Dudler, 1993). In addition, double negative ruminant y8 T
cells express a surface molecule called T19 which is a 215kd cell surface molecule
(Mackay et al. 1989, 1991). In cattle, the equivalent family is WC1 and has been
characterised at the molecular level (Wijngaard et al. 1994). These molecules consist
of extracellular repeating domains which exhibit strong homology to the macrophage
scavenger receptor cysteine rich domain. Recent data has provided evidence for at
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least 50 T19 genes in the sheep (Walker et al. 1994).The function of the T19/WC1
families are unknown at present although one possibility is that the molecule
represents a functional homologue of the CD4/CD8 accessory molecules (Walker et
al. 1994). Hanby-Flarida and colleagues (1996) utilise a mAb specific for WC1 to
show that this receptor is involved in activation of y8 T cells by an undefined
pathway.
Other significant features of ruminant y8 T cells are the lack of expression of CD2
and CD6 and the greater degree of receptor complexity which exists. In sheep,
analysis of y and 5 chain constant regions has shown that although the 8 chain is well
conserved between species, the hinge region of the ovine y chains differs from other
TCR chains (Hein et al. 1990). In particular, they possess a longer extracellular C
region domain than any other TCR chain and there are five cysteine residues in the
extracellular C region. The consequences of this are purely speculative at present.
However, it is tempting to speculate that there may be a link between these findings
and the increased numbers of yS T cells in this species.
y8 T cell function
The y8 T cell population remains a much studied yet poorly understood cell subset
from a functional point of view. It is apparent that it recognises antigen in a manner
which differs from the a(3 T cell population as although some MHC class I or class II
restricted clones have been identified (Kozbor et al. 1989; Flament et al. 1994), this
would appear to be uncommon. Similarly, y8 T cell lines recognising non classical
class I molecules (Bonneville et al. 1989, Vidovic et al. 1989) and CD1 (Brenner et
al. 1986; Faure et al. 1990) have been described. y8 recognition of CD1 will be
discussed in more detail in Section B.
Schild and colleagues (1994) use two y8 T cell hybridomas specific for MHC
molecules to show that antigen recognition by these cells differs fundamentally from
antigen recognition by a(3 T cells. Neither of the two clones used required a
functional antigen presenting pathway in the stimulator cells and alterations in
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residues predicted to be important for aP T cell recognition did not affect the
specificity of binding.
Rock and colleagues (1994) analysed the lengths of the CDR3 regions of aP and y8
TCRs and showed that y8 T cells are more similar to immunoglobulins than to aP T
cells. This implies a role for the y8 T cell as a mediator of cellular immunity without
the need for APCs.
Interestingly, and in support of these data is the demonstration by Sciammas and
colleagues (1994) that a y5 T cell clone (Tgl4.4) recognises a transmembrane
glycoprotein in a non MHC restricted manner. A soluble recombinant form of the
antigen recognised by the clone was used to show that Tgl4.4 was capable of
recognising unprocessed glycoprotein in the absence of APCs. Consistent with this,
Weintraub and colleagues (1994) showed that the y8 T cell G8, is stimulated by the
non-classical class I molecule T22 in the absence of peptides. Further evidence for
the redundancy of the TAP transporter system in y8 T cell responses was
demonstrated by Moriwaki and colleagues (1993) who showed that the KN6 y8 T
cell clone can be activated by both the TAP2-deficient cell line (RMA-S) and
splenocytes from TAP1 mutant mice.
Further information on the role of y8 T cells has been obtained by utilising y8 TCR
deficient mice (TCRS"7"). Several studies utilizing these mice have indicated a role for
y8 T cells in the immune response to intracellular bacteria and parasites (Tsuji et al.
1994, Mombaerts et al. 1993). Interestingly, a recent report has demonstrated
impaired IgA responses in these mice suggesting a specialized role for y8 T cells in
mucosal immunity (Fujihashi et al. 1996)
Recently it has been shown that y8 T cells can be stimulated by thymidine containing
nucleotide conjugates (Constant et al. 1994) and also by phosphate modified sugars
(Schoel et al. 1994). Tanaka and colleagues (1995) demonstrated stimulation by
isopentenyl pyrophosphate. Morita and colleagues (1995) demonstrated that prenyl
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pyrophosphate antigens are presented to yS T cells through an extracellular pathway
not dependent on classical or non-classical MHC molecules or on antigen uptake and
processing. Thus, it is now becoming apparent that y8 T cells may represent a subset
of T cells which are functionally distinct from a(3 T cells and exist to increase the
hosts ability to deal with foreign agents by increasing the range of substrates that can
be recognised and subsequently induce an immune response.
1A.4.3 Other T cell subsets
Two further T cell subsets will be discussed due to their potential significance with
regard to CD1 function. These are double negative (DN) T cells and NK1+ T cells.
Double negative T cells
Double negative T cells represent a minor population of T cells which express
neither the CD4 nor CD8 co-receptor. The majority of DN T cells are y8+ with a
small percentage of a[l'. The origin, differentiation and selection of TCR repertoires
of DN T cells is controversial, however it is generally agreed that these cells are not
progenitors of double positive immature thymocytes (Crispe et al. 1987) and that
upon activation can acquire cytolytic or cytokine producing ability (Ballis and
Rasmussen, 1990; Zlotnik et al. 1992). This subset of T cells has received particular
attention as DN cells have been postulated as being potentially autoreactive due to an
association with autoimmune disease e.g. SLE (Shivakumar et al. 1989). DN T cell
lines have also been shown to recognise CD la, CD lb and CDlc (Porcelli et al. 1989,
1992, Faure et al. 1990). The nature of this CD1 restriction is described in more
detail in section B.l .3.
NK1.1+ T cells
NK1.1+ T cells are a subset of T cells so named because of expression of NK1.1
which is a member of the NKR-P1 family normally associated with NK cells. The
NK1.1+ T cells have a distinct phenotype characterized by an activation/ memory
phenotype (CD44hlgh, CD45RBlow, CD62L|0W), expression of the IL-2R[3 chain
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(CD122) and are usually either CD4+ or CD4CD8" (MacDonald, 1995). Notably,
they also express a variety ofNK cell markers including CD 16, Ly-49A and Ly-49C.
Other significant features of this subset include the expression of a lower TCR
density and the use of restricted TCR repertoires. In the mouse, this is manifest by
the use of Val4Ja281 paired with VP8, V(37 or V(32 (Lantz and Bendelac, 1994;
Ohteki and MacDonald, 1996). A human counterpart of this murine subset exists
consisting of the invariant Va24JaQ paired with V(3ll (Dellabona et al. 1994)
although there has been no demonstration to date of human NK1.1+ T cells.
These cells have been shown to recognise an unconventional ligand as they develop
normally in TAP deficient mice (Adachi et al. 1995). However, their requirement for
P2-microglobulin implicates non-classical class I or CD1 molecules as potential
candidates for their ligand (see Section IB.3.5).
A key functional feature of this subset is the capacity to produce large amounts of the
cytokine interleukin-4 (Yoshimoto and Paul, 1994) which suggests an involvement
in Thl/Th2 lineage commitment. Further studies using (32m_/" mice have shown that
these mice produce minimal or no IL-4 whereas a(3_/", CD8 CD4"7" mice produced
IL-4 (Yoshimoto et al, 1995b). In addition, by using goat anti-mouse IgD to
stimulate IgE production, Yoshimoto and colleagues (1995a) showed that
CD4+NK1.1+ T cells are essential for switching to IgE. Due to this potential for
regulating the immune response and the dissimilarity of this cell population to either
CD4 helper or CD8 cytotoxic T cells, it has been suggested that these cells may
represent a third class of T cell - 'T regulator cells' (Vicari and Zlotnik, 1996). The
role of CD1 as a ligand for this subset of T cells and resulting functional significance
is discussed in Section IB.3.5.
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SECTION B
1B.1 Non-Classical Class I And MHC Related Molecules
In addition to the class I molecules described in Section A, there exists a number of
genes which also map to the MHC but do not share the typical polymorphism and
wide tissue distribution that is associated with classical class I molecules. These
genes are termed non-classical class I (NCCI) genes and are of interest in that the
CD1 genes, although not mapping to the MHC also share these features of limited
polymorphism and restricted tissue distribution. In addition, many NCCI molecules
possess truncated carboxy-termini which may result either in secretory isoforms or an
unusual method of insertion into the plasma membrane (Stroynowski, 1995).
The demonstration of lack of polymorphism by NCCI molecules has inevitably led to
much speculation about their role. Indeed, the lack of polymorphism which is
considered characteristic of this group of molecules has been cited as evidence that
these molecules are non-functional (Klein et al. 1991). However, the more popular,
and currently more accepted view, is that the lack of polymorphism is a key to the
distinct role of these molecules rather than an indicator of functional redundancy.
NCCI molecules have been best characterized in man and mice although they have
been described in many species (Shawar et al. 1994). A canine NCCI molecule
(DLA-79) has recently been described by Burnett and Gerahty (1995).
1B.1.1 Human non-classical class I molecules
In man, the non-classical class I loci are HLA-E, HLA-F, HLA-G and the recently
described MICA (HLA-X ) and MICB (Bahram et al. 1994; Bahram and Spies.
1996). The best studied of these molecules is HLA-G.
HLA-G
HLA-G is present on villous trophoblasts (Kovats, 1990), in foetal eye tissue
(Shukla et al. 1990) and foetal liver. HLA-G mRNA has also been demonstrated in
PBLs and skin (Kirszenbaum et al. 1994; Ulbrecht et al. 1994) and more recently in
normal and transformed mononuclear phagocytes (Yang et al. 1996).
Expression of HLA-G in the placental trophoblast has intriguing implications for
immune regulation between mother and foetus. The trophoblast cells are interspersed
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between maternal and embryonic cells throughout pregnancy and in situ
hybridization has shown HLA-G transcripts to be prominent in first trimester
placentas (Yelavarthi et al. 1991). Assuming some role for HLA-G as an antigen
presenting molecule, it is generally considered that the presence of such a
non-polymorphic member of the MHC family in such a 'critical' position allows a
means whereby MHC restricted rejection of the foetal tissue would not occur. The
fact that HLA-G has been shown to bind to CD8 is consistent with the ability of
trophoblast cells to modulate T cell function (Sanders et al. 1991). The population of
NK cells which are found in this area may also be functionally regulated by HLA-G.
In support of this theory, HLA-G has been shown to protect transfected NK targets
from lysis in a similar fashion to classical MHC class I molecules (Chumbley et al.
1994).
In addition to the membrane bound form, soluble HLA-G is also present and is
generated by alternative splicing which results in termination of the open reading
frame 21 amino acids after the a3 domain (Ishitani et al. 1992; Fuji et al. 1994).
Other alternatively spliced forms of HLA-G have also been demonstrated which lack
either the al domain or the al and a2 domain (Ishitani et al. 1992). Although
traditionally considered as relatively non-polymorphic, a recent paper by Van der
Ven and Ober (1994), demonstrates the presence of extensive nucleotide variability
in the a2 domain of HLA-G in African Americans. However, as described above,
alternatively spliced forms of HLA-G exist which do not contain these polymorphic
regions so this paper is still consistent with a role for HLA-G as an immunologically
'neutral' molecule at the maternal/foetal interface.
Relevant to this is the work of Lee and colleagues (1995) which defines a unique
peptide binding motif for HLA-G with a diversity significantly lower than classical
class I molecules. In addition they demonstrate that the soluble form of HLA-G
described above does not associate with TAP in the same manner as membrane
bound HLA-G.
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It is of interest that a primate, the cotton-top tamarin (Sanguinus Oedipus) has
expressed class I genes which are most closely related to HLA-G and is highly
susceptible to viral pathogens (Watkins et al. 1990).
The other human NCCI molecules i.e. HLA-E, HLA-F and MICA/ MICB have been
less well studied. HLA-E has been shown to be highly transcribed in most tissues
(Koller et al. 1988) however cell surface expression is variable (Shimizu et al. 1988,
Srivastava et al. 1987). This is thought to be a result of defective binding of available
endogenous peptides (Ulbrecht et al. 1992). A role for HLA-E is purely speculative
at present, however it has been suggested that since HLA-E accumulates in the
endoplasmic reticulum it may influence peptide binding by classical class I
molecules or modulate peptide loading (Ulbrecht et al. 1992). HLA-F is the least well
studied of the human NCCI molecules, however transcripts have been demonstrated
in a number of tissues (Gerahty et al. 1990) including resting T cells and skin cells.
More recently, transcripts have also been demonstrated in foetal liver (Houlihan et al.
1992). This implies that HLA-F may be involved in haematopoiesis or foetal
development (Shawar et al. 1994).
The novel MHC class I genes MICA and MICB genes have recently been identified
by Bahram and colleagues (1994) and Bahram and Spies (1996) and although sharing
some features of NCCI genes including erratic tissue expression, conservation of
certain amino-acids and divergence from known MHC class I genes, these genes
exhibit polymorphism and evolutionary studies indicate that the MIC genes are a
second lineage of evolutionarily conserved MHC class I genes (Bahram et al. 1994).
The function of the molecules encoded by these genes is currently unknown.
1B.1.2 Murine non-classical class I molecules
The majority of the murine class I genes are located in the Q, T and M regions.
Products of the H-2T and H-2Q loci have been shown, under some circumstances, to
restrict T cell responses whereas one product of the H-2M locus, H-2M3 has been
shown to present peptides with an N-formyl methionine.
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H-2T
The best studied members of the T locus are the thymus leukaemia antigen (TL) and
Qa-1 antigens.
The TL antigens were originally identified on leukaemic T cells (Old et al. 1963) and
are also found on cortical thymocytes and Langerhans cells (Stroynowski, 1990). The
TL antigen is predicted to fold into an antigen presenting structure and recently
peptide has been shown to bind to TL (Sharma et al. 1996). Using transgenic mice
which expressed the H-2T18d on virtually all nucleated cells, Sharma and colleagues
showed that TL antigens can bind peptides with blocked NH2 termini implying that
peptides have been selected from a novel degradative pathway. Another notable
feature observed using this model was the presence of increased numbers of CD4+ T
cells displaying an altered T cell repertoire implying that TL has an influence on T
cell differentiation. These studies suggest that TL may have adopted a functional
niche in a similar fashion to H-2M3 whereby a distinct set of peptides can be bound
and presented.
Qa-1 antigens are encoded by the T-23 gene. There have been several reports of
H-2T region encoded antigens restricting T cell responses (Vidovic et al. 1989,
Bonneville et al. 1989, Ito et al. 1990, Weitraub et al. 1994). In each of these cases,
the responding T cells were y8 T cells and in the case of the G8 y5 line (Weintraub et
al. 1994) the restriction by T22 was shown to be peptide independent.
Fragments of M.bovis heat shock protein 65 (FISP65) can stabilize Qa-1 surface
expression implying that either heat shock induces chaperones which promote the
expression of Qa-1 or that peptides derived from degraded HSPs could bind within
the binding site and thus facilitate surface expression (Imani and Soloski, 1991).
Analysis of the putative peptide binding groove of Qa-1 shows replacement of
threonine at positions 143 and 147 with serine which has the effect of opening up the
peptide binding groove at the carboxyl end (Connoly et al. 1993). The same
threonine residues are found in some other NCCI molecules (human and primate).
Although the peptide binding groove of Qa-1 is similar to most other class I
molecules, there is a requirement by some Qa-1 for the product of the Qa-1
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determinant modifier (Qdm) gene (Aldrich et al. 1988). The Qdm peptide has
recently been identified (Aldrich et al. 1994) and it is possible that despite the
apparent capability to bind a range of peptides, preferential chaperoning of certain
peptides exists. A further notable feature of Qa-1 molecules is their ability to form
heterodimers with other class I molecules (Wolf and Cook, 1995). It is postulated
that the formation of such heterodimers may allow cell surface expression of class I
molecules which are unstable (either due to weak (32m association or lack of peptide)
such that they are capable of interaction with exogenous peptide or effector
molecules on other cells (Wolf and Cook, 1995; Soloski et al. 1995).
H-2Q
H-2Q region genes encode both cell surface and secreted molecules (Robinson,
1987). The best studied Q region molecules are the Qa-2 antigens which are encoded
by the Q7 and Q9 genes. Qa-2 antigens exist in both soluble and membrane bound
forms as a result of premature stop codons in exon 5 (corresponding to the TM
domain of classical class I molecules). This results in both the production of soluble
Qa-2 and Qa-2 antigens that are attached to cell surfaces via
glycosylphosphatidylinositol (GPI) lipid anchor. GPI-anchored Qa-2 can undergo
post-translational cleavage also resulting in the generation of a soluble form of the
molecule (Tabaczewski et al. 1994). The potential role of such GPI anchored Qa-2
molecules is speculative however it is known that GPI linked class I proteins can
move across domain boundaries defined on the surface of cells (Edidin and
Stroynowski, 1991) and it is also proposed that GPI-anchoring targets Qa-2
molecules to specialized endocytic vesicles (caviolae) which function in
internalization of membrane attached proteins. Qa-2 has also been shown to be
defective in CD8 binding, a feature which has been attributed to differences in the a3
region (Teitell et al. 1993).
Analysis of peptides which are capable of binding to Qa-2 has revealed conflicting
results. Rotzschke and colleagues (1993) described the Qa-2 molecule as one with a
high stringency due to binding of a limited range of peptides. In contrast, however,
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Joyce and colleagues (1994) utilizing different techniques, demonstrated that indeed
Qa-2 molecules can bind 'a large array' of different peptides. This challenges the
popular view that the limited polymorphism of non-classical class I molecules has
been maintained such that these molecules can bind and present relatively invariant
antigens.
H-2M3
H-2M3 (initially known as Hmt) is a product of the H-2M locus. This NCCI
molecule has been shown to present N-formylated peptides to CTLs - a feature which
was originally demonstrated by examination of the maternally transmitted antigen
(Mta) which consists of H-2M3, (32m and Mtf peptides, the latter being the product
ofmitochondrial Mtf genes (ND1) (Shawer et al. 1990). Subsequently, these findings
were extended to show that N-formylated peptides of pathogens can also be
presented by H-2M3. Since bacterial protein synthesis is initiated with an N-formyl
methionine (as is mitochondrial protein synthesis), this provides a means whereby
H-2M3 can present bacterial peptides to CTLs as has been shown for Listeria
monocytogenes (Kurlander et al. 1992, Pamer et al. 1992) thus exploiting an inherent
difference between microbial and mammalian antigens. More recently it has been
shown that in addition to N-formylated peptides, H-2M3 can also present a minor
histocompatibility antigen encoded by the COI mitochondrial gene (Morse et al.
1996).
The rat also expresses an M3 homologue - RT1.M3 (Wang et al. 1995). X-ray
crystallography of this molecule bound to a nonamer of rat ND1 reveals that
although the overall structure of M3 is similar to classical class I molecules, a novel
method of peptide binding exists whereby the N-formylated peptides are positioned
such that the peptide is moved one residue along the groove and the N-terminal
pocket is closed (Wang et al. 1995).
H-2M3 thus demonstrates a function which provides an explanation for limited
polymorphism indicating that the H-2M locus has specifically evolved and been
retained to recognise invariant 'non-self antigens.
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IB.1.3 The neonatal receptor for Ig - FcRn
The neonatal receptor for IgG, FcRn, is responsible for unidirectional transport of
immunoglobulin from the intestinal lumen, across enterocytes and into the blood
stream. This occurs due to binding of IgG at the acidic pH of the gut (pH 6.0)
followed by receptor mediated endocytosis and subsequent release of the IgG at the
higher pH of the blood (pH 7.4). FcRn was initially isolated and purified from
neonatal rat intestinal epithelium (Jakoi et al. 1985). This was followed by cloning
and sequencing of the molecule by Simister and Mostov (1989).
Sequence and structural analysis revealed that FcRn was homologous to MHC class I
molecules albeit that it is more divergent from classical class I molecules than the
non-classical class I molecules whilst being more closely related than CD1
molecules. Subsequent studies using mouse intestinal cDNA libraries revealed the
existence of a similar molecule in this species (Ahouse et al. 1993). FcRn has also
been shown to be functionally expressed on the surface of adult rat hepatocytes
(Blumberg et al. 1995) where it is thought to function in the transport of IgG either
from the blood to bile or by providing a mechanism for the transcytosis of IgG from
the apical to the basolateral surface of the hepatocyte. This expression of FcRn in the
liver and other extraintestinal tissues (lung, spleen and endothelial cells) together
with pharmacokinetic studies of IgG,/Fc fragments in (32m" " mice (Ghetie et al. 1996)
implies that FcRn may also be involved in the maintenance of serum IgG levels.
Story and colleagues (1994) isolated the human homologue of this receptor (hFcRn)
utilising an a2 domain probe based on the structure of the rat FcRn. The implication
therefore is that hFcRn is involved in IgG transport across the placental barrier.
Recent analysis of the crystal structure of the rat FcRn (Burmeister et al. 1994) has
intriguing implications for the study of CD1. Previously, the relationship between
these two molecules was solely as MHC related molecules. However, a key amino
acid residue, (Pro 162), responsible for closure of the peptide binding groove in FcRn
such that it cannot bind peptide is shared with all CD1 molecules. In addition,
sequence identity between CD1 and FcRn is highest in the a2 domain implying
possible structural similarity within this region.
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The genomic structure of a mouse FcRn gene has recently been described (Kandil et
al. 1995) which reveals an exon-intron organisation similar to that of MHC class I
genes. Two notable differences however are that the 5'UT region of the FcRn gene is
split into two exons and that the majority of the cytoplasmic region and the entire
3'UT are encoded by a single exon. This is also a feature of the CD1 genes (also
MICA and H2-T18) although Kandil and colleagues (1995) suggest that as these
genes do not form a phylogenetic cluster, this similarity was probably acquired
independently.
1B.1.4 Mechanisms of antigen presentation by NCCI molecules
As discussed in the individual sections, there is variability in the dependence of the
NCCI molecules on a functional TAP transporter system to generate an antigenic
epitope. Several groups have demonstrated that the murine TL antigen is expressed
independently of TAP function (Moriwaki et al. 1993; Holcombe et al. 1995;
Rodgers et al. 1995) and, in addition, that TL is thermostable at physiological
temperatures in the absence of peptide implying that binding of specific peptides is
not required for transport and stable expression at the cell membrane (Holcombe et
al. 1995). As discussed earlier, there is also recent data to show that TL binds
peptides with blocked NH2 termini (Sharma et al. 1996). However, despite these
marked variations when compared to classical MHC class I function, TL antigens can
nevertheless mediate a transplantation rejection response and TL specific CTLs can
be elicited (Morita et al. 1994; Sharma et al. 1996).
In contrast however, the Qa-2 antigen has been shown to be dependent on the TAP
system (Tabaczewski et al. 1994; Stroynowski,1995) and this fact taken in
conjunction with its wider tissue distribution and potential to bind a diverse array of
peptides (Joyce et al. 1994) indicates a closer similarity to classical class I molecules.
Different again, is the M3 molecule which, as described above binds a limited array
ofN-formylated peptides. Thus, although generally considered as a group, the NCCI
molecules exhibit characteristics ranging from 'class I-like' in terms of processing
and peptide specificity e.g. Qa-1, to H-2M3 which although resembling class I in
terms of processing and presentation is highly restricted in terms of peptides which
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will bind to the TL antigens which appear to possess an alternative antigen
processing pathway possibly selecting peptides from a novel degradative pathway
(Holcombe et al. 1995, Sharma et al. 1996).
Hence when considering possible relevant similarities between the NCCI molecules
and the CD1 family, it may be more prudent to consider the NCCI molecules not as a
relatively homogeneous family but as a family consisting of many functionally
divergent members, some of which may have relevant similarities or may provide
clues to the function of the CD1 family.
1B.2 The CD1 Family
The CD1 family is a family of molecules with structural homology to MHC class I
and low but significant sequence homology to both MHC class I and MHC class II.
Members of the CD1 family have been demonstrated in a number of species and it is
clear that marked interspecies variation exists in terms of both the numbers of CD1
genes present and the isotypes ofCD1 which these genes encode.
CD1 genes and molecules will now be discussed in more detail both in general terms
and with interspecies comparisons.
1B.2.1 CD1 genes
CD1 genes have been identified in man, mice, rats, rabbits and sheep. All the CD1
genes possess separate exons which encode the six functional domains of the
molecule. The exon arrangement is shown below and consists of 5' untranslated and
leader; external al, a2 and a3 domains; transmembrane and proximal cytoplasmic
tail and the remainder of the cytoplasmic tail and 3' untranslated region (Martin et al.
1987; Calabi et al. 1989b, 1989c). The highest sequence homology exists within the
a3 domain - in this domain, there is at least 75% identity between all CD1
sequences. The exon structure of the CD1 genes strongly resembles that of MHC
class I and is one of the the most significant similarities between the two families.
However, the genes encoding the cytoplasmic/ 3' untranslated domains of CD1 and
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MHC class I differ in that three exons encode this region in MHC class I compared to
only one exon in CD1 (Calabi et al. 1991).
5'UT/L al a2 a3 TM/C C/3'UT
Exon 1 Exon 2 Exon 3 Exon 4 Exon 5 Exon 6
A key feature of the CD1 genes is a lack of significant polymorphism. This is in
marked contrast to the extensive polymorphism which is associated with MHC class
I genes. In humans, sequencing of CD1 clones from different individuals has
revealed only single amino acid changes (Martin et al. 1987; Aruffo and Seed, 1989)
and a similar situation has been reported in the mouse (Bradbury et al. 1988). In the
rat, only three allelic variations were found within the 12 rat strains tested (Ichimaya
et al. 1994).
Relationship of CD1 to the MHC
The pattern of exon arrangement illustrated above is similar to MHC class I genes
with the exception of additional exons encoding the longer cytoplasmic tails ofMHC
class I molecules. Although the a3 regions of both CD land MHC class I molecules
are highly conserved, there is no significant homology at the nucleotide level
between the two domains (Martin et al. 1986). Comparisons between the CD1 a3
domain and MHC class I and class II molecules have shown that the CD1 a3 domain
is related to both MHC class I a chains and MHC class II (3 chains (Calabi and
Milstein, 1986; Martin et al. 1986). By analysing consensus sequences for CD1 a-d,
Balk and colleagues (1989) showed that the CD1 a3 region is more homologous to
the MHC class II [32 domain than the MHC class I a3 domain. Therefore it is
apparent that the CD1 genes should be considered as being equally related to both
class I and class II MHC genes.
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Interspecies comparison of CD1 genes
Interspecies comparisons of the CD1 genes are interesting as this provides clues to
the evolution of the CD1 family. An interesting feature of the CD1 genes is that
homology is greater between the same isotype in different species than between
different isotypes in the same species (Calabi et al. 1991). This implies that the
different CD1 isotypes evolved structural features relative to conserved functions
prior to the radiation of mammalian species (Porcelli, 1995).
1B.2.1.1 Humans
In humans, five CD1 genes have been described (CD1A-E) which encode four
protein products (CDla-d). No product of the CD IE gene has yet been described.
CD1 genes in other species are generally classified according to their homology to
the human genes.
Sequence comparisons of the CD1 genes in the al and a2 domains allow division
into two main groups with CD1 A-C forming one group and CD ID forming the
second. The CD IE gene is in an intermediate position (Calabi et al. 1989c).
Comparison of sequences at the 3' end however reveals an alternative grouping
dividing the CD1 molecules into 3 distinct types (Porcelli, 1995). CDle has a
cytoplasmic tail significantly longer than the other CD1 isotypes (Calabi et al. 1991).
CDlb,-c and -d possess a 7 amino acid cytoplasmic tail containing a YXXZ motif
(where Z is a hydrophobic residue) which is associated with sequences which target
to an endosomal compartment in other proteins e.g. CD3 chains (Letourneur and
Klausner, 1992). It has recently been shown that CD lb does indeed localize to an
endocytic compartment and that this localization is dependent upon the
tyrosine-based motif in the cytoplasmic tail (Sugita et al. 1996).
CD la in contrast, has a shorter tail (3 amino acids following the membrane anchor
sequence) and contains two cytoplasmic cysteine residues which may be involved in
disulphide-linked interactions with other proteins (Porcelli, 1995). In addition, the
arrangement of the cysteine residues generates a similar motif to that ofCD8a which
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interacts with p56lck (Turner et al.1990). It is interesting to speculate that this may
indicate a functional difference between CD la and the remaining CD1 isotypes.
1B.2.1.2 Rodents
In the mouse, two CD1 genes exist - CD1D.1 (mCDl.l) and CD ID.2 (mCD1.2)
which show greater than 95% identity in their coding regions. The presence of 2
such closely related genes may imply evolutionary pressure to maintain this locus
(Bix and Locksley, 1995). These genes have closest homology to human CD ID.
Recent studies in the rat have revealed a similar situation i.e. the existence of
members of the CD ID group only (Ichimiya et al. 1994).
1B.2.1.3 Rabbits
The CD1 family in rabbits is interesting as this species has members of both groups
of CD1 genes i.e. CD IB-like and CD ID-like. Probing genomic libraries from
cotton-tail and domestic rabbit with a human CD1 probe yielded a clone from the
domestic rabbit which was CD IB-like and a clone from the cotton-tail rabbit which
was CD ID-like (Calabi et al. 1989b). Southern blot analysis of domestic rabbit DNA
has identified the presence of up to eight genes in this species, only one ofwhich is a
member of the CD ID group based on hybridization with a probe from the cotton-tail
rabbit (Calabi et al. 1989b).
1B.2.1.4 Ruminants
In ruminants, the majority of studies on the CD1 family have been at the protein level
(Section IB.2.2.3). Recent molecular studies in the sheep have however shown the
presence of up to seven CD1 genes in this species (Ferguson et al. 1996). Four genes
have been cloned and sequenced and all four clones possess closest homology to
human CD IB (Ferguson et al. 1996). The nature of these clones is illustrated below.
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Identification and cloning of ovine CD1
The sheep CD1 sequence SCD1A25 was identified by screening a sheep foetal
thymocyte library with a human CD1C probe (a3 domain and flanking intron
sequence). A sheep CD1 probe was subsequently generated by PCR amplification of
the a3, transmembrane and cytoplasmic domains. This probe was used to screen both
the foetal thymocyte library and a lamb thymocyte library and resulted in the
identification of the clones SCD1B-42, SCD1B-52 and SCD1T10. Further molecular
techniques were used to establish full length sequence for SCD1A25 and SCD1B-42.
SCD1T10 is a truncated CD1 sequence which begins 26 bp upstream of the start of
the a2 domain. The 3'UT region of SCD1T10 is notably longer than the other sheep
genes i.e. 642 bp and lacks a consensus polyadenylation signal and a polyA tail. The
SCD1B-52 clone contains a precise deletion of the oc3 domain. The nucleotide
identity between equivalent exons in SCD1B-42 and SCD1B-52 is >93%. Of
particular note also is the fact that the two sequences are 96% identical in the 3'UT
region. These two observations combine to suggest that SCD1B-42 and SCD1B-52
are alleles.
The information presented in the above section implies that the CD1 genes originated
prior to the radiation of mammalian species since members of the same families of
CD1 genes are found in both man and rabbit. Further, Calabi and colleagues (1989b)
27
conclude that the slow rate of evolution of these genes (as indicated by the
interspecies gene similarities) indicates that the absence of members of the CDla-c
family in the mouse is due to a deletion occurring after the mouse and rabbit/human
separation.
IB.2.2 CD1 molecules and tissue distribution of CD1
Initial studies on the CD1 family utilizing CD1 specific mAbs demonstrated the
unusual tissue distribution of the CD1 molecules on cortical thymocytes (McMichael
et al. 1979, Rienhertz et al. 1980). The anti-CD 1 mAbs were subsequently used to
study biochemical properties of the CD1 molecules. Immunoprecipitation
demonstrated that the CD1 a chain was associated with [32m implying structural
relationship to MHC class I molecules (Cotner et al. 1981). mAb studies on the CD1
molecules will be discussed in more detail in the following species specific sections.
CD1 molecules consist of a 43-49kd a chain non-covalently associated with
[32-microglobulin ((32m). As with MHC class I molecules, the extracellular al, a2
and a3 domains are each 90 amino acids long and contain variable numbers of
N-linked glycosylation sites (depending on isotype). As a result, the a chain varies in
size according to isotype (see table below).
ISOTYPES (MAN) RAT MOUSE RABBIT SHEEP/
CATTLE
CD la (49kd)
CD lb (46kd) + +
CDlc (43kd) ?
CD Id (49kd) + (55kd) +(50kd) +
Althought the exon arrangement and association with [32m suggests that CD1
molecules are similar to MHC class I molecules, analysis of the nucleotide and
amino-acid sequences demonstrate that the two families are only distantly related
(Martin et al. 1986, Calabi et al. 1989c). The domain with greatest homology
between the two proteins is the a3 domain however a considerable degree of
28
divergence exists even in this domain. It appears particularly significant that identity
between all CD1 sequences in the a3 domains is much higher than between MHC
class I sequences (Calabi et al. 1991). In CD1, 55.6% of the 90 amino-acid residues
in the a3 domain are completely conserved which is in contrast to only 26.75% of
residues in MHC class I (Hughes, 1991). This suggests that there has been strong
evolutionary pressure to maintain the conserved nature of this domain implying an
important conserved function.
Structural analysis of the al and a2 domains suggests that CD1 does not possess a
structural homologue of either the MHC class I or class II peptide binding groove
(Calabi et al. 1989c). In addition, CD1 contains more hydrophobic regions in the al
and a2 domains than the MHC molecules. This is particularly pronounced in CD lb
and CDlc) and may be of significance when considering the potential of lipid
antigens to bind to CD1 and is discussed in more detail in Section IB.3.2.
1B.2.2.1 Expression of CD1 molecules in man
CDla-c
CD1 was the first differentiation antigen to be recognised by a mAb when in 1979
McMichael and colleagues described the recognition of the majority of human
thymocytes but not peripheral cells by the monoclonal antibody NA1/34. This
antibody was subsequently shown to recognise the CD la molecule (Initially named
HTA1 or T6). The mAbs 4A76 and M241 were subsequently shown to recognise
CD lb and CDlc respectively.
Initially, mAbs recognising these thymocyte antigens were considered to be
homologues ofmurine TL antigens (see Section IB. 1.2 ). Subsequently however they
were shown to have a lower molecular weight (Van de Rijn et al. 1983) and not to
map to the MHC (Calabi and Milstein, 1986).
CD la is expressed on cortical thymocytes and dendritic cells. In addition, this
molecule is also present on epidermal Langerhans' cells whereas CD lb is only
expressed on cortical thymocytes and dendritic cells.
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CDlc in addition to being expressed on cortical thymocytes, dendritic cells and 10%
of Langerhans' cells is also expressed on a subset of B lymphocytes (Small et al.
1987).
CDld
The gene encoding the fourth CD1 molecule, CDld, was isolated from a human
thymocyte library before the CDld molecule itself was detected by mAbs (Balk et al.
1989). Subsequently, Bilsland and Milstein (1991) raised a specific antisera to the
CD ID gene product utilizing a CDld fusion protein to immunize mice. This
monoclonal antibody (NOR3.2) defined a 49kd molecule expressed on a cortical
thymocyte cell line. Blumberg and colleagues (1991) demonstrated CDld expression
on human B cells and intestinal epithelial cells utilizing an anti-murine CD1 mAb,
1H1.
A later study by Canchis and colleagues (1993) revealed a wider distribution of
CDld including many non-lymphoid tissues where expression was demonstrated on
epithelial cells, vascular smooth muscle cells and parenchymal cells.
Thus, consistent with the genetic analysis revealing the CD ID gene to be the most
divergent member of the CD1 family, CDld expression is similarly divergent when
compared to the other CD1 isotypes.
1B.2.2.2 CD1 molecules in rodents
The murine CD1 molecules, CDld.l and CDld.2 (mCDl.l and mCD1.2) are
expressed mainly on gastro-intestinal epithelium epithelium and hepatocytes. Within
the thymus, CD1 transcription is very low illustrated by the fact that it is not
detectable by Northern hybridization (Bleicher et al. 1990, Bradbury et al. 1988).
However, its presence is detectable by the sensitive S1 nuclease protection assay and
by ribonuclease mapping (Bradbury et al. 1990).
Murine CD1 is expressed at relatively high levels within the intestine, however there
have been differing reports on the localization of murine CDld within this tissue.
Bleicher and colleagues (1990) described expression on all epithelial cells within the
gut (by immunofluorescence) using the mAbs 3C11 and 1H1. In contrast, in situ
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hybridization experiments to detect mRNA in this region (Lacasse et al. 1992),
showed that only Paneth cells at the base of the crypts contain CD1 mRNA. Further
controversy over the exact location of mCDl expression in the gut has recently
arisen. Sydora and colleagues (1996) were unable to detect mCDl expression on
intestinal epithelial cells by flow cytometry (utilizing the mAb 3C11) however low
levels of expression were detected on intestinal intraepithelial lymphocytes.
In the rat, immunochemical techniques demonstrated CD1 on intestinal epithelial
cells and hepatocytes using the mAbs 1H1 and 3C11 (Burke et al. 1994). Using
molecular techniques however, rat CD ID shows several differences in expression
when compared to murine CD ID (Ichimaya et al. 1994). These include a quantitative
difference in the thymus in that CD1 mRNA can be detected by Northern
hybridization and that CD1 mRNA expression by intestinal epithelial cells is lower
than in other organs and is not detectable by Northern hybridization, only by the
more sensitive RT-PCR. In addition, high levels of expression were also detected in
non-lymphoid organs - liver, heart, kidney and lung.
1B.2.2.3 CD1 molecules in ruminants
The CD1 family in sheep and cattle has been characterized at the protein level using
a number of mAbs. In sheep, the mAbs recognise a 46kd molecule in association
with (32m which is most closely related to human CD lb in terms of expression
(Bujdoso et al. 1989; Hopkins and Dutia, 1991; Dutia and Hopkins, 1991). One mAb,
SBU-T6 (Mackay et al. 1985) recognises a molecule with a wider tissue distribution -
in addition to staining thymocytes and dendritic cells, expression has also been
shown on B cells and Langerhans' cells. As such, this mAb has been considered as a
CDlc or pan-CD 1 mAb (Dutia and Hopkins, 1991). In cattle, similar results have
been published with the majority of mAbs showing a CD lb like reactivity with the
exception of SBU-T6 (MacHugh et al. 1988; Parsons and MacHugh, 1991; Howard
et al. 1993b). The mAbs which show CD lb-like reactivity have been clustered as
BoCDlw2 and SBU-T6 as BoCDlwl (Howard and Naessens, 1993). More recently,
two additional mAbs (CC43 and CC118) have been described which recognise an a
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chain of 43kd in cattle. In addition to staining of thymocytes and dendritic cells,
these mAbs also stain B cells and monocytes. However staining of cells in Bos
taurus but not Bos indicus indicates recognition of a polymorphic antigen (Howard et
al. 1993a). These two mAbs have been clustered as BoCDlw3 (Howard and
Naessens, 1993).
CD1 antigens have also been described in goats (Davis and Ellis, 1991) and pigs
(Pescovitz et al. 1984, Denham et al. 1994). As in sheep and cattle, both these species
also possess an isotype of CD1 which exists on B cells as identified by SBU-T6 in
goats and 76-7-4 in pigs.
1B.2.3 Modulation of CD1 expression
CD1 expression has been shown to be modulated under the influence of cytokines
and also in certain neoplastic diseases. In general, CD1 expression appears to be
upregulated in inflammatory disease and in vitro under the influence of certain
inflammatory cytokines.
1B.2.3.1 CD1 modulation by cytokines
Although CD1 expression is not constitutive on human monocytes, expression of
CDla-c has been induced by stimulation with the cytokines GM-CSF and IL-4
(Porcelli et al.1992) and CDlc expression has been induced by GM-CSF alone
(Kasinrerk et al. 1993). Cytokines which induce MHC class I and class II expression
e.g. IFNy, do not however induce CD1 expression (Kasinrerk et al. 1993). This
GM-CSF/IL-4 induced CD1 expression can be suppressed by IL-10 (Thomssen et al.
1995). Taken together, this evidence for CD1 modulation both by pro-inflammatory
and anti-inflammatory cytokines again points to the CD1 molecule having an
important role within the immune system. The fact that some cytokines have
differential effects on CD1 and MHC class II expression (e.g. IFNy, IL-10) shows
that CD1 expression is not regulated in parallel with MHC class II molecules
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implying an alternative role for CD1 other than classical antigen presentation. This
also indicates that transcription factors for CD1 differ from those for MHC class II.
1B.2.3.2 CD1 modulation in disease
The expression of CD la on Langerhans' cells within the gingival epithelium has
been shown to increase under the influence of IL-1 (Walsh et al. 1986) and IL-6 and
TNFa (Ishii et al. 1990). Bruynzeel-Koomen and colleagues, (1988), report an
association between the expression of CD1 antigen and Fc receptor for IgE on
epidermal LC from patients with atopic dermatitis. In addition to modulation of CD1
expression as a result of elaboration of inflammatory cytokines, there are also some
interesting reports of CD1 modulation on neoplastic cells. In particular, a study of
CD1 expression on leukaemic B and T cells (Salamone et al. 1990) describes CD1
expression on neoplastic cells of both the myeloid and lymphoid lineage in acute and
chronic leukaemias. The detection of CD la on leukaemic cells of T lineage was
restricted to cells with an immature phenotype while in contrast, CD la was
preferentially expressed on the surface of cells ofmature B phenotype.
Other notable features include the fact that some patients showed a great variability
in the percent of CD1 positive cells when samples were analysed on different days
(occurring without concomitant variation in other cell surface antigens), and that
there is a positive correlation between expression of CD la and CD25 observed in
acute non-lymphoblastic leukaemia suggesting a link between CD1 expression and
activation events in these cells. The finding that CD1 expression on B cell neoplasms
appears mainly on cells of mature B phenotype, whereas CD la on T cell neoplasms
is restricted to cells with an immature phenotype mirrors the normal physiological
pattern of CD1 expression on these cell types.
1B.3. CD1 Function
The function of the CD1 family of molecules has been the subject of much debate
over recent years. The existence of these molecules on cell types with central roles in
antigen presentation (i.e. dendritic cells, B cells, monocytes) together with their
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degree of homology to both class I and class II major histocompatibility antigens is
consistent with a role in antigen presentation.
The other major cell type expressing CD1, which is not in the above category of
antigen presenting cells, is the cortical thymocyte. High levels of CD1 are present in
a region where MHC class I appears to be downregulated, hence a role for CD1
molecules in T cell ontogeny is possible e.g. as a surrogate class I molecule. The role
ofCD1 in T cell ontogeny is discussed in more detail in Section IB.3.5.1.
Finally, there is some evidence for the involvement of CD1 molecules in a cellular
activation pathway. It has been shown in one T cell model that addition of CD1
mAbs induced an increase in intracellular Ca2+ and IL-2 production (Theodorou et al.
1990). In addition to antigen presentation, MHC class II molecules have been shown
to have a signalling role in both B cells and T cells (Odum et al. 1991, reviewed in
Wade et al. 1993) hence a combined antigen presentation and signalling role could
also exist for CD1.
1B.3.1 CD1 as a restriction element for T cells
The major focus of attention by researchers interested in functional aspects of the
CD1 family has been the capacity for CD1 to act as a restriction element for certain
populations of T cells.
Recognition of CD1 by T cells was first shown by Porcelli and colleagues (1989)
who demonstrated specific recognition of CD la and CDlc by DN a (3 (BK6) and y8
(IDP2) T cell lines respectively. Subsequently, recognition of CDlc was shown by
the DN y5 T cell clone J2B7 (Faure et al. 1990) and recognition of CD lb by the DN
a(3 T cell line, DN1 (Porcelli et al. 1992). A human intestinal intraepithelial
lymphocyte (IEL) T cell line exhibiting CDlc specific cytotoxicity has also been
described (Balk et al. 1991).
More recently, NK1.1+ T cells have also been shown to exhibit CD1 restricted
responses (Bendelac et al. 1995a, c) - the significance of this reactivity is discussed
in Section IB.3.5.
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As discussed in section B.2.1, although the domain structure of the CD1 molecules
resembles that ofMHC class I molecules, there are also similarities with MHC class
II molecules. In view of this, a recent report of CD1 restricted CD4+ T cells is
particularly interesting (Cardell et al. 1995). Non-classical class I and CD1 restriction
was demonstrated in peripheral CD4+ T cells of MHC class II deficient mice which
showed some similarities to NK1+ T cells (i.e. memory phenotype, high cytokine
production) although unlike NK1+cells they possess a diverse TCR repertoire. These
data suggests that CD4 may be able to serve as a co-receptor for CD1 recognition in a
similar fashion to CD8 (which has been shown to associate with CD la by
immunoprecipitation [Snow et al. 1985, Ledbetter et al. 1985]). Whilst all of the
above experiments demonstrated the potential for CD1 recognition by T cells, there
is no indication of the precise nature of the ligand being recognised. Subsequent
research has begun to address this question with the result that two major groups of
antigens have been shown to be capable of being presented by CD1 molecules.
1B.3.2 Presentation of antigen by CD1
Peptide presentation by CD1
A peptide binding motif for murine CD1 has recently been demonstrated (Castano et
al. 1995). Screening random peptide phage display libraries with Drosophila cells
expressing recombinant soluble CD 1-[32m complexes revealed a well defined core
motif. Features of both class I and class II associated peptides are demonstrated in
this analysis. The 'class-II like' properties are the long (20-22mer) peptides (MHC
class I typically binds 8-10mers), hydrophobic amino acids at certain positions and
an affinity of interaction similar to MHC class II associated peptides. The major
'class I-like' property is the existence of three highly restricted anchors, which, if
mutated, markedly reduce peptide binding (Castano et al. 1995).
Lipid/ Glycolipid
Recognition of a microbial antigen by T cells in a CD1 restricted manner was first
shown in 1992 by Porcelli and colleagues. In these studies, the cell line DN1
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(generated by repeated stimulation of a(3 double negative T cells with CD1+
monocytes and soluble extract of M. tuberculosis) proliferated in a CD lb restricted
manner in response to mycobacterial antigen. These results have recently been
extended by Beckman and colleagues (1994) to demonstrate the specific nature of the
antigen that is involved in this response. Purification of the mycobacterial antigen
which is responsible for the proliferative response of line DN1 revealed it to be a
mycolic acid - a mycobacterial cell wall constituent. Thus it was shown that the
immune system has devised a method to allow the presentation of non-protein
antigens to T cells.
More recently, it has been demonstrated that mycobacterial lipoarabinomannan
(LAM) can be presented by CD lb. Sieling and colleagues (1995) isolated two
mycobacteria reactive double negative a(3 T cell clones, LDN4 and BDN2, from the
skin of a leprosy patient and normal PBMCs respectively. Biochemical methods were
used to show that the fraction responsible for proliferation of these T cell clones was
LAM and that CD lb was the restriction element involved in the recognition. In
addition, it was shown that LAM could induce the production of IFNy and small
amounts of IL-4 by these CD1 restricted T cells.
Summary of CD1 and antigen presentation
Considering the available sequence data within the putative antigen binding region of
the CD1 molecule which implies significant structural divergence from classical
MHC molecules within this region (Calabi et al. 1989c) and the suggestion that the
proline residue in position 162 may result in closure of the peptide binding groove
(as in FcRn - see Section IB. 1.3), it would seem more likely that if antigen
presentation is a function of the CD1 family, then it must be 'unconventional1.
Analysis of nucleotide sequence in the al and a2 domains reveals a lack of positive
selection of non-synonymous nucleotide substitutions which are characteristic of
polymorphic MHC genes (Hughes, 1991). This therefore suggests a lack of selective
evolutionary pressure for amino acid variability within this region which would not
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be consistent with binding of diverse arrays of peptides as is the case for classical
MHC molecules.
Hence the reports of lipid presentation are easier to reconcile with the sequence
information than the report of the murine CD1 peptide binding motif identified
above. Relevant to this debate, Cheroutre and colleagues (1995) suggest that peptides
binding to mCDl were only defined because the starting material was a peptide
display library or alternatively, that CD1 can bind a variety of hydrophobic
molecules including both peptides and non-peptides. An additional caveat to the
study using peptide display libraries is the fact that certain peptides have been shown
to bind to proteins that under normal physiological circumstances do not bind peptide
(Devlin et al.1990). Despite these reservations however the possibility remains that
members of the CD Id group of CD1 molecules do bind and present peptide under
physiological conditions. If this is true then the implication is that the functions of
the CDla-c group and the CD Id group are distinct.
1B.3.3 CDld/ mCDl - functional considerations
That the CDld group ofmolecules may have a different function from the other CD1
molecules is suggested by its markedly different patterns of expression. Whilst this
may simply reflect a molecule that is performing the same function but in different
tissues, the presence of this molecule in rodents that lack the other CD1 isotypes
suggests that it has been retained to perform some necessary function.
Of particular interest is the expression of CDld on intestinal epithelial cells which
may indicate a role in mucosal immunity. Intestinal intraepithelial lymphocytes
represent a somewhat unique population of T cells which predominantly express
CD8, have a restricted T cell repertoire and are capable of spontaneous cytotoxicity
(Taunk et al. 1992). Panja and colleagues (1993) demonstrate direct evidence of
CDld involvement in T cell proliferation by showing that an anti-CD Id mAb blocks
the response in a proliferation assay with intestinal cells as stimulators. Thus it
appears that CDld is involved in T cell - epithelial interactions within this region and
it is plausible that there may be a role for CD1 involving sampling/ uptake of
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lumenal peptides with a resultant involvement in the induction of the immune
response or induction of systemic oral tolerance (Cheroutre et al. 1995).
Balk and colleagues (1994) show that CD Id is expressed on the surface of human
intestinal epithelial cells (IECs) in a (32m independent manner and with no N-linked
carbohydrate such that the molecule was reduced to 37kd. The conformational
alterations which would be likely to result from these changes would make it seem
unlikely that antigen could be presented by this molecule, at least in the conventional
sense. It is noteworthy however that there is some debate as to requirement of
mCDl.l for (32m as Brutkiewicz and colleagues (1995) demonstrate the requirement
of (32m for mCD 1.1 expression in their system.
1B.3.4 Antigen processing pathways for CD1
As described in Section A.l, MHC class I and class II molecules have distinct
processing pathways which generate the complex of MHC molecule and peptide at
the cell surface. NCCI molecules exhibit varying dependence on a functional TAP
transporter system to generate an antigenic epitope (Section IB. 1.4)
CD1 molecules have been shown to be expressed on cells of patients with a TAP
deficiency (Hanau et al.1994) implying that CD1 does not utilize the MHC class I
system for loading antigen. In addition, presentation of mycobacterial antigen to the
double negative, CD lb restricted T cell line DN1 (Porcelli et al.1992) was strongly
inhibited by chloroquine suggesting that CD1 antigen presentation may have more
similarities to MHC class II presentation than to classical MHC class I presentation.
Consistent with this, Seiling and colleagues (1995) demonstrated that the
presentation of mycobacterial LAM also requires uptake of the antigen into an
endosomal compartment. It has recently been demonstrated by Sugita and colleagues
(1996) that CD lb localizes to endosomal compartments as a result of a tyrosine
motif in the cytoplasmic tail. This motif (YXXZ - where X is any amino-acid and Z
is a hydrophobic amino-acid) is also found in CDlc and CD Id thus it is likely that
these molecules also localize to endosomal compartments where presumed loading of
antigen occurs.
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1B.3.5 CD1 and NK1.1+T cells
As described in Section 1A.4.3, members of the NK1.1+ T cell subset have recently
been shown to recognise CD1 molecules. Bendelac and colleagues (1995a, 1995c)
demonstrate a role for the CD1 ligand both in positive selection of thymocytes and in
stimulation ofmature T cells.
1B.3.5.1 CD1 and NK1.1+ T cell ontogeny
The strong expression of CD1 by cortical thymocytes but not by medullary
thymocytes would be consistent with CD1 having a role in T cell ontogeny
particularly as the relationship between CD1 and MHC Class I expression in the
thymus is a reciprocal one i.e. only low levels ofMHC I are seen in the cortex with
higher levels in the medulla.
It is therefore interesting to speculate that CD 1 may perform some role in the process
of thymic selection - fulfilling the role ofMHC class I in a region where the latter is
only present at low levels (Gambon et al. 1988). Several reports have described a
covalent association of CD8 with CD1 in the thymus (Snow et al. 1985, Ledbetter et
al. 1985, Blue et al.1989). The significance of this finding is not clear although it has
been suggested that a switch from CD8/CD1 to CD8/Class I association may
represent a maturation stage in T cell ontogeny (Blue et al. 1989).
As described in Section 1A.4.3, Val4+ cells in mice and the corresponding Va24
subset in man are a class of T cells which mainly express an invariant TCR i.e.
Val4Ja281 in mice and Va24JaQ in humans (Lantz and Bendelac, 1994). Using
mAbs directed against Va24 and vpil, Dellabona and colleagues (1994) show that
Va24-JaQVpil receptors are present within the DN cell subset in all individuals.
This striking conservation both within and between species of a restricted repertoire
would be consistent with constraints imposed by a non-polymorphic ligand such as
the non-classical class I molecules or CD1.
Adachi and colleagues (1995) investigate the receptor-ligand relationship further by
showing that the ligand for Val4Ja281 T cells is present in class II "'" mice and
TAP"'" mice but is lost in p2m "'" mice. Evidence is also provided that this P2m
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associated molecule is not encoded within the MHC and that cells are positively
selected by bone marrow derived haematopoietic cells (thymic epithelial cells are not
required), a feature also previously described by Bix and colleagues (1993).
Bendelac and colleagues (1995a) extended this research by showing that the NK1.1
subset of thymocytes in mice was CD1 specific. T cell hybridomas derived from
NK1.1+ T cells were stimulated by thymocytes from various mouse strains - this
stimulation was abrogated in (32m"'" mice and in the presence of the anti-mouse
CD 1.1 mAb 3C11. Recognition of the ligand was shown to depend on TCR
expression and the ligand had a restricted tissue distribution similar to CD1. Further
experiments utilizing recombinant vaccinia virus expressing the mCDl.l gene to
infect mouse fibroblast cell lines resulted in cells capable of stimulating the
hybridomas - again this stimulation was blocked with 3C11. Following on from this
work, Bendelac (1995c) showed that immature CD4+CD8+ thymocytes were the
likely source of CD1 for positive selection of developing thymocytes by excluding
cells of myeloid origin (i.e. dendritic cells and macrophages), B cells and mature
(medullary) T cells. These results suggest that the the main cell type selecting the
Val4-Ja281+ CDl-specific thymocytes are CD1 expressing CD4+CD8+ cortical
thymocytes.
Thus for the first time there is evidence suggesting that CD1 participates in the
positive selection of specific T cell subsets providing an explanation for CD1
expression on cortical thymocytes.
1B.3.5.2 CD1 and activation of NK1.1+ T cells
The studies described above in which Bendelac and colleagues (1995a) demonstrate
CD1 recognition by NK1.1+ T cells also show that the CD1 ligand is capable of
inducing activation of mature T cells. As discussed in Section 1A.4.3, it is known
that this subset of T cells has a role in IL-4 production and thus in Th2 lineage
commitment and IgE production. It has been postulated that stimuli which elicit IgE
production e.g. helminth infection and exposure to allergens occur at sites where
CD1 is constitutively expressed (i.e. intestinal epithelium and skin) thus allowing
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IL-4 production by NK1.T T cells in response to the stimuli (Yoshimoto et al.
1995b).
It has also been shown that there is an associated expression of the Fc receptor for Ig
with CD1 on Langerhans' cells from atopic dermatitis patients (Bruynzeel-Koomen et
al. 1988).
SJL mice (which are known to produce limited amounts of IgE in response to a
variety of stimulants) have recently been shown to have a marked deficiency of CD4+
NK1.1+T cells (Yoshimoto et al. 1995a). This further supports a key role for NK1.1 +
T cells in Thl/ Th2 lineage commitment as a result of their capacity for IL-4
production, indeed it has been postulated that expression of CD Id by intestinal
epithelial cells may contribute to the propensity for type 2 responses following oral
immunization (Fearon and Locksley, 1996).
In summary then, it is apparent that this family ofmolecules can be compared to both
MHC class I and class II molecules but current evidence points to a unique function
distinct from that of classical MHC molecules. Within the family, the division
between the CDla-c isotypes and the CD Id isotypes would now appear to be one of
both sequence and function - possibly implying different evolutionary requirements
by different species for the CD1 molecules and the functions they perform.
1B.4 Thesis Objectives
As discussed in preceding sections, the CD1 molecules can be divided into two
groups, CDla-c and CD Id. The predicted amino acid sequence of the CD IE gene
places the putative CDle molecule in an intermediate position between the two
groups. It is clear that the mouse is not the most useful model for research into the
CD1 family as mice only possess members of the CD Id group and whilst much
research has been performed using this model, it is obvious that research into the
CD1 family using mice can only address questions relevant to group 2 genes and
molecules.
The sheep is a useful model for the study of CD1 for the following reasons. Ready
access to high CD1 expressing tissues from abattoir specimens and blood and lymph
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compartments render this a system highly amenable to research. A number of mAbs
are available which recognise ovine CD1. Previous work using these mAbs has
indicated the presence of at least 2 isotypes of CD1 - an isotype with CD lb like
distribution (recognised by the majority of mAbs) whilst SBU-T6 (and CC43 and
CC118 in cattle) recognise a molecule with a wider distribution possibly more
similar to to CDlc. Recent molecular analysis of the ovine CD1 family has shown
that up to seven ovine CD1 genes may exist. Four of these genes, which are all
CD IB-like, have been cloned (Ferguson et al. 1996). Although four ovine CD1 genes
have been identified, these all encode CDlb-like molecules. Immunochemical
research suggests that there are at least two CD1 isotypes on the basis of tissue
reactivity of anti-CD 1 mAbs.
The aims of this thesis were therefore to extend the understanding and knowledge of
the ovine CD1 family. Initial work was centred on characterizing previously
available and new mAbs in more detail. This involved both immunochemical and
biochemical analysis of the ovine CD1 antigens. Subsequent work utilized the
information gained at the protein level to enable further investigation of the ovine
CD1 genes. The combination of these two approaches has resulted in the
identification of a novel CD1 NFF-terminal sequence with closest homology to the





The companies supplying the reagents used in this work are referred to in the text.
All company addresses are listed in Appendix III.
2.A IMMUNOCHEMISTRY
2A.1 Monoclonal Antibodies
The monoclonal antibodies (mAbs) used in this research are listed in Tables 1 and 2
with appropriate references. Table 1 lists the anti-CD 1 mAbs used and Table 2 lists
other mAbs used as controls and in double staining FACS experiments.
2A.2 Immunostaining
Tissue preparation
Unless otherwise specified, tissue was obtained from lambs at the local abbatoir.
Tissue was cut into small blocks, mounted in OCT embedding medium (Tissue Tek)
and snap frozen in liquid nitrogen. 8-10|lm cryostat sections were cut onto
Vectabond (Vector Labs.) treated slides, air dried overnight, fixed for 10 minutes in
ice cold acetone then stained or stored at -70°C.
Cytospins
Cytospins for immunostaining were prepared by spinning lOOjil of cell suspension
(5 x 105 ml"1 ) at 1000 rpm for 5 minutes using a Cytospin-2 (Shandon). Cytospins
were then fixed in ice cold acetone for 10 minutes before staining or storage at -70°C.
Staining
Staining was carried out using an indirect immunoperoxidase technique with a
commercially available kit (Vectastain Elite ABC kit, Vector Labs.). Slides were
rehydrated for 10 minutes in blocking buffer (0.08% Tween 20, 2% normal sheep
serum, 0.1% bovine serum albumin in PBS). Incubation with primary antibody was
carried out for one hour at room temperature. Slides were washed in blocking buffer
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TABLE 2.1
Anti-CD 1 mAbs used in immunochemistry with isotype and original reference listed.
TABLE 2.2
mAbs used as controls and in double staining flow cytometry experiments. Isotype
and original references are listed.
TABLE 2.1
MONOCLONAL ISOTYPE REFERENCE
SBU-T6 IgG, Mackayetal. 1985
VPM5 IgM Bujdoso et al. 1989
TH97A IgG2a Davis et al. 1986
CC13 IgG3 Machugh et al. 1988
CC14 IgG,
fl
CC43 IgG, Howard et al. 1993a
CC118 IgG,
II







MONOCLONAL SPECIFICITY ISOTYPE REFERENCE
VPM53 Anti-campylobacter IgG, McOrist et al. 1987
VPM30 ov B cell IgM Naessens and Howard, 1991
VPM65 ov CD14 IgG, Gupta et al. 1996
VPM46 ov MHC II IgG2a Dutia et al. 1990
SBU-T8 ov CD8 IgG2a Maddox et al. 1985
SBU-T4 ov CD4 IgG2a Maddox et al. 1985
DU2104 pan B cell IgM Mackay et al. 1992
VPM19 ov MHC I IgG, Hopkins and Dutia. 1990
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then incubated with biotinylated secondary antibody for 30 minutes. Slides were
washed again in blocking buffer then incubated in HRP-streptavidin complex for 30
minutes. Prior to visualization of the bound antibody-HRP complex, endogenous
peroxidase was blocked by incubating sections for 20 minutes at 37°C in lOmM (3-D
glucose, 5 units ml"1 glucose oxidase (Glucose oxidase type II-S, Sigma), ImM
sodium azide, 0.1M PBS. Visualization of bound antibody-HRP complex was carried
out in either a solution of filtered 3,3' -diaminobenzamine (DAB, Sigma) (lOmg
DAB, 20mls PBS, 40|ll H202) or using a DAB substrate kit (Vector Labs.) according
to manufacturers instructions. In cases where this kit was used, a black stain was
obtained by adding nickel solution to the substrate prior to use.
Following colour development (5-7 minutes), sections were washed in tap water,
lightly counterstained in haematoxylin, dehydrated through graded alcohols and
mounted in DePeX mounting medium (BDH).
2A.3 Flow Cytometry
Cell Preparation
Single cell suspensions of thymocytes, splenocytes and mesenteric lymph node were
prepared by teasing out fresh tissue into RPMI medium. The resulting cell
suspension was washed twice then overlaid onto Lymphoprep (Nycomed) and spun
at 800 x g for 20 minutes at room temperature. Cells were resuspended in FACS
buffer (PBS, 0.5% BSA, 0.05% sodium azide, pH 7.2), washed, counted and
resuspended to give 4xl06 cells ml"'.
Blood was collected by jugular venipuncture into heparinized containers. Lysis of
RBCs was performed by adding 10 mis of blood to 35 mis of prewarmed lysis buffer
(0.16M NH4C1, 0.017M Tris pH7). White cells were then centrifuged at 200 x g and
lymphocytes purified by harvesting over Lymphoprep as above. Cells were then
washed twice in RPMI and resuspended in FACS buffer.
Afferent and efferent lymph was obtained from chronic cannulation of the prefemoral
efferent and pseudoafferent lymphatics (Hall, 1967; Hopkins et al. 1986). The lymph
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was collected into sterile plastic bottles bottles containing 400u of heparin. Cells
were washed twice in FACS buffer then resuspended to give 4x106 cells ml"1 .
Single Staining Flow-Cytometry
4xl05 cells were incubated for 30 minutes at 4°C with 25pi of mAb (either saturated
supernatant or ascites titrated to give optimal dilution). Cells were washed twice in
FACS buffer then incubated for 30 minutes at 4°C with 25pl of FITC conjugated
anti-mouse Ig (The Binding Site). Cells were washed twice in FACS buffer then
analysed on a FACScan (Becton Dickinson).
Double Staining
For double staining using mAbs with different isotypes, 4x105 cells were incubated
with 25pl of each mAb (one of which was biotinylated) for 30 minutes at 4°C. Cells
were washed twice in FACS buffer then incubated with 25pl of isotype specific
anti-mouse conjugated FITC and 25pl of streptavidin-phycoethrin (SA-PE,
Amersham International) for 30 minutes at 4°C. Cells were then washed and analysed
as above.
For double staining using antibodies of the same isotype, cells were first incubated
with the mAb to be labelled with FITC. Cells were washed as above then, following
incubation with FITC-antiglobulin conjugate and washing, free sites of the FITC
conjugate were blocked by incubating with the same primary antibody for 30 minutes
at 4°C. Cells were then incubated with the second biotinylated antibody prior to
labelling with SA-PE as above.
The mAbs and conjugates used in flow cytometry experiments were titrated to
establish optimal working concentrations. Isotype specific negative controls were
used in single staining experiments and similarly for the mAb to be labelled with
FITC in double staining experiments. Biotinylated normal mouse serum was used as
a control for the biotinylated mAb in double staining experiments
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2A.4 Purification of Ascitic Fluid
Immunoglobulin (Ig) from ascitic fluid was purified by caprylic acid precipitation as
follows. 1ml of ascitic fluid was acidified by addition of 25pl glacial acetic acid
(BDH) followed by the precipitation of unwanted protein by the addition of 50pl
caprylic acid (octanoic acid). This was incubated on a roller at 20°C for 30 minutes
then spun at high speed in a microcentrifuge for 5 minutes. The mixture was then
incubated on ice for 30 minutes after which time solidified caprylic acid was
removed from the surface and the supernatant which contained the Ig dialysed
extensively into 0.1M NaHC03, pH 8.4 for 24 hours.
2A.5 Biotinylation of Monoclonal Antibodies
Purified immunoglobulin from ascites was adjusted to a concentration of lmg ml"1 in
0.1M NaHC03, pH 8.4. Biotinylation was then carried out by incubating the Ig for 5
hours with biotin (biotin-amido caproate N-hydroxysuccinimide ester) in DMSO (10
mg ml"1) at a biotin to protein ratio of 75pg : lmg. The biotinylated Ig was then
extensively dialysed against 0.1M PBS, 0.01% sodium azide, pH7.2 for 24 hours at
4°C before a final 2 hour dialysis against PBS azide containing 20% glycerol.
Biotinylated mAbs were then stored at -20° C.
2A.6 Immunoprecipitation
2A.6.1 Iodination of cells
Iodination of thymocytes was carried out using an Iodogen chemical labelling
method. A lmg ml"1 solution of Iodogen (l,3,4,6-tetrachloro-3a,6a-di-
phenylglycouril) in dichloromethane was made and eppendorf tubes were prepared
by drying 100pi of the Iodogen solution onto the tube under a stream of nitrogen in a
fume hood. 2x107 thymocytes were suspended in 0.1ml of PBS and transferred to an
iodogen treated tube.
lmCi of sodium iodide (I125, Amersham International) was added and incubated at
20°C for 15 minutes whilst being shaken every 2 minutes. Iodinated cells were then
washed twice in 20mls of PBS.
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Labelled cells were then lysed in 1ml TNT lysis buffer (Appendix I) containing
0.2mM phenylmethylsulfonylchloride, for 30 minutes on ice. Nuclear material was
then removed by centrifugation at 13,000 x g for 10 minutes. The supernatant was
removed and stored at -70°C.
2A.6.2 Precipitation of Antigen
Standard ELISA plates
ELISA plates (Immulon 2, Nunclon, Denmark) were coated with 75|il goat
anti-mouse immunoglobulin (Sigma) at a concentration of 1 OjLtg ml"1 in borate
buffered saline pH 8.2 (Appendix I) and incubated at 4°C for 12 hours. Plates were
then washed five times in PBS/0.01% Tween 20 prior to addition of 75|ll of mAb
(either neat saturated supernatant or ascites at a dilution of 1:1000 in PBS) and
incubation at 20°C for 1 hour. Plates were then washed as above and incubated
overnight at 4°C with 75|ll1 of I125-labelled lysate. After washing, bound antigen was
eluted by boiling for 3 minutes in 75p,l of SDS-PAGE sample buffer (see Section
2.7).
Streptavidin coated ELISA plates
Enhancement of the signal obtained from immunoprecipitates was achieved by using
streptavidin-coated microtiter plates (Boehringer Mannheim). The streptavidin
coated plates were incubated with a 1:2000 dilution of anti-mouse Ig-biotin overnight
at 4°C. Plates were washed in PBS/0.1% BSA then incubated in specific mouse mAb
for 4 hours at 4°C. Plates were washed as above then incubated with I125 labelled
lysate overnight at 4°C. Bound antigen was eluted as previously described.
2A.6.3 Autoradiography
Following elution, labelled antigen was fractionated by polyacrylamide gel
electrophoresis (PAGE) as described in section 2A.7. Gels were stained, destained
and dried as described in section 2A.8. Dried gels were then placed in a film cassette
and exposed to X-ray film (X-Omat TR, Kodak) at -70°C.
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2A.7 Polyacrylamide Gel Electrophoresis (PAGE)
Proteins were fractionated by SDS PAGE. Resolving gels were either single
concentration 12% or 5-20% linear gradient polyacrylamide gels and consisted of
12% acrylamide, 0.32% bisacrylamide in 375mM Tris-HCl pH8.7, 0.1% SDS, 0.05%
w/v ammonium persulphate (APS), 0.05% v/v TEMED. The stacking gel consisted
of 3% acrylamide, 0.1% bisacrylamide in 125mM Tris-HCl pH 6.8, 0.1% SDS,
0.05% w/v APS, 0.1% TEMED. Gels were run in Tris-glycine buffer containing SDS
(255mM glycine, 0.1% SDS, 50mM Tris HC1).
Samples were boiled for three minutes in sample buffer (2% SDS, 20% glycerol,
0.125M Tris-HCl pH 6.8, 0.004% bromophenol blue) prior to electrophoresis
through vertical slab gels using Bio-Rad Mini Protean II gel equipment. Gels were
run at a constant 200 Volts for 30 minutes or until the dye front reached the bottom
of the gel. Pharmacia low molecular weight markers (range 14.4kd-94kd) were run
on each gel.
2A.8 Staining of SDS-PAGE Gels
Gels for autoradiography were stained in 0.025% Coomassie brilliant blue-R in 20%
v/v methanol, 5% v/v acetic acid for 30 minutes. Gels were then destained in several
changes of 20% v/v methanol, 5% v/v acetic acid and dried onto wet 3mm filter for 3
hours at 80°C on a vacuum drier (Biorad Labs. Gel drier, model 583).
2A.9 Two-Dimensional Electrophoresis
First Dimension
First dimension gels were cast in capillary tubes within a casting tube (Biorad). A gel
solution consisting of 8M urea (Schwarz/Mann Biotech), 3.5% acrylamide, 0.2%
bisacrylamide, 10% w/v Nonidet-P40 (NP40), 5% ampholines (pharmalyte pH3-8,
Pharmacia) was made in milliQ water. Once polymerized, first dimension gels were
connected to sample chambers and positioned in the apparatus (Mini-protean II 2-D
cell, Biorad). Samples were dissolved in sample buffer (8M urea, 5% ampholine, 2%
NP40), loaded into the chamber and overlayed with 8M urea, 1% ampholine.
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First dimension gels were run with an upper chamber (anode) buffer of 0.1M NaOH
and lower chamber (cathode) buffer of 0.1M H3P04. Following completion of the
first dimension, gels were extruded from the capillary tubes using equilibration
buffer (0.125M Tris pH 6.8, 10% glycerol, 2.3% SDS) and used directly in the
second dimension or stored at -70°C.
Second Dimension
Vertical slab gels were prepared for the second dimension as described in section
2A.7. First dimension gels were placed on the surface of the stacking gel with the top
end (anode) of the gel at the left side. Excess equilibration buffer was removed with
blotting paper and the gel run in Tris-glycine buffer as described above. 2D gels were
then either blotted (Section 2A.10) or dried and subjected to autoradiography
(Section 2A.6.3).
2A.10 Western Blotting
Following SDS-PAGE separation, the proteins were transferred to nitro-cellulose
membrane (Flybond C, 0.45|im, Amersham International) using a semi-dry
electroblotter (Trans-Blot SD, Bio-Rad). Transfer was performed in blotting buffer
(25mM Tris, 20% v/v methanol) for 1 hour at a constant current of 120mA.
Following blotting, non-specific sites on the membrane were blocked in a solution of
5% v/v fat free dried milk in PBS for 1 hour at 20°C before incubation overnight in
primary antibody diluted in PBS. Blots were then washed 5 times over 30 minutes in
wash buffer (PBS, 0.1% Tween 20) at 20°C. Detection of bound antibody was carried
out by incubating blots for 1 hour at 20°C in a 1:1000 dilution of anti-mouse
Ig-biotin (Sigma) followed by incubation for 30 minutes in a 1:2000 dilution of
streptavidin- alkaline-phosphatase conjugate (Boehringer Mannheim).
Blots were washed twice in 0.1M Tris-HCl pH 9.5 then developed in a solution of
0.1M Tris HC1 pFl 9.5, 4mM MgCl2, 0.2mg ml"1 nitro-blue tetrazolium (NBT,
Sigma), lOOmg ml"1 5-bromo-4 chloro-3 indolyl phosphate (BCIP). The reaction was
stopped by washing in tap water.
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2A.11 Protein Detection on Blots
Proteins were directly visualized on blots using 'Protogold Colloidal Gold Sol'
(BioCell). Proteins were blotted onto nitrocellulose as described above and the
membrane blocked in PBS/0.3% supplied detergent for 30 minutes at 37°C. The
membrane was washed 3 times over 15 minutes in PBS/0.3% detergent, 3 times over
3 minutes in distilled water then incubated in 'Protogold' solution for 3 hours with
continuous shaking. In order to enhance the stain, the membrane was washed 5 times
over 10 minutes in distilled water and incubated in equal quantities of initiator and
enhancer for 20 minutes, washed thoroughly and dried.
2A.12 Enhanced Chemiluminescence (ECL)
ECL was used to provide increased sensitivity in development of membranes which
were probed with the mAb SBU-T6. Blotting, blocking of non-specific sites and
washing were as in section 2A. 10 with the exception of washes being carried out in a
solution of PBS, 0.5% Tween 20. Blots were then incubated in a 1:1000 dilution of
anti-mouse Ig-biotin (Sigma) for 1 hour at 20°C, washed as above then incubated in a
1:2000 dilution of biotinylated HRP streptavidin complex (Amersham) for 1 hour at
20°C. Following extensive washing over a 45 minute period, detection of bound HRP
complex was carried out using ECL western blotting detection reagents (Amersham)
as follows. Washed membranes were incubated in the detection reagents for exactly 1
minute, excess reagent was drained off then covered on both sides with cling-film.
Membranes were then place protein side up in a film cassette and a sheet of X-ray
film placed (X-Omat TR, Kodak) on the surface for 15-60 seconds. Further
exposures were made if necessary based on the results of the short exposures.
2A.13 Affinity Purification of Antigen
2A.13.1 Preparation of thymus lysate
Thymus tissue from 4 lambs was homogenized in 1 litre of ice cold HBSS for 1
minute. Cells were spun at 600 x g for 15 minutes at 4°C and resuspended in TNT
lysis buffer (Appendix I) containing 0.2mM PMSF. Cells were then lysed on ice for
30 minutes and nuclei removed by spinning at 600 x g for 20 minutes at 4°C. The
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supernatant was retained and sodium azide added to 0.05%. The lysate was
centrifuged to remove high molecular weight debris at 20,000 x g for 2 hours at 4°C
and filtered through Millipore prefilters before being used directly on an Affigel
column or storage at -70°C.
2A.13.2 Monoclonal antibody affinity chromatography
Ascites was purified by caprylic acid precipitation as described in Section 2A.4.
Purified Ig was dialysed into 0.1M phosphate buffer pH7.2 containing 0.05% azide
overnight at 4°C. Dialysis was continued for a further 4 hours in fresh buffer.
Dialysed protein was then linked to washed Affigel 10 (Biorad) at 30mg protein ml"1
Affigel suspension by incubating overnight at 4°C. Ig linked Affigel was centrifuged
(200 x g), the supernatant removed and the Affigel blocked by incubating on a rotor
in 1M ethanolamine pH8 for 1 hour at 20°C. Affigel was centrifuged and washed in
PBS. 0.1% azide before being poured into a column. Non-specifically bound material
was removed from the column by washing in 15mM triethanolamine (TEA) 0.5%
sodium deoxycholate (DOC) pH8 for 30 minutes followed by a 30 minute wash in
15mM TEA, 0.5% DOC, 0.5M NaCl, pHl 1.3.
The column was then washed with lOmls PBS, 0.1% azide followed by lOmls TNT
buffer before running the lysate (prepared as described in Section 2A.12.1) through
the column at a very slow rate over 48 hours. Following absorption of antigen, the
column was washed in TNT buffer followed by TEA/DOC pH8 for 30 minutes each
before elution of antigen from the column with TEA/DOC/NaCl pH11.3. Eluted
fractions were immediately neutralized by the addition of 0.3ml 0.5M TEA pH7.9
ml"1 fraction. Following elution, the column pH was immediately returned to pH7.3
by washing with PBS. Eluted fractions were tested by ELISA (see Section 2A.13)
and the peak fractions pooled and stored at 4°C.
2A.14 ELISA
Eluted antigen was diluted 1:10 in PBS/azide then 75(0,1 was added to each well of an
ELISA plate and incubated overnight at 4°C. Plates were then washed three times in
52
PBS/0.1% Tween 20 and non-specific sites blocked by incubating in 2% BSA in
PBS for 30 minutes at 20°C. Plates were washed as above, 75pl mAb was added and
the plates were incubated for 1 hour at 20°C. After a further wash, 75pl of a 1:1000
dilution of anti-mouse Ig-HRP conjugate (SAPU) was added and incubation
continued for 30 minutes in the dark at 20°C. Plates were washed again then
incubated in the dark with HPX substrate (0.8% O-phenylenediamine, 0.1M
Na2HP04, 0.05M citric acid, 0.0016% v/v H202) for 15-20 minutes. The reaction was
stopped by adding 50|ll 2M sulphuric acid. The optical density of the reaction was
measured at 492nm on a Dynatech MR 3000 micro ELISA plate reader.
2A.15 Deglycosylation of Antigen
Purified antigen was deglycosylated using N-glycosidase F (Boehringer Mannheim).
Antigen was boiled for 3 minutes in 0.75% SDS then incubated overnight at 37°C in
0.01M EDTA, 1% Triton-X 100 containing 0.1 unit N-glycosidase-F.
2A.16 Isolation of Antigen for NH2-Terminal Sequencing
Precipitation of antigen
Antigen eluted from Affigel columns was precipitated by the addition of 4 volumes
of ethanol (BDH) overnight at -20°C in Corex tubes. Precipitated antigen was
recovered by centrifugation at 13000 x g for 20 minutes. The pellet was air dried and
resuspended in SDS sample buffer.
Gels and blotting
The gel system was as described in section 2A.7 with the following modifications.
Molecular biology grade reagents were used and all buffers were made fresh prior to
each isolation. The stacking gel contained 375mM Tris-HCl pH 8.7 and the gel was
prerun in 0.125M Tris-HCl pH 6.8 containing 50|iM glutathione. A dye was used to
monitor the progress of the gel. Once the dye had reached the interface between
stacking and resolving gel, the buffer was replaced with normal running buffer
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(50mM Tris, 255mM glycine, 0.1% SDS) containing O.lmM thioglycolate and run
as normal.
The gel was then blotted onto Pro-blott membrane (Applied Biosystems) using a wet
blotting system. The gel was soaked for 5 minutes in blotting buffer (lOmM
CAPSpHll [3 cyclohexylamino-1 -propane sulfonic acid], 10% methanol) and the
membrane was wetted in methanol for 3 minutes prior to equilibration in blotting
buffer. Blotting was then carried out at 50V for 2 hours. After blotting, the membrane
was rinsed in deionised water, saturated in 100% methanol for 5 seconds and then
stained in 0.1% Coomasie-blue R-250 in 40% methanol/1% acetic acid for 1 minute.
The membrane was destained in 50% methanol, rinsed extensively in deionised
water, dried and bands of interest excised.
2B MOLECULAR BIOLOGY
All DNA sequencing was carried out by Mr. I. Bennet on a LI-COR DNA sequencer
(model 4000L).
2B.1 RNA Isolation
The following steps were taken to minimise RNAase contamination. Where
appropriate, solutions were treated with diethyl pyrocarbonate (DEPC). 0.2% DEPC
was added to solutions which were well mixed, stored for at least 1 hour at 4°C then
autoclaved. Sterile plasticware was used and gloves worn at all times.
2B.1.1 Isolation of total RNA
Total RNA was isolated from cells using RNAzol B (Biogenesis). For thymocyte
RNA, fresh tissue was placed on ice and cell suspensions made in RPMI. Cells were
washed twice, the medium removed then resuspended in RNAzol at 1ml per 5x107
cells. For PBLs, cells were isolated by ammonium chloride lysis of RBC (section
2A.3), density centrifugation followed by washing twice as above. Cells in tissue
culture flasks were washed once in PBS then lysed directly by addition ofRNAzol B
to the flask. Following lysis, chloroform was added to 10%, samples vigorously
shaken and stored on ice for 5 minutes. Samples were centrifuged at 13000 x g for 15
minutes, the upper aqueous phase was transferred to a fresh tube and an equal
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volume of ice-cold isopropanol added. Precipitation was carried out for 1 hour on ice
then samples were centrifuged at 13000 x g for 15 minutes. RNA pellets were
washed with 75% ethanol, air dried then resuspended in ImM EDTA pH7. If not for
immediate use, RNA was stored in aliquots at -70°C.
2B.1.2 Isolation of mRNA
PolyA+ RNA was isolated either directly using the Invitrogen Fasttrack mRNA kit
(Invitrogen) or by selecting polyA RNA from total RNA using streptavidin
paramagnetic particles (Promega) according to manufacturers instructions.
2B.1.3 RNA analysis
Quantitation of RNA was determined by spectrophotometry with an OD260 of 1.0
being equivalent to 40pg ml"1 of RNA. Absorbence readings at A280 were also
measured to check sample purity - pure RNA preparations have A260/A280 ratios of
2.0.
Gel analysis was also used to demonstrate the intact nature of the RNA. Clear 28S
and 18S bands were required to indicate that the RNA had not undergone
degradation. Approximately 5pg of total RNA was run on a denaturing agarose gel as
follows. 1.5g of agarose was added to 82mls of phosphate buffer (20mM sodium
phosphate pFI7). The agarose was melted then cooled to 60°C. 18ml of formaldehyde
was then added in a fume hood immediately prior to pouring the gel. RNA samples
were denatured in 3 volumes of denaturing load buffer (60% v/v deionised
formamide, 7.2% formaldehyde, 20mM phosphate buffer, 0.1M EDTA) for 15
minutes at 52°C. 1 volume of dye mix (30% Ficoll, 0.05% bromophenol Blue,
lOOmM phosphate buffer, 0.25pg ill"1 EtBr) was then added and samples run for 90





cDNA synthesis was carried out using a first strand cDNA synthesis kit (Amersham
International). Random hexanucleotide primers or oligo-dT primers were used to
initiate the cDNA synthesis from total or polyA+ RNA according to the
manufacturers instructions.
Alternatively, synthesis was carried out using Superscript II RNase H" Reverse
Transcriptase (RT) (GibcoBRL) as follows. 5pg total RNA plus 150ng random
primers (Amersham International) were made to 12pl in SDW and heated to 70°C for
10 minutes then chilled on ice. Buffer (250mM Tris-HCl pH8.3, 375mM KC1, 15mM
MgCl2) dithiothreitol (GibcoBRL) and dNTP mix were then added and the mixture
incubated at 25°C for 10 minutes. The mixture was heated to 42°C for 2 minutes prior
to addition of 200 units RT and incubation at 42°C for 50 minutes. The reaction was
then inactivated by heating at 70°C for 15 minutes.
2B.2.2 Adaptor ligated cDNA
cDNA synthesis was also carried out to allow 'RACE' (Rapid Amplification of
cDNA Ends) PCR reactions to be performed. For this technique, cDNA synthesis
was carried out using the Marathon cDNA amplification Kit (Clontech) according to
the manufacturers instructions. Briefly, 1 pig of polyA+ RNA was used as a substrate
for first and second strand cDNA synthesis. Adaptors were then ligated onto the ends
of the cDNA population allowing the subsequent use of adaptor primers in PCR
reactions (see section 2B.3)
2B.3 Polymerase Chain Reaction
PCR reactions were carried out in sterile 0.5ml eppendorf tubes with final reaction
volume of 50pl or lOOpl. The basic components of the PCR reaction were as follows,
lx PCR reaction buffer (50mM KC1, lOmM TrisCl pH8.3, 1.5mM MgCl2), lOOpM
each dNTP (Pharmacia), DNA template, 25-50 pmoles of each primer. These
constituents were mixed then briefly spun and overlaid with 50pl mineral oil
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(Sigma). Reaction tubes were then heated to 94°C for 3 minutes and cooled to 80°C
prior to the addition of 1 unit of Taq (Thermus aquaticus DNA) polymerase enzyme
(GibcoBRL) per reaction. Cycling was carried out using a Hybaid Omnigene thermal
cycler. Cycling parameters varied according to substrate and primers and as such are
described in the relevant results chapters. Oligonucleotide primers were purchased
from Cruachem Ltd. or Perkin-Elmer. Sequences of all the primers used in this work
are listed in Appendix II.
2B.4 Analysis of PCR Products
Following PCR, 10% of the reaction was analysed on a 1% w/v agarose gel (Type I:
low EEO, Sigma). Agarose was melted in TAE buffer (Appendix I) containing lpg
ml"' ethidium bromide. Samples were mixed with 1/5 volume of 5x DNA sample
buffer, loaded and the gel run at 70-80V for 60-90 minutes. EcoRI/Hindlll digested
lambda DNA markers (NBL) were run on each gel.
2B.5 Purification of DNA
DNA from PCR reactions which was subsequently to be cloned was purified by
excising the relevant band from the gel and subjecting it to one of two purification
methods. Small fragments of less than 500bp were purified using Spinbind DNA
extraction units (FMC Bioproducts) according to the manufacturers instructions.
Larger PCR products and plasmids were purified using the Geneclean II kit (Bio 101
Inc) according to the manufacturers instructions.
2B.6 Cloning of PCR Products
PCR products which had been purified as described above were cloned using the TA
cloning kit (Invitrogen). Briefly, ligations were set up as 1:1 to 1:3 molar ratio of
vector : PCR insert. 1-2 [il of the ligation reaction was then used to transform INVaF
cells and the transformed cells were plated onto LB/ampicillin/X-gal plates (section
2B.6.1) and incubated overnight at 37°C. Transformed colonies were identified by
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blue/white selection and positive clones were picked and grown overnight in 10ml
LB containing 50|ag/ml ampicillin.
2B.7 Bacterial Cultures
2B.7.1 Growth media
All bacterial strains were cultured in Luria Bertani (LB) broth (Appendix I) with the
exception of MCI061/p3 which were cultured in TYM medium (Appendix I). The
medium was supplemented with ampicillin (50pg/ml) since the vectors pCRII,
pBluescript and pCDNA3 all contain the ampicillin resistance gene. LB/agar plates
or TYM/agar plates were made with 1.5% (w/v) bacteriological agar (Oxoid)
supplemented with 50|ig/ml ampicillin and stored at 4°C. When plating INVaF' cells
containing the vector pCRII from the TA Cloning kit (see section 2B.6 ), each 10cm
plate was supplemented with 50jJ,gml~' 5-bromo-4-chloro- 3-indolyl-(3-D-galactoside
(X-gal, Melford laboratories) to allow blue-white selection.
2B.7.2 Competent cells
The E. coli strains used in this work were INVaF' (TA cloning kit), XLl-blue and
DH5a (GibcoBRL). In addition, MC1061/p3 were made supercompetent according
to the method of Simmons (1993). Single colonies were picked into 5ml TYM and
grown for 4 hours then diluted to 100ml and grown to midlog OD600= 0.5. Cells were
then diluted to 500ml and again grown to midlog OD600= 0.5. Cultures were rapidly
chilled, pelleted at 2800 x g for 15 minutes then resuspended in 30mM CH3COOK,
50mM MnCl2, lOOmM KC1, lOmM CaCl2, 15% glycerol (v/v). Cells were pelleted
again at 1500 x g for 10 minutes then gently resuspended in lOmM
3-[N-Morpholino] propanesulfonic acid (pH 7), 75mM CaCl2, lOmM KC1,
15%glycerol before being aliquoted into prechilled eppendorf tubes and snap frozen
in liquid nitrogen. Competent cells were then stored at -70°C.
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2B.8 Preparation of Plasmid DNA
Plasmid DNA for sequencing was isolated using Qiaprep-spin columns (Qiagen Ltd)
according to the manufacturers instructions. Preparation of plasmid DNA for analysis
of insert sizes and screening of multiple colonies was performed as follows. 6ml
overnight cultures were pelleted at 400 x g for 10 minutes and resuspended in 1M
glucose, 1M Tris pH 8, 0.5M EDTA pH8. Cells were then lysed in 10M NaOH, 20%
SDS for 10 minutes at 20°C. Precipitation of bacterial DNA was carried out by
addition of 3M CH3COOK, incubation on ice for 10 minutes and high speed
centrifugation for 3 minutes. The supernatant was then phenol/chloroform extracted,
precipitated with isopropanol, washed in ethanol and resuspended in 50 p.1 TE buffer
(Appendix I).
2B.9 Restriction Endonuclease Digestion ofDNA Samples
Restriction endonuclease digests of plasmid DNA to allow analysis of inserts was
carried out as follows. The reaction was typically carried out in a 20|ll volume
containing 2p,l plasmid DNA, 10 units of enzyme and the appropriate enzyme buffer.
Digests were carried out at 37°C for 2-4 hours for the majority of enzymes used.
Digestion using the enzyme BstXI was carried out at 45°C. Following digestion,
inserts were analysed by running 1 Opl of the reaction on an agarose gel (as in section
2B.4) alongside uncut plasmid.
2B.10 In Situ Hybridization (ISH)
2B.10.1 Preparation of slides and tissues
Slides
Glass slides for ISH were prepared as follows. Slides were washed overnight at 60°C
in 10% Decon, rinsed in running tap water for 4 hours then placed in distilled water
for 2 hours. Slides were then baked overnight at 150°C prior to treatment with
3-aminopropyltriethoxysilane (TESPA) as follows. Baked slides were incubated for 5
seconds at 20°C in 2% TESPA in acetone, washed twice in acetone then finally
rinsed in water before baking dry at 42°C.
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Tissues
Tissues were excised immediately post-mortem and fixed in 4% paraformaldehyde.
Paraffin sections were then cut onto TESPA treated slides. Sections were stored at
4°C for 1-2 weeks before use.
2B.10.2 Riboprobe synthesis
Inserts for riboprobe synthesis were contained within the vector pCRII thus allowing
the use of the T7 and Sp6 promoters to prime the synthesis reaction. Two restriction
digests of the plasmid were set up and the cut plasmids then purified using
Geneclean II. The synthesis reaction was set up in a 20|ll reaction containing 2|ll
digoxigenin (DIG) labelling mix (Boehringer Mannheim), 3 pi cut plasmid DNA,
lOmM DTT, 60U RNasin (Pharmacia), 60U RNA polymerase in lx appropriate
buffer. The reaction was allowed to proceed for 3 hours at 37°C then terminated by
adding 80pl DEPC-water. 20pg glycogen was then added and the probe was ethanol
precipitated for 1 hour at -20°C. RNA was pelleted at high speed for 15 minutes,
washed twice in 75% ethanol resuspended in DEPC-water and stored at -70°C.
2B.10.3 Hybridization
Sections were dewaxed in xylene for 10 minutes then rehydrated through graded
alcohols. Slides were then washed in DEPC-PBS for 5 minutes then transferred to
0.2N HC1 for 15 minutes followed by incubation in 0.3% Triton-X for 15 minutes.
Slides were rinsed then incubated in proteinase K solution for 5-20 minutes. After a
brief rinse, slides were fixed in 4% paraformaldehyde, rinsed then prehybridized for
1-2 hours in 2xSSPE (Appendix I)/ 50% formamide. Riboprobes were diluted in
hybridization buffer (ImM Tris, lx Denhardts, 2x SSPE, 50% formamide, 0.5%
SDS, 0.5% dextran sulphate, 0.25mg/ml salmon sperm DNA), heated to 85°C for 4
minutes then cooled on ice. 30pl was then added to each slide, a coverslip applied
and hybridization carried out overnight at 42°C.
Following hybridization, coverslips were removed in 4x SSPE then slides washed in
2x SSPE for 30 minutes at 20°C, O.lx SSPE for 10 minutes at 20°C, O.lx SSPE for
60
30 minutes at 50°C, O.lx SSPE for 20 minutes at 20°C. Slides were washed in DIG
buffer 1 (Appendix I) for 5 minutes then DIG antisera (10% normal rat serum,
1:2000 anti-digoxigenin-Fab fragments (Boehringer Mannheim) in DIG buffer 1)
applied for 2 hours at 20°C. Slides were washed in DIG buffer 1 2x 15 minutes then
DIG buffer 3 (Appendix I) lx 5 minutes before applying substrate for colour
development (NBT, X-phosphate, levamisole). Colour development was allowed to
proceed for up to 2 hours then slides were rinsed in PBS, water and mounted in
crystalmount (Biogenesis).
2B.11 Generation of cDNA Library
2B.11.1 cDNA synthesis
mRNA was prepared as described in Section 2B.1. cDNA synthesis was carried out
using a cDNA synthesis kit (Pharmacia) according to manufacturer's instructions
using 5|J,g mRNA as a substrate for first and second strand cDNA synthesis. Double
stranded cDNA was purified on a S-300 column and BstXI adapters (Invitrogen)
were ligated overnight at 12°C followed by a second S-300 purification. Following
these proceedures, 100pl of purified, adaptor ligated library was obtained. This was
stored at -20°C whilst the results of test ligations were obtained (Section 2B.11.3)
2B.11.2 Preparation of vector
INVaF' cells were transformed with the vector pCDNA3 and resultant colonies
grown overnight in LB/ ampicillin as previously described. Plasmid DNA was
purified using Qiagen mini plasmid kit columns (Qiagen Ltd) then digested using the
enzyme BstXI overnight at 45°C. Digested plasmid was ethanol precipitated,
resuspended in phosphatase buffer and treated with phosphatase (Shrimp alkaline
phosphatase, Gibco BRL) for 1 hour at 37°C. Phosphatase was inactivated by heating
the reaction for 15 minutes at 65°C. Digested, phosphatased plasmid was purified
using Geneclean II and adjusted to a concentration of 50pgmf'.
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2B.11.3 Library ligation and purification
Test ligations using the double stranded adaptor ligated DNA described above were
set up using O.lpg of vector and varying quantities of column effluent. A random
selection of colonies were grown up in overnight culture and analysed to establish the
size range of library inserts. Based on colony numbers obtained following
transformation of competent cells with a percentage of the ligation reaction, a large
scale ligation was set up as follows. lp.g of prepared vector was combined with 50|il
column effluent in a total volume of 70jll ligation buffer (66mM Tris-HCl pH7.6,
ImM spermidine, lOmM MgCl2, 15mM DTT, 0.2mg/ml DNase-free BSA ). 100
units of T4 ligase was added and the reaction allowed to proceed overnight at 12°C.
A total of one third of the ligation reaction was used to transform supercompetent
DH5a cells which were plated onto 10cm LB/ampicillin/agar plates and incubated
overnight at 37°C. Colonies were removed by the addition of prewarmed LB and
scraping with an L-shaped glass spreader. Cells were then pelleted and plasmid DNA
extracted using the Qiagen Maxi -plasmid kit (Qiagen Ltd).
2B.12 Library Expression and Screening
2B.12.1 Transfection of COS cells
COS 7 cells were used for the transfection and were cultured in DME (Appendix II),
10% FCS, 200mM L-Glu, 100U ml"1 penicillin-streptomycin. Cells were plated out
the night before use at 2 x 106 cells per 80cm2 flask. The following day, flasks were
washed in 2 x 25 ml DMEM and 5ml transfection mix consisting of 2mg
DEAE-dextran, O.lmM chloroquine, 20qg purified DNA in 5ml DMEM was added.
After incubation for 3 hours at 37°C, the transfection mix was poured off and flasks
washed in 25ml PBS. 5ml 10% DMSO in PBS was added and left on the cells for 2
minutes at 37°C. Flasks were washed twice in 25 ml PBS and incubated overnight in
30ml culture medium. The following day, cells were trypsinised and transferred to
new flasks, grown for 1 more day and harvested for Dynal bead selection (see
below).
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2B.12.2 Magnetic separation of transfected cells
Cells were harvested from flasks by incubating in 0.02% EDTA pH7.2 (prewarmed)
at 37°C for 30 minutes. Cells were pelleted at 400 x g for 5 minutes, resuspended in
lml of mAb tissue culture supernatant and incubated on ice for 1 hour. Cells were
pelleted at 400 x g (4°C), washed twice in cold PBS/0.1% BSA and resuspended in
lml PBS. Washed cells were incubated with washed Dynal beads (Dynabeads
M-450, Dynal) at 2x107 beads per ml of sample for 30 minutes at 4°C. Positive cells
were selected against a magnet (Dynal MPC), washed four times in cold PBS and
transferred to an eppendorf tube.
2B.12.3 Preparation of plasmid DNA
Plasmid DNA from positively selected cells was prepared as follows. Excess PBS
was removed from the beads/cell mixture using the magnet. 400pl 0.6% SDS, lOmM
EDTA was added, the solution vortexed and incubated at 20°C for 30 minutes. lOOpl
5M NaCl was added, the solution vortexed and incubated at 4°C overnight.
Following centrifugation at 13000g for 5 minutes, the supernatant was removed and
phenol chloroform extracted twice. 0.02|ig tRNA was added as a carrier and the
DNA ethanol precipitated, resuspended in 100p.l TE and ethanol precipitated a
second time. The pellet was finally resuspended in 20|il TE and stored at -20°C.
2B.12.4 Preparation of spheroplasts
500|ll MC1063/p3 E. Coli were transformed with 5|il of HIRT DNA by incubating
on ice for 30 minutes followed by a 5 minute 'heat-shock' at 37°C. Transformed
bacteria were grown for 1 hour in LB then plated onto LB/agar plates containing
50|J.g/ml ampicillin and incubated overnight at 37°C. The following day, a solution of
LB/ampicillin (50|ig ml"1) was used to create a slurry of bacterial clones using an
L-shaped glass spreader. The bacteria were grown in liquid culture (LB/amp) from
OD600 = O.lto OD600=0.7. At this stage chloramphenicol was added to 150pg/ml and
cultures continued for a further 16 hours. 100ml of this overnight culture was
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centrifuged at 3000 x g for 10 minutes at 4°C and the pellet resuspended in 5ml 20%
sucrose/ 50mM Tris-HCl pH8 at 4°C. 1ml of 5mg ml"' lysozyme in 0.25M Tris-HCl
pH8 was added and incubated on ice for 5 minutes then 2ml of 2.5M EDTA added
followed by a further 5 minute incubation on ice. 2ml of 50mM Tris-HCl pH8 was
added and incubated at 37°C for 5 minutes. The solution was placed on ice,
conversion to spheroplasts checked under light microscopy and 20ml prewarmed
DME/ 10% sucrose/ lOmM MgCl2 added dropwise with frequent inversion then
incubated at 20°C for 20 minutes.
2B.12.5 Transfection of COS cells with spheroplasts
COS cells were plated out the night before at lxlO6 cells per 3ml DME/10% FCS/
200mM L-Glu, 100U ml"' penicillin-streptomycin in 6cm diameter tissue culture
petri plates (Falcon 3004, Becton Dickinson, Plymouth, U.K.). Media was removed
the following day and 3ml of spheroplast suspension added to each dish. Dishes were
taped up with 'Parafilm' (American National Can, Greenwich) and spun at 500 x g for
10 minutes with no brake setting. Fluid was aspirated and 1.5ml of a 50% (w/v)
solution of polyethylene glycol (PEG) at room temperature was added slowly to the
centre of each dish. After 1 minute, PEG was washed off with 3 x 3ml of DME and
cells were incubated for 4 hours at 37°C in DME/ 10% FCS/ 15|Ugml"' gentamycin
sulphate. Debris was washed off and cells incubated for 48hrs in DME/ 10% FCS/
200mM L-Glu/ 15|ig ml"1 gentamycin sulphate prior to harvesting by incubating in
prewarmed EDTA pH 7.2 for 15 minutes at 37°C and Dynabead selection as
described in section 2B.12.2.
2B.13 Transfection of C127 Cells
2B.13.1 Transfection
C127 cells were grown in DME, 10% FCS, 200mM L-Glu, 100U ml"1 penicillin-
streptomycin (DME 10). Cells were seeded into 6 well plates at 5 x 105 cells per well
and transfected the next day (70% confluent). Transfection was carried out using
DOTAP Transfection Reagent (N-[l-(2,3-dioleoyloxy) propyl] -N,N,N-trimethyl-
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ammoniummethylsulphate - Boehringer Mannheim) as follows. For each
transfection, 5jLLg of DNA and 60(il of DOTAP were each made to lOOpl in PBS,
mixed together and incubated at 20°C for 10 minutes. 3ml ofmedium was then added
to the DOTAP/ DNA mixture and the cells cultured in this transfection mixture
overnight. The following day, this was removed and replaced with medium
containing the selecting agent (see below). Cells were grown for a further 3 days then
harvested and seeded at 3 different concentrations in 6 well plates (103, 104, 105 cells
per well).
2B.13.2 Selection of transfected cells
Since the transfecting DNA was contained within the vector pCDNA3 which
contains the ampicillin resistance gene, transfected cells were selected using the
antibiotic geneticin disulphate (G418, Gibco-BRL). Cells were maintained at all
times in DME 10 plus G418 at a final concentration of 0.5mg ml"1. Medium was
changed every 3 days and transfected cells were identified as individual clones
appearing after approximately one week of culture. Once individual clones were
identified, they were isolated and transferred to 24 well plates then cultured as
normal.
2B.13.3 Analysis of transfected cells
Once cells had grown to confluence in T175 flasks, they were removed for FACS
analysis or preparation of cytospins. Medium was removed, cells rinsed in versene
then incubated in EDTA pH7.2 at 37°C until cells detached. Cells were then washed
in FACS buffer and analysed as described in section 2A.3. For preparation of RNA,





Agarose gels were run as described in section 2B.4. Nucleic acids were blotted onto
Hybond N+ (Amersham International) using overnight capillary transfer in a buffer of
0.4N NaOH. Following blotting, the membrane was rinsed in 2xSSC (Appendix I)
then used for hybridization.
2B.14.2 Generation of radiolabeled probes
DNA oligonucleotides to be used as probes were labelled with [y32P]ATP (Amersham
International). The labelling reaction consisted of lOpmol DNA, 3ml [y32P]ATP,
50mM Tris-HCl pH7.6, lOmM MgC12, lOmM 2-mercaptoethanol, 0.6u T4
polynucleotide kinase (United States Biochemical Corporation). The mixture was
incubated at 37°C for 30 minutes then 65°C for 5 minutes.
2B.14.3 Hybridization
Membranes were prehybridised at 50°C for four hours in 0.5% dried milk, 0.02M
NaP04 pH7, 2.85N SSC, ImM EDTA, O.lmgmf1 yeast RNA, 1% SDS. The labelled
oligonucleotide(s) were added and hybridization carried out overnight at 50°C.
Membranes were washed in lxSSC twice for 15 minutes each at 22°C then in
O.lxSSC for 15 minutes at 52°C. This wash was repeated until background signal




EXPRESSION OF OVINE CD1
3.1 Introduction
In humans, five CD1 genes exist for which four protein products have been described
(CD la, CD lb, CDlc and CD Id). The CDla-c isotypes have a broadly similar
distribution being present on cortical thymocytes, dendritic cells, Langerhans' cells
(CDla and CDlc) and a subpopulation of B cells (CDlc). In contrast, CDld has a
much wider distribution with expression on epithelial cells, vascular smooth muscle
and parenchymal cells. In particular, expression on intestinal epithelial cells and
hepatocytes is a prominent feature of the CDld isotype (Canchis et al. 1993).
In the sheep, previous studies have shown that the majority of mAbs form a distinct
cluster consistent with recognition of the ovine homologue of human CD lb (Dutia
and Hopkins, 1991). The mAbs which have been shown to constitute this cluster are
CC13, CC14, CC20, CC40, CC90, CC132, CC122, TH97A and VPM5 (Hopkins
and Dutia, 1991; Hopkins et al. 1993). Transfection of COS cells with cDNA clones
encoding human CD1 molecules has shown that CC20 recognises a homologue of
human CD lb (Howard et al. 1993b). The mAb, SBU-T6, has been shown to have a
wider tissue distribution (Mackay et al. 1985; Dutia and Hopkins, 1991). As such,
this mAb has previously been considered to be specific for CDlc or reactive to all
CD1 isoforms (Dutia and Hopkins, 1991).
In cattle, two additional mAbs, CC43 and CC118 have recently been described
(Howard et al. 1993a). These recognise a molecule in cattle with a much wider tissue
distribution than previously described for CD1 mAbs in this species. In addition,
these mAbs immunoprecipitate a 43kd a chain compared to the 46kd a chain
recognised by the CDlb specific mAbs and SBU-T6.
In cattle, the mAbs which show CD lb-like reactivity have been clustered as
BoCDlw2, SBU-T6 as BoCDlwl and CC43 and CC118 as BoCDlw3 (Howard and
Naessens, 1993).
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In order to clarify the situation in the sheep with the previously studied mAbs and
characterize the mAbs CC43 and CC118, immunohistology was carried out on a
variety of tissues together with FACS analysis of blood, lymph (afferent and
efferent), and thymocytes. Although in most cases staining was carried out using all
the mAbs, CC20 was taken as representative of the CD lb mAbs due to availability
and the fact that it has been characterized by molecular means (Howard et al. 1993b).
Following studies on normal tissues, immunohistology was also carried out on
sections of gut from sheep infected with Mycobacterium paratuberculosis. Briefly,
infection with this organism can result in chronic disease of intestinal and lymphoid
tissues termed paratuberculosis or Johne's disease. The disease can be classified as
'tuberculoid' or 'lepromatous' according to the major lesions present. The former is
characterized by the infiltration of many lymphoid cells plus scattered focal
aggregates of macrophages with low mycobacterial load; the latter by heavy
infiltration of macrophages packed with mycobacteria. The reason this work was
carried out was to investigate whether infection with this bacterium would result in
any detectable upregulation of CD1 expression. This was considered a possibility
because of the recent evidence that CD1 is capable of presenting mycobacterial




All the mAbs used demonstrated the same pattern of staining within the thymus i.e.
strong staining of cortical thymocytes and isolated dendritic cells (DCs) within the
medulla. This staining is characteristic of CD1 a-c isotypes and is shown in Figure
3.1.
Within the skin, all the mAbs stain DCs in the dermis (Figure 3.2). In addition, the
mAb SBU-T6 also stains Langerhans' cells (LCs) within the epidermis (Figure 3.2a
and 3.2b). As shown in Figure 3.2c, CC118 stains DCs but not LCs. CC43 exhibited
the same staining pattern as CC118.
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In peripheral lymphoid organs, the mAbs SBU-T6, CC43 and CC118 demonstrate an
identical pattern of reactivity. In the spleen, there is staining of mantle zone B cells
in secondary follicles and also cells in the marginal zone and scattered red pulp
constituents (Figure 3.3). Within lymph nodes, there is a marked staining of cells
within the follicular mantle (Figure 3.4a) in addition to paracortical dendritic cells
(Figure 3.4b). The CD lb mAbs fail to stain B cells, however they do stain
subcapsular and paracortical dendritic cells. The staining characteristic of all the
CD lb mAbs is shown in Figure 3.4c which demonstrates staining of lymph node
DCs by CC20.
In the liver, SBU-T6, CC43 and CC118 also demonstrate an identical pattern of
reactivity and strongly stain Kupffer cells within the parenchyma (Figure 3.4d).
Within the intestine, the mAbs SBU-T6, CC43 and CC118 again form a cluster with
consistent staining of lamina propria macrophages (Figure 3.5a and 3.5b). No
staining of intestinal intraepithelial lymphocytes is observed with these mAbs. In
addition and consistent with the pattern of staining seen in spleen and lymph node,
these 3 mAbs also stain B cells in the dome region of small intestinal Peyers patches
and colonic lymphoid nodules (Figure 3.5c and 3.5d). Only very weak staining is
evident within the centre of the lymphoid tissue (F). No reactivity was observed
using the CD lb specific mAbs on intestinal tissue from 6-12 month old animals.
However, studies using tissue from late foetal lambs revealed a consistent pattern of
reactivity of these mAbs with crypt epithelial cells. Figure 3.6a and 3.6b demonstrate
this staining which is in contrast to that seen with SBU-T6 which fails to stain the
epithelial cells but stains lamina propria macrophages as described above (Figure
3.6c). Additional studies using foetal tissue demonstrated the presence of a network
of CD1 positive dendritic cells within the ileal peyers patches of the intestine
recognised by SBU-T6, CC43 and CC118. No positive lymphocytes were observed
in this region (Figure 3.7a and 3.7b). The significance of these results is discussed
below.
Within the central nervous system, staining of microglial cells was observed with
SBU-T6 and CC118. Figure 3.8 shows staining of these cells in the cerebellar
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medulla with CC118 (3.8a) and SBU-T6 (3.8b). No staining was seen in this tissue
using the CD lb mAbs.
Immunostaining of cytosmears of afferent lymph and mammary macrophages was
also carried out. The results are shown in Figure 3.9. Figure 3.9a shows afferent
lymph DCs staining with SBU-T6, Figure 3.9b with CC20. Figure 3.9c shows
mammary macrophages stained with SBU-T6 and developed using an alkaline
phosphatase system (this section was obtained from Dr. P. Berthon).
CD1 expression in disease
Sections from M.paratuberculosis infected sheep were also stained with a range of
mAbs. Sections from lesions characterized as either tuberculoid or lepromatous were
examined. Figure 3.10 shows the results of staining sections from a case of
lepromatous paratuberculosis with group 1 and group 2 mAbs. Figure 3.10a and
3.10b show staining of lymphoid cell aggregates by the mAbs CC118 (a) and
SBU-T6 (b). It is evident from Figure 3.10a that, as in lymph node and spleen
germinal centres, there is regulation of CD1 expression within the aggregate of
lymphoid cells as demonstrated by the crescent shaped region in the stained area in
Figure 3.10a. Figure 3.10c shows staining of isolated clusters of cells by the mAb
CC20 in lamina propria lymphoid tissue. Figure 3.10d is a higher magnification
(x400) which demonstrates clearly that the positive cells are arranged in isolated
clusters.
Figure 3.11 shows the results of staining sections from a case of tuberculoid
paratuberculosis with group 1 and group 2 mAbs. Figure 3.11a and 3.11b show
intense staining of lamina propria macrophages by the mAbs CC118 (a) and SBU-T6
(b). Figures 3.11c and 3.1 Id show intracytoplasmic staining of intestinal epithelial
cells by the mAb CC20.
The results of immunohistology are summarized in Table 3.1 with the CD lb type
mAbs being assigned to group 1 and SBU-T6, CC43 and CC118 assigned to group 2.




Immunoperoxidase stained sections of frozen thymus showing cortex (C) and
medulla (M). Mabs (a) CC118, (b) SBU-T6, (c) CC20 and (d) CC40 all demonstrate
strong staining of cortical thymocytes and isolated dendritic cells within the thymic
medulla (DC).
Magnification a, b, c - x400.



















Immunoperoxidase stained sections of frozen mammary skin.
SBU-T6 (a and b) shows staining of epidermal Langerhans' cells (arrowheads) and
dermal dendritic cells (arrows).
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Immunoperoxidase stained sections of frozen spleen showing red pulp (RP), white
pulp (WP) and marginal zone (MZ).
SBU-T6 (a), CC118 (b) and CC43 (c) show staining of mantle zone B cells within
the germinal centre (arrowheads) and scattered red pulp constituents.
Magnification a, b - x250.







Immunoperoxidase stained sections of frozen lymph node (a, b and c) and liver (d).
(a) CC118 showing staining restricted to mantle zone B cells (MZ) within the
germinal centre. Only isolated cells are stained within the follicle (F). Magnification
xlOO.
(b) SBU-T6 showing staining of dendritic cells within the lymph node paracortex
(arrowheads). Magnification x250.
(c) CC20 showing staining of subcapsular and paracortical dendritic cells
(arrowheads). Magnification x250.












Immunoperoxidase stained sections of frozen small intestine (a and b), jejunal Peyers
patch (c) and colonic lymphatic tissue (d).
(a) CC118 and (b) SBU-T6 show intense staining of lamina propria macrophages
(arrowheads). Magnification x250.
(c) SBU-T6 staining lymphocytes in the dome region of the Peyers patch (PP)
(arrowhead). Magnification xlOO.
(d) CC118 staining of dome region lymphocytes within a follicle (F) in colonic
lymphatic tissue. Magnification xlOO.
FIGURE 3.5
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Immunoperoxidase stained sections of frozen small intestine from late foetal lamb,
(a) CC20 and (b) CC14 show staining of cells lining the intestinal crypts.
(c) SBU-T6 shows staining of lamina propria macrophages.





















Immunoperoxidase stained sections of frozen small intestine from late foetal lamb
showing ileal Peyers patches.
SBU-T6 (a) and CC20 (b) show staining of dendritic cells within the lymphoid
tissue.
Magnification (a) - x250.





Immunoperoxidase stained sections of frozen cerebellum.
(a) SBU-T6 and (b) CC118 show staining of microglial cells within the medulla
(arrowheads).
Magnification (a) - xlOO.





Immunostained cytosmears of afferent lymph dendritic cells (ADCs) (a and b) and
mammary macrophages (c).
(a) SBU-T6 and (b) CC20 staining of ADCs.
(c) SBU-T6 staining ofmammary macrophages.
Magnification (a) - x250.
Magnification (b) and (c) - x400.
FIGURE 3.9
FIGURE 3.10
Immunostained sections of frozen small intestine from a sheep with lepromatous
paratuberculosis.
(a) CC118 and (b) SBU-T6 show staining of lymphoid cell aggregates within
follicles in the lamina propria.
(c) and (d) CC14 show staining of focal clusters of cells within lymphoid aggregates.
Magnification (a), (b) and (c) - xlOO.




Immunostained sections of frozen small intestine from a sheep with tuberculoid
paratuberculosis.
CC118 (a) and SBU-T6 (b) show intense staining of lamina propria macrophages.
CC14 (c) and (d) shows staining on the apical surface of villous epithelial cells (c)




Table summarising the results of immunostaining using anti-CDl mAbs. On the
basis of this staining, the mAbs are divided into:
Group 1 (CC13, CC14, CC20, CC40, CC90, CC132, CC122, TH97A and VPM5).
Group 2a (SBU-T6).
Group 2b (CC43, CC118).
TABLE 3.2
Table summarising the results of FACS analysis using anti-CDl mAbs. The mAbs
are grouped as above.
TABLE 3.1
TISSUE GROUP 1 GROUP 2a GROUP 2b












SPLEEN White pulp dendritic cells










LIVER Kupffer cells - + +
CNS Brain, spinal cord - + +
TABLE 3.2
CELL TYPE GROUP 1 GROUP 2a GROUP 2b
THYMOCYTES + + + (LOWER
INTENSITY)




EFFERENT LYMPH B cells - + +
AFFERENT LYMPH B cells
Dendritic cells
- + +




Flow cytometry was carried out on resting cell populations to establish the location
of constitutive CD1 expression as recognised by the group 1 and group 2 mAbs.
Thymocytes
The results of flow cytometry analysis using group 1 and group 2 mAbs on
thymocytes are shown in Figure 3.12. All the group 1 mAbs and SBU-T6
consistently stain 70% of thymocytes. In contrast, CC43 and CC118 stain 35% of
thymocytes with a lower intensity.
CD 1 has been shown in other species to exhibit reciprocal expression to MHC class I
within the thymus. In order to confirm this reciprocal expression within sheep
thymus, double staining was carried out using SBU-T6 and VPM19 (MFIC class I
specific). The result of this experiment is shown in Figure 3.13 and demonstrates the
mutually exclusive nature of the thymocyte populations expressing CD1 and MHC
class I.
Dendritic Cells
Single staining of afferent lymph dendritic cells with group 1 and group 2 mAbs is
shown in Figure 3.14. All mAbs stain approximately 70% of DCs including CC43
and CC118 although these latter mAbs demonstrate a lower intensity of staining.
Peripheral Blood Lymphocytes
Single staining results using gate 1 or gate 2 are shown in Figure 3.15. These results
show the increase in staining that occurs when the gate is enlarged to encompass
large lymphocytes and monocytes.
Double staining was carried out using the group 2 mAbs in conjunction with B cell
markers and a MHC class II marker (VPM46). The results are shown in Figure 3.16
and demonstrate that these antibodies recognise a non-B cell class II positive cell
when the larger gate is used. This was further investigated using the mAb VPM65
which recognises the ovine homologue of human CD 14 and can thus be used as a
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monocyte marker. This demonstrates that the group 2 mAbs recognise the majority
of peripheral blood monocytes.
In order to show that these antibodies were not recognising T cells, double staining
was carried out using mAbs for CD4, CD8 and y5 T cells. The results are shown in
figure 3.17 and confirm the absence of CD1 from these cell populations.
Afferent And Efferent Lymphocytes
Single and double staining results are shown in Figure 3.18 and 3.19. As expected,
CC118 and SBU-T6 recognise B cells in afferent and efferent lymph (identical
results were obtained using CC43). The apparently lower percentage of cells stained
in afferent lymph is a result of the fact that VPM30 stains activated T cells in
addition to B cells. To confirm this, double staining was also carried out using the B
cell marker DU2104 and SBU-T6. This is shown in Figure 3.19g. This demonstrates
that SBU-T6 recognises virtually all B cells in afferent lymph.
It is apparent therefore that the group 1 and group 2 mAbs have distinct patterns of
reactivity with cells in blood and lymph which parallels the results obtained by
immunostaining. The flow cytometry results also allow division of the group 2 mAbs
into group 2a (SBU-T6) which stains thymocytes and dendritic cells in an identical
way to the group 1 mAbs and group 2b (CC43 and CC118) which stain thymocytes
and dendritic cells at lower intensity and in the case of thymocytes stain a lower
percentage (although this is not seen on immunostaining of thymus sections - Figure
3.1a). The flow cytometry results are summarised in Table 3.2.
3.3 Discussion
The results obtained with the group 1 mAbs were to a certain extent expected in that
they demonstrated recognition of a molecule consistent with human CD lb i.e.
cortical thymocytes and dendritic cells in various tissues. The recognition by these
mAbs of CD1 on crypt epithelial cells within the intestine represents the only
situation where group 1 mAbs recognise a cell type that the group 2 mAbs do not.
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FIGURE 3.12
Flow cytometry analysis of sheep thymocytes.
(a) Forward and side scatter profile of thymocytes showing analytical region.
(b) Frequency histograms of thymocytes within the analytical region stained with
negative control VPM53 (... .), CC20 ( ) and CC118 ( ).
(c) Frequency histograms of thymocytes within the analytical region stained with
negative control (....), CC20 ( ) and CC43 ( ).
(d) Table showing percentage of cells stained when compared to the control and the














Two colour staining of sheep thymocytes using the analytical region defined in
Figure 3.12a.
(a) Negative control dot plot using biotinylated NMS (FL2) and VPM53 (FL1). The
negative control was used to set a quadrant as shown.
(b) Dot plot showing VPM19 (Class I) staining on FL1 and SBU-T6 staining on FL2.
%
FIGURE 3.14
Flow cytometry analysis of sheep afferent lymph dendritic cells.
(a) Forward and side scatter profile of dendritic cells within the analytical region.
(b) Frequency histograms of dendritic cells stained with negative control (. . . .),
VPM5 ( ) and CC118( ).
(c) Frequency histograms of dendritic cells stained with negatve control (. . . .),
VPM5 ( ) and CC43 ( ).
(d) Table showing percentage cells of stained when compared to the control and the
































Flow cytometry analysis of sheep peripheral blood mononuclear cells (PBMs).
(a) and (d) Forward and side scatter profile ofPBMs showing analytical regions 1 (a)
and 2 (d).
(b) and (c) Frequency histograms ofPBMs stained with negative control (....) and
SBU-T6 ( ) within region 1 (b) and region 2 (c).
(e) and (f) Frequency histograms of PBMs stained with negative control (....) and
CC118 ( ) within region 1 (e) and region 2 (f).
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FIGURE 3.16
Two colour staining of sheep PBMs using the analytical region defined in Figure
3.lid.
(a) Negative control dot plot using biotinylated NMS (FL2) and VPM53
(FL1).
(b) and (c) Dot plots showing CC20 staining on FL1 with VPM30 (b) or VPM65 (c)
staining on FL2.
(d), (e), (f) Dot plots showing SBU-T6 staining on FL1 with VPM46 (d), VPM30 (e)
or VPM65 (f) staining on FL2.
(g), (h), (i) Dot plots showing CC118 staining on FL1 with VPM46 (g), VPM30 (h)
or VPM65 (i) staining on FL2.
FIGURE 3.16
FIGURE 3.17
Two colour staining of sheep PBMs.
(a) Forward and side scatter profile ofPBMs showing analytical region.
(b) Negative control dot plot using biotinylated NMS (FL2) and VPM53
(FL1).
(c), (d), (f) Dot plots showing SBU-T6 staining on FL2 with DU2104 (c), SBU-T8
(d) and CC15 (f) on FL1.




Frequency histograms and two colour staining of sheep efferent lymph lymphocytes.
(a) Forward and side scatter profile of efferent lymphocytes showing
analytical region.
(b) Frequency histograms of lymphocytes within the region stained with
negative control (....), CC118 ( ) and SBU-T6 ( ).
(c) Negative control dot plot using biotinylated NMS (FL2) and VPM53
(FL1).
(d), (e), (f) Dot plots showing VPM30 staining on FL2 with VPM53 (d), CC118 (e)
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FIGURE 3.19
Frequency histograms and two colour staining of sheep afferent lymph lymphocytes.
(a) Forward and side scatter profile of afferent lymphocytes showing
analytical region.
(b) Frequency histograms of lymphocytes within the region stained with
negative control (....), CC118 ( ) or SBU-T6 ( ).
(c) Negative control dot plot using biotinylated NMS (FL2) and VPM53
(FL1).
(d), (e), (f) Dot plots showing VPM30 staining on FL2 with VPM53 (d), CC118 (e)




The group 2 mAbs demonstrated a much wider pattern of reactivity than is
associated with any of the recognised CD1 isotypes in humans. The major notable
features of the group 2 mAbs are:
• recognition of the majority of circulating B cells ( in contrast to the subset of B
cells recognised in humans).
• recognition of peripheral blood monocytes.
• recognition of tissue macrophages in various organs.
The remainder of this discussion will focus on the potential significance and possible
functional implications of CD1 expression as demonstrated by the mAbs used in
these experiments.
3.3.1 CD1 Expression by Antigen Presenting Cells
3.3.1.1 Dendritic cells
The presence of CD1 on dendritic cells, Langerhans' cells and a subset of B cells is
well recognised. The presence of all isotypes of CD1 on dendritic cells is a consistent
finding. Considering the key role of these cells in the immune response as described
in Chapter 1, it is logical to conclude that if CD1 has a functional role then it is likely
to have some involvement in DC function - potentially this could be envisaged as a
role in presentation of antigen.
Functional studies using sheep afferent lymph dendritic cells have shown that DCs in
resting lymph are characterised by uniform CD 1 expression however, after both
primary and secondary immune responses, there are detectable alterations in CD1
expression (Hopkins et al. 1989; Coughlan et al. 1996). Following secondary antigen
challenge (by OVA) in vivo CD1 expression is significantly reduced 2-8 hours post
challenge but by 24 hours levels become elevated compared with pre-challenge
values (Coughlan et al. 1996). This modulation occurs in parallel with modulation of
certain other cell surface markers including MHC class II and would be consistent
with a role for CD1 in the immune response.
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3.3.1.2 B cells
Whilst CD1 expression on dendritic cells is well recognised, the expression of ovine
CD1 described here i.e. monocytes, macrophages and the majority of circulating B
cells differs from mouse and man.
CD1 as recognised by the group 2 mAbs is found on the majority of circulating and
afferent and efferent lymph B cells. In addition B cells in defined anatomical
locations in the peripheral lymphoid tissues express CD1. In peripheral lymphoid
tissues, mantle zone lymphocytes are considered to be resting B cells; plasma cells
terminally differentiated B cells and germinal centre cells actively proliferating B
cells (Hsu and Jaffe, 1984).
Marker expression is highly variable among different stages of B cell activation and
it is difficult to study phenotypic changes associated with B cell maturation as there
is no bursa analogue in mammals (although ileal Peyers patches in sheep do have B
lymphopoietic capacity). Relevant to this point is the finding that B cells within the
Peyers patches in both foetal and adult intestine are not stained by group 1 or group 2
mAbs (Figures 3.5 and 3.7) implying that CD1 does not play a similar role in the
ontogeny of B cells as is proposed for T cells.
In peripheral blood, the pattern of CD1 expression on ovine B cells differs from the
human situation. In humans, CDlc and CD Id are expressed on B cells (Blumberg et
al. 1991; Calabi et al. 1991). CDlc is expressed on approximately 90% of B cells at
birth although subsequently the percentage of positive B cells decreases with age.
CDlc has also been shown to be expressed on B cells from children suffering from
severe combined immunodeficiency (SCID).
The group 2 mAbs consistently stain the majority of B cells in peripheral blood in
adult sheep in contrast to the small percentage of cells which are recognised in
human adults.
The secondary lymphoid organs i.e. the lymph nodes, spleen and gut associated
lymphoid tissue are the site of initial contact with antigen for B cells. The B cell
areas within this tissue are the lymphoid follicles. Primary lymphoid follicles are
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found prior to antigen challenge and consist of a network of FDCs and recirculating
B cells.
Secondary lymphoid follicles are characterised by the presence of germinal centres
(see below). During the exponential growth of blast cells as the germinal centre is
formed, the small recirculating B cells are excluded from the follicle centre and form
the follicular mantle (Liu et al. 1992).
The following is a diagrammatic representation of the structure of a secondary
follicle with the follicular mantle either entirely surrounding the GC or forming a cap
over it.
Results of immunohistology demonstrate a distinctive pattern of staining with the
group 2 mAbs in the follicular mantle in germinal centres in both lymph nodes and
spleen. Thus CD1 expression is restricted to the small recirculating B cells of the
mantle and is lost as the B cells develop through centroblast and centrocyte stages.
Within the spleen, the white pulp consists of sheaths of lymphocytes (mainly T cells)
surrounding the central arteries forming the periarterial lymphoid sheaths (PALS)
and lymphoid nodules (mainly B cells) which can form germinal centres as in lymph
nodes. Group 2 CD1 expression is observed here as in lymph nodes. The red pulp
consists of blood filled sinusoids and cords of cells between the sinusoids. These
cords contain macrophages, monocytes and lymphocytes in addition to blood
elements. Group 2 mAbs stain scattered red pulp constituents and also cells within
the marginal zone which consists of a layer surrounding the PALS and B cell
follicles predominantly composed of intermediate sized lymphocytes and
macrophages.
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Thus it is apparent that in lymphoid follicles within peripheral lymphoid tissue i.e.
lymph node and spleen, as the B cells develop into centroblasts and centrocytes
following contact with antigen, there is a marked down-regulation of CD1
expression. The significance of this observation is unclear. However loss of cell
surface expression following cell activation is a feature of a number of surface
molecules including MHC class II and it is possible that CD1, having performed its
'function' in the resting cell, is not required as the cell becomes activated.
3.3.1.3 Monocytes/ Macrophages
One of the major differences between CD1 expression in the sheep and in humans is
the constitutive expression on monocytes/ macrophages of the antigens defined by
the group 2 mAbs in the sheep.
Although CD1 expression is not constitutive on human monocytes, expression of
CDla-c has been induced by stimulation with the cytokines GM-CSF and IL-4
(Porcelli et al. 1992) and CDlc expression has been induced by GM-CSF alone
(Kasinrerk et al. 1993). Cytokines which induce MHC class I and class II expression
e.g. IFNy, do not however induce CD1 expression (Kasinrerk et al. 1993).
In humans, CD la expression has been shown on certain monocytic leukaemias
(Misery et al. 1992). Possible explanations for expression by these neoplastic cells
include deregulated expression of the CD la gene or the presence of a neoplastic cell
population representative of blast cells at a stage in ontogeny common to both
monocytes and Langerhans' cells.
Considering the expression of the molecule recognised by these mAbs on
monocytes, it is perhaps not surprising that they also recognise tissue macrophages -
again this pattern of staining is one which has not been described in other species.
Recognition of CNS microglial cells by the group 2 mAbs represents the first
description of CD1 expression within the CNS.
Constitutive expression of CD1 by the majority of ovine monocytes and
macrophages may indicate the presence of a different CD1 isotype on these cells. If
this is true then expression of this different isotype on ovine B cells could explain the
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inconsistency between the percentage of B cells which stain positive for CD1 in
humans compared to sheep.
3.3.2 CD1 In The Intestine
Group 1 mAbs
An unexpected finding was the presence of CD1 expression on foetal intestinal
epithelium and also on cells lining the crypts. This is a feature restricted to the group
1 mAbs and indeed represents the only situation where group 1 mAbs stain a cell
population that the group 2 mAbs do not.
In humans and mice, CD1 is expressed on intestinal epithelium, however, this is a
feature of the CD Id isotype and is not found with the human CD lb isotype.
Experiments in rodents using in situ hybridization to detect mRNA in this region
(Lacasse et al. 1992), showed that Paneth cells at the base of the crypts contain CD1
mRNA. CD1 expression in this region in late foetal lambs may have a role in
mucosal immunity. As described in Section IB. 1.2, the murine non-classical class I
molecule, TL is expressed on intestinal epithelial cells and has been proposed as a
restriction element for populations of T cells within this area with invariant TCRs.
CD1 in the sheep may therefore play a similar role although it is surprising to find
this pattern of expression with molecules recognised by the group 1 mAbs
(i.e.CD lb-like) when comparisons to other species would indicate that intestinal
epithelial CD1 expression is normally a feature of the CD Id isotype.
One alternative and purely speculative suggestion is that CD1 in this region could
play a role in the neonate analogous to the rat neonatal receptor for Ig (Section
IB.1.3).
Group 2 mAbs
The group 2 mAbs recognise cells within the lamina propria of the intestine which
resemble lamina propria macrophages. In addition, intense staining of certain areas
of the gut associated lymphoid tissue has been demonstrated. Again this is consistent
with the staining seen within lymphoid follicles in lymph node and spleen.
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The presence the group 2 CD 1 molecule(s) within the lamina propria and B cell areas
of the intestine is consistent with its presence on macrophages and B cells as
described above. In cattle, CC43 and CC118 have been shown to stain intraepithelial
cells within the intestine - this was not seen using these mAbs in sheep.
3.3.3 Modulation of CD1 expression in disease
It is apparent from Figures 3.10 and 3.11 that expression of both group 1 and group 2
CD1 molecules is modulated during mycobacterial infection. The pattern of
reactivity observed with the the group 2 mAbs (Figures 3.10 and 3.11 (a) and (b))
reflects that seen in normal tissue i.e. staining of macrophages and regulated
expression within B cell areas.
The alterations in group 1 CD1 expression which occur in tissue infected with
mycobacteria is interesting in view of the recent demonstration that T cells can
recognise mycobacterial antigens in the context of CD lb (Beckman et al. 1994,
Sieling et al. 1995). The focal clusters of CD lb positive cells which are seen in
Figures 3.10c and 3.1 Od could represent antigen presenting cells which have
up-regulated their CD1 levels in order to present the mycobacterial antigen to T cells.
It is possible that the macrophages which are present in the lamina propria (Figures
3.11a and 3.11b) become activated as a result of the infection and elaborate
cytokines which result in induction of CD1 within epithelial cells. However,
although this staining is apparently specific for the group 1 mAbs, it is intracellular
and as such may be artefactual although no such intracytoplasmic staining was
observed in controls or with group 2 mAbs. A recent report by Sugita and colleagues
(1996) describes localization ofCD lb to endocytic compartments. Assuming that the
staining observed in the intestine with the group 1 mAbs is not an artefact, it may
represent internalized CD1 that has been targeted to these endosomal compartments.
3.3.4 Summary
In summary therefore, it has been shown that all the 'professional' antigen presenting
cells in the sheep (i.e. B cells, monocytes, macrophages and dendritic cells)
constitutively express members of the CD1 family. The fact that CD1 expression is
restricted to APCs (with the exception of cortical thymocytes and intestinal epithelial
cells) implies a role for this molecule on these cells. In addition, the existence of a
CD1 molecule with a much wider distribution than CD1 molecules in man and
mouse may imply that sheep have retained or acquired a functional requirement for
this CD1 isotype which does not exist in man or mouse.
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CHAPTER 4
CHARACTERISATION OF OVINE CD1 ANTIGENS
4.1 Introduction
A variety of biochemical studies have been carried out on human and rodent CD 1
antigens and to a lesser extent on ruminant CD1. Surface iodination and subsequent
immunoprecipitation with anti-CD 1 mAbs demonstrated the different a chain
molecular weights associated with the different human CD1 isotypes (see Chapter 1).
In ruminants, the majority of mAbs immunoprecipitate a 46kd a chain consistent
with CD lb in humans. Exceptions to this are the putative anti-CD 1 mAbs, CC43 and
CC118, which have been shown to immunoprecipitate an a chain of 43kd in cattle
(Howard et al. 1993a). The biochemical nature of the CD1 antigens has been further
studied utilising the techniques of 2-dimensional electrophoresis, deglycosylation
and NH2-terminal sequencing.
Of the techniques listed above, only immunoprecipitation has been carried out using
anti-CD 1 mAbs in sheep. In order to further characterise the antigens recognised by
the group 1 and group 2 mAbs (as classified in Chapter 3), the techniques of
immunoprecipitation, two dimensional electrophoresis and Western blotting were
employed. Subsequently, affinity purification of antigens was carried out allowing
ELISA studies and NH2-terminal sequencing of the CD1 proteins. These studies were
considered to be of particular interest in view of the possible existence of a novel
CD1 isotype(s) as defined by flow cytometry and immunostaining data.
mAbs
For the majority of the studies described below, comparisons are made between
group 1 and group 2 mAbs. SBU-T6 and CC118 are used as group 2a and group 2b
mAbs respectively. CC20, which has been shown to recognise COS cells transfected





Immunoprecipitation of antigens from I125 labelled thymocytes was performed with
all the mAbs. Previous studies in the sheep have shown the existence of a 46kd a
chain with all the mAbs used (Dutia and Hopkins, 1991). A similar situation exists in
cattle with the exception of CC43 and CC118 which immunoprecipitate a 43kd
heavy chain (Howard et al. 1993). Figure 4.1a shows the results of
immunoprecipitation using the ELISA plate method with a panel of anti-CD 1 mAbs.
Under these conditions, all the mAbs immunoprecipitated a 46kd heavy chain in
association with p2 microglobulin with the exception of CC43 and CC118 which
failed to immunoprecipitate using this method.
In order to enhance any signal with these two mAbs, a similar technique utilising
streptavidin coated ELISA plates to provide an additional amplification step was
performed. Figure 4.1b shows the results of this experiment and demonstrates that
CC43 and CC118 immunoprecipitate an a chain of the same 46kd size as SBU-T6.
4.2.2 Western Blotting and Two-Dimensional Electrophoresis
Western blotting was carried out to establish whether any of the available mAbs
recognised antigen blotted onto nitrocellulose. Fresh thymocytes were lysed,
fractionated on a 12% SDS-polyacrylamide gel and blotted onto nitrocellulose. Strips
of the blot were subsequently incubated with individual mAbs. Figure 4.2a shows
that CC20 recognises a 46kd antigen. None of the other antibodies recognised blotted
antigen with the exception of SBU-T6 which gave a weak signal at 46kd when blots
were developed using enhanced chemiluminescence (ECL) (Figure 4.2b).
In order to further investigate the protein species recognised by the mAbs, the
technique of two dimensional (2-D) electrophoresis was used. In particular, a major
aim was to establish any obvious differences between the species recognised by the
group 1 and group 2 mAbs. Fresh thymocytes were lysed in sample buffer and run on
a two-dimensional gel as described in section 2A.9. The gel was subsequently blotted




(a) Autoradiograph of surface I125 labelled thymus lysate immunoprecipitated with a
panel of anti-CD 1 mAbs and run on a 5-20% non-reducing SDS-PAGE gel.
Immunoprecipitation was carried out using the ELISA plate method and normal
mouse serum (NMS) used as a negative control.
(b) Autoradiograph of surface I125 labelled thymus lysate immunoprecipitated with
SBU-T6, CC43, CC118 and NMS control. Immunoprecipitation was carried out
using streptavidin coated ELISA plates.
FIGURE 4.1a
NMS CC20 TH97A CC40 CC122 CC13 CC14 CC90 SBU-T6 CC43 CC118
FIGURE 4.1b
NMS SBU-T6 CC118 CC43
102,
FIGURE 4.2
Western blotting of thymus lysate.
(a)Western blot of thymus lysate incubated with NMS (lane 2) or CC20 (lane 1) then
developed using alkaline phosphatase.
(b)Westem blot of thymus lysate incubated with NMS (lane 1) or SBU-T6 (lane 2)


















electrophoresis (which allows separation of basic proteins) was used in the first
dimension (pH range 3.5-10). The CD1 antigens were concentrated at the acidic end
of the gel indicating that the proteins are not highly basic. Following investigation
using different ampholine ranges, optimal separation and definition of proteins was
obtained using isoelectric focusing in the first dimension with a pH range of 5 to 8.
The result of such a blot incubated with CC20 shown in Figure 4.3a illustrating a
range of protein species at 46kd and a single species at 33kd.
Repeating this experiment and incubating the blot with SBU-T6 followed by
development by chemiluminescence failed to produce a defined signal thus
comparison of group 1 and group 2 mAbs by this method was not possible.
A further attempt to compare the 2-dimensional pattern obtained with group 1 and
group 2 mAbs was carried out by running immunoprecipitated antigen on a
2-dimensional gel. Thymocytes were surface labelled with I125 and lysate was
immunoprecipitated as described for single dimension immunoprecipitations then
fractionated on a two-dimensional gel which was subsequently dried down and
exposed to X-ray film for several weeks. Figures 4.3b and 4.3c show the result of
antigen immunoprecipitated with SBU-T6 and CC20 respectively and run on a
2-dimensional gel. As a result of poor intensity and definition of protein spots, a
detailed comparison of the immunoprecipitates is not possible, however it is apparent
that the two immunoprecipitates are broadly similar.
4.2.3 Affinity purification of CD1 antigens
Affinity columns were made as described in Section 2A.12 using the mAbs SBU-T6,
CC14 and CC118. Following elution of these columns, the resulting purified antigen
was used for ELISA, blotting and NH2-terminal sequencing.
4.2.3.1 ELISA
The three purified antigens were coated onto ELISA plates and tested for reactivity
with a range of CD1 mAbs. The results are shown in Table 4.1. An irrelevant mAb
was also used as a control in these experiments. A negative result was considered to




Optimal conditions for analysis of CD1 in two-dimensional electrophoresis are
illustrated below. These conditions were used in the blot and immunoprecipitations






(a) 2-D IEF blot of thymocyte lysate incubated with CC20 then developed using
alkaline phospatase. This demonstrates 9 spots at 46kd with one smaller spot at 35kd.
(b) and (c). Autoradiograph of I125 labelled thymus lysate immunoprecipitated with
SBU-T6 (Figure 4.3b) or CC20 (Figure 4.3c) and run on a 2-D gel. Multiple poorly























Table showing ELISA data. Immunopurified CC14, SBU-T6 and CC118 antigens
were coated onto ELISA plates and incubated with a variety of anti-CD 1 mAbs.
Figures shown represent the readings obtained following detection of bound antibody
by indirect peroxidase technique and reading at OD595 on an ELISA reader. Each
result is the mean (+/- standard deviation) of three experiments performed in parallel.
An irrelevant mAb was also used as a control in these experiments. A negative result
was considered to be one which was less than the mean of the control plus three
times the standard deviation associated with that control. Using this criterion, these
data show that all the mAbs recognise the CC14 and SBU-T6 antigens with the
exception of CC118 (p < 0.001). The only mAbs to recognise the CC118 antigen are



































deviation associated with that control. Using this criterion, these data show that all
the mAbs recognise the CC14 and SBU-T6 antigens with the exception of CC118 (p
< 0.001). The only mAbs to recognise the CC118 antigen are CC118 (p — 0.011) and
SBU-T6 (p = 0.0005).
4.2.3.2 Western Blotting Using Purified Antigen
Deglycosylation
Having purified the antigen, and possessing a mAb from each of the groups which
blotted (i.e. CC20 and SBU-T6) further blotting experiments were carried out using
the purified CC14 and SBU-T6 antigens as protein on the blot.
Figure 4.4 shows the result of an experiment in which immunopurified untreated
antigen (lanes 1 and 3) and antigen treated with the enzyme N-glycosidase F (lanes 2
and 4) were fractionated by SDS-PAGE. The gel was blotted onto nitrocellulose,
incubated with CC20 then developed using ECL. This demonstrates that both the
CC14 antigen (lanes 1 and 2) and the SBU-T6 antigen (lanes 3 and 4) possess a
protein backbone of 33kd.
SBU-T6 - Blotting
Subsequent experiments using SBU-T6 to blot revealed some unexpected results.
Figure 4.5 shows the results of a non-reducing gel of immunopurified, acetone
precipitated CC14 and SBU-T6 antigen incubated with SBU-T6 and developed using
ECL. Whilst recognising the expected 46kd band on the CC14 antigen, major bands
of approximately 33kd and 66kd were observed on the SBU-T6 antigen in addition to
a much weaker band at the expected size of 46kd.
The nature of the 33kd and 66kd bands were further investigated by running samples
in non-reducing sample buffer alongside samples prepared in reducing buffer. Figure
4.6a shows the result of blotting immunopurified CC14 antigen (lanes 1 to 4) and
SBU-T6 antigen (lanes 5 to 8) followed by incubation in SBU-T6 and development
using ECL. Lanes 1 and 5 contain unprecipitated antigen in non-reducing buffer;
lanes 2 and 6 unprecipitated antigen in reducing buffer; lanes 3 and 7 precipitated
antigen in non-reducing buffer and lanes 4 and 8, precipitated antigen in reducing
buffer. The result demonstrates that, as before, SBU-T6 only recognises a 46kd band
on the CC14 antigen. With the SBU-T6 antigen however, the additional 33kd band
which is recognised (lane 5) forms a dimer when the antigen is acetone precipitated
(lane 7). The strength of the signal generated by the antigen in lane 7 has resulted in
poor definition of individual bands and as such the 67kd antigen is indicated with an
arrow. That the larger molecular weight antigen which appears following acetone
precipitation is a dimer of the 33kd antigen is confirmed in lane 8 when the use of a
reducing buffer reduces the antigen to 33kd. The lack of a visible 33kd band in lane
6 is probably the result of loading a smaller amount of antigen due to the use of a
less concentrated sample buffer.
The nature of the SBU-T6 antigen was further investigated by blotting the SBU-T6
antigen onto nitrocellulose then incubating one strip in CC20 (Figure 4.6b - lane 1)
and incubating another strip in 'Protogold' protein detection solution (Figure 4.6b -
lane 2). This shows that indeed the major protein present in the SBU-T6 antigen is at
33kd but this protein does not contain the epitope which is recognised by CC20.
In order to confirm that the 33kd antigen did not represent a deglycosylated form of
the 46kd antigen, precipitated SBU-T6 antigen was deglycosylated and run on a gel
as above. Figure 4.6c shows the results of this experiment. Lane 1 contains
precipitated untreated antigen; lane 2 contains precipitated and deglycosylated
antigen and lane 3 contains precipitated, deglycosylated and reduced antigen. This
shows that treatment of the SBU-T6 antigen with N-glycosidase-F reduces the size of
the 33kd antigen to 25kd thus demonstrating that the 33kd antigen is glycosylated.
The 46kd band only appears very faintly on this blot. The reason for this is not
certain however it was a general finding that antigen purified on different occasions




Deglycosylation of CD1 antigen.
Western blot of immunopurified CC14 antigen (lanes 1 and 2) and SBU-T6 antigen
(lanes 3 and 4). In lanes 2 and 4 the antigen has been deglycosylated. The blot was
incubated in CC20 and developed using ECL. This blot shows that the peptide
backbone of both these antigens as rcognised by CC20 is 33kd.
FIGURE 4.5
Western blot of acetone precipitated immunopurified CC14 antigen (lane 1) and
SBU-T6 antigen (lane 2) incubated with SBU-T6 and developed using ECL. This
shows that a band of 46kd is recognised on CC14 antigen but on SBU-T6 antigen,





(a) Western blot of immunopurified CC14 antigen (lanes 1 to 4) and SBU-T6 antigen
(lanes 5 to 8) incubated with SBU-T6 and developed using ECL. Lanes 1 and 5
contain unprecipitated antigen; lanes 2 and 6 contain unprecipitated, reduced antigen;
lanes 3 and 7 contain precipitated antigen; lanes 4 and 8 contain precipitated, reduced
antigen. In addition to showing the different molecular weight antigens recognised by
SBU-T6 on immunopurified SBU-T6 antigen in addition to the 46kd antigen
recognised on the CC14 antigen, this blot also shows that precipitation of the
SBU-T6 antigen results in the formation of a homodimer of the 33kd antigen.
(b)
Lane 1 - Western blot of SBU-T6 antigen incubated in CC20 and developed using
alkaline phosphatase.
Lane 2 - The same blot as in lane 1 but incubated in protein detection solution. This
shows the presence of two proteins - one at 46kd and a more prominent one at
30-33kd. CC20 does not recognise an epitope on this lower molecular weight protein.
(c)
Western blot of SBU-T6 antigen incubated in SBU-T6 and developed using ECL. In
lane 1, the antigen is precipitated; in lane 2, precipitated and deglycosylated and in
lane 3, precipitated, deglycosylated and reduced.
This shows that the smaller molecular weight protein recognised by SBU-T6 is




The main reason however for purifying these antigens was to obtain the
NH2-terminal amino-acid sequence - obviously this was of particular importance for
the SBU-T6 antigen.
The antigens were ethanol precipitated and fractionated by SDS-PAGE prior to
wet-blotting onto 'ProBlotf membrane as described in section 2A.15. After blotting,
the gel was stained in Coomassie Brilliant Blue to check transfer of proteins to the
membrane. Figure 4.7 demonstrates a stained gel of SBU-T6 antigen which had
retained a visible amount of protein on the gel and shows the presence of the 33kd
and 67kd bands which are recognised by SBU-T6 on a blot of purified antigen
(Figure 4.5).
On repeating this experiment, the 33kd and 67kd bands were again the most
prominent although a weaker band was present at 46kd (not shown). The 46kd band
and the 67kd band were excised from dried membrane and sent for sequencing. The
46kd band yielded two proteins and as a result the sequences were somewhat
ambiguous. The most likely sequences of the two proteins (based on the subsequent
sequence of the 67 kd band) are shown in Figure 4.8a. Sequence 1 matches the first
13 residues of the 67 kd sequence. A search of the database failed to reveal any
significant homology of sequence 2 to other proteins.
The 67kd band revealed a 29 amino-acid sequence shown in Figure 4.8b. When
compared to known CD1 sequences of different species, this sequence revealed
closest homology (66%) to the predicted amino-acid sequence of human CD IE in
this region.
The NE^-terminal sequence of the antigen recognised by CC14 was also obtained
using the same method. Following blotting of the antigen and drying of the
membrane, only a 46kd band was visible - this was excised and sent for sequencing .
13 amino-acids were obtained for the CC14 sequence and over this region there was
100% homology to the predicted amino-acid sequence of the ovine CD1 clones
SCD1B-42 and SCD1B-52 (Figure 4.9) and 85% homology to SCD1A25 which is
the only other ovine CD1 clone for which sequence is available in this region
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FIGURE 4.7
Photograph of a gel following SDS-PAGE of precipitated SBU-T6 antigen and
staining with Coomassie Brilliant blue. Lane 1 shows diffuse bands at 65-70kd and
30-35kd. Lane 2 shows marker bands. This gel demonstrates the size of the major









NH2-terminal sequencing results from the band excised at 46kd following
SDS-PAGE of immunopurified, precipitated SBU-T6 antigen. Two protein
sequences were detected resulting in some ambiguity in residues. However, utilizing
the sequence obtained for the 67kd band (Figure 4.8b), the individual sequences 1
and 2 were deduced.
FIGURE 4.8a
46kd band
SEQUENCE 1 EES P S FRLIQI SSFA
SEQUENCE 2 X D Q G Q F V L H Q K
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FIGURE 4.8b
N-terminal sequencing results from the 67kd band. 33 residues were obtained and the
sequence is compared known human, sheep and mouse sequences. The highest
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FIGURE 4.9
NH2-terminal sequencing of the 46kd band obtained following SDS-PAGE of
immunopurified and precipitated CC14 antigen. The sequence is compared to sheep
sequences and human CD IB. This demonstrates 100% identity of this antigen with
the predicted amino-acid sequence of the protein encoded by SCD1B-42/
SCD1B5-52 over this region.
I
FIGURE 4.9
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Immunopurified CC118 antigen was also sent for sequencing however sequence was
not obtainable due to N-terminal blockage.
4.3 Discussion
Biochemical studies on CD1 antigens
The results of immunoprecipitation reveal that the mAbs CC43 and CC118
immunoprecipitate an a chain of the same molecular weight as the other CD1 mAbs
i.e. 46kd. This is in contrast to the situation in cattle where these mAbs
immunoprecipitate a 43 kd a chain (Howard et al. 1993). Results obtained using I'25
immunoprecipitates in 2-dimensional electrophoresis did not yield a signal of
required definition or intensity to allow detailed comparison between the molecules
recognised by group 1 and group 2 mAbs. Despite this, it would appear that there is
no major difference between the patterns of protein species generated by
2-dimensional electrophoresis. In addition, the results demonstrate that the ovine
CD1 a chain consists of a similar number of protein species when compared to
murine and human CD1 when analysed in this fashion (Van Agthoven and Terhorst,
1982; Mosser et al. 1991) i.e 9 or 10 different protein spots within an IEF range 5 to
8.
The finding that SBU-T6 recognises an epitope present on a 33kd CD1 antigen (and
its 67kd homodimer) is unexpected as there is no evidence for immunoprecipitation
by this antibody of a molecule of this size. This may reflect the fact that the
immunoprecipitations were carried out using surface labelled cells whereas antigen
purification allows the mAb access to both intracellular and extracellular proteins.
Although there have been no specific reports of CD1 antigens existing in forms
outwith the 43-49kd range, the fact the CD1 genes are known to undergo alternative
splicing would be consistent with the existence of different molecular weight
isoforms (see Chapter 7). Boumsell and colleagues (1989) present
immunoprecipitates which clearly show bands at 30kd and approximately 60kd
although no controls are shown and this is not commented on by the authors. In
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addition, immunoprecipitation of rat spleen cells with anti-CD 1 mAbs revealed a
65kd band and a 29kd band in addition to the 'expected' 45kd band.
It is possible that the 33kd antigen could represent an intracellular form of the
antigen which would explain why the mAb does not immunoprecipitate this isoform
from surface labelled cells. An additional explanation involves the possibility of the
33kd antigen representing the product of an alternatively spliced CD1 gene.
SCD1B-52 contains a precise a3 deletion and, as discussed in Chapter 7, alternative
splicing is known to be a feature of the CD1 genes. Indeed, a deletion of any one of
the external domains could equate to a molecule of this size. Caveats to this theory
however are the inability of SBU-T6 to immunoprecipitate a 33kd antigen and in
addition, the deglycosylation data shown in Figure 4.6c clearly shows that the 33kd
antigen is not glycosylated to the same extent as the 46 kd antigen i.e. the 46kd band
is reduced by 13kd following deglycosylation whereas the 33kd band is reduced by
8kd. Since all the potential glycosylation sites are contained within the al and a2
domains, a molecule lacking the a3 domain would therefore be expected to
demonstrate the same extent of glycoslyation as a complete protein. It is possible
however that a combination of alternative splicing and differential glycosylation
could combine to produce the 33kd band. Relevant to this discussion is the
demonstration by Balk et al (1994) that CD Id can exist as a 37kd protein with no
N-linked carbohydrate.
Another possible explanation for this result is that the smaller protein represents a
proteolytic product of the intact 46kd antigen. Relevant to this hypothesis is the
evidence that the mAbs 1H1 and 3C11 (which recognise mCDl.l)
immunoprecipitate a 37kd band in addition to the 'expected' 48kd a chain from
murine cells (Bleicher et al. 1990). Also, the mAb 1H1 immunoprecipitated species
of 35, 28 and 17kd from CDld transfected cells in addition to the 48kd major protein
(Blumberg et al. 1991). This is perhaps the most likely explanation for this
phenomenon, indeed a similar situation has been described in the murine
non-classical class I antigen, TL and is referred to as the 'TL breakdown
phenomenon' (Chorney et al. 1991). Pickering and Wolcott (1979) first demonstrated
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degradation of the TL antigen postlysis and concluded that an autolytic mechanism
was functioning and cleaving TL at a susceptible hinge region similar to that found in
immunoglobulin molecules.
Explanation of these results is further complicated when considering the ELISA
results. The fact that SBU-T6 is a representative of the group 2 mAbs and as such
recognises an antigen with a wider distribution than the group 1 mAbs suggests that
this mAb may, as previously proposed, represent a 'pan-CD 1' mAb (Dutia and
Hopkins, 1991). SBU-T6 recognises not only its own antigen but also the group 1
antigen and that of CC118. The group 1 mAbs recognise a group 1 antigen (CC14)
and SBU-T6 antigen but not CC118. This data cannot be reconciled with SBU-T6
recognising an epitope common to all the CD1 antigens since the anti-CD lb mAbs in
turn recognise SBU-T6. The cross-reactivity that is clearly occurring under these
conditions may be a feature of the generally conserved nature of the CD1 antigens.
The only definite conclusion to be made from the ELISA data is that CC118
recognises a different antigen from the group 1 mAbs.
NH2-terminal sequencing results
Initial attempts at obtaining an NH2-terminal sequence for human CD1 antigens
indicated that the NH2-terminus was blocked (Lerch et al. 1986). Subsequently
however, Wang and colleagues (1988) reported the NH2-terminal sequence of the
rabbit CD lb antigen and more recently, Woolfson and Milstein (1994) have reported
the NH2-terminal sequence of a human CD la protein. These sequences are compared
with the sequences obtained using the mAbs CC14 and SBU-T6 in Figure 4.10. This
indicates that the point of cleavage of the signal peptide from the mature protein
differs between different isotypes in the same species and between the same isotypes
in different species.
Although the CC14 sequence is a 100% match to the predicted sequence of the
proteins encoded by the SCD1B-42 and SCD1B-52 genes, complete accuracy of the
SBU-T6 sequence cannot be assumed as this represents the sequence of a novel
protein. The initial sequence obtained for the 46kd antigen (Figure 4.8a) contained
several ambiguous residues and was only clarified after obtaining the sequence of the
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67kd band. In this respect, it is of note that the NH2-terminal sequence published for
rabbit CD lb (Wang et al. 1988) differs at residues 1 and 14 from the predicted
sequence of the rabbit CD lb gene published later (Calabi et al. 1989) - see Figure
4.10.
When the sequence of the SBU-T6 protein is compared to other CD1 sequences of
different species, it is clear that the most significant homology exists with the
predicted sequence of HCD1E (Figure 4.8b). Identity to the other CD1 sequences is
less than 55% in all cases across this region and of particular note is the fact that the
SBU-T6 sequence is no more homologous to the known sheep CD1 sequences than
to the CDla-d isotypes in other species providing strong evidence that this is the
sequence of a novel sheep CD1 isotype.
The isolation of the SBU-T6 antigen and its partial identity to the predicted
amino-acid sequence of the CD IE gene was an unexpected but very interesting
finding as a protein product of the CD IE gene has not yet been reported. The
significance and origin of the second protein identified alongside the CD1 protein at
46 kd is uncertain and in view of the fact that no homology to other proteins could be
found, it will not be discussed further.
As discussed in Chapter 1, analysis of the al and a2 regions of the CD1 molecules
has allowed division of the CD1 molecules into two classes based on the presence of
defined class specific residues. These residues are shown as boxed regions in Figure
4.11. The SBU-T6 antigen shares four class specific residues out of a possible five
with the predicted sequence of human CD1E (Figure 4.11). HCD1E is the only CD1
gene to have class specific residues of glycine at positions 30 and 33 in the al
domain. Considering this information together with the overall sequence homology
to CD IE, it is logical to conclude that the CD1 molecule recognised by SBU-T6 may
represent the sheep homologue of the antigen encoded by the CD IE gene. Although
no protein product of this gene has yet been described in humans, all of the human
CD1 genes have been shown to be transcribed in the MOLT-4 cell line implying that
the CD IE gene is transcriptionally active and does not represent a pseudogene. An
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alternative possibility is that the the antigen recognised by SBU-T6 represents a
novel CD1 isotype which may be peculiar to ruminants.
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FIGURE 4.10



















































































Interspecies comparison of NH2-terminal CD1 amino-acid sequences to illustrate the
existence of class specific residues. CD la, CD lb and CDlc belong to group 1 and
CD Id forms group 2. Human CDle is in an intermediate position as it shares some
class specific residues with both group 1 and group 2 proteins. With the exception of
the Leucine residue at position 14, the SBU-T6 protein shares class specific residues
with the predicted sequence of the HCD1E gene.
FIGURE 4.11
CLASS SPECIFIC CD1 RESIDUES
10 20 30
HCD1A S F H V TWI ASFYNHSWKQNLV S G
GROUP 1 HCD1B S F H V I QTS S FTNS TWAQTQG S G
HCD1C S F H V I QI F S F VNQS WARGQG S G
HCD1D P L R N L QI SSFANSSWTRT D G L A W L G
GROUP 2 mCDl.I T F R N L QMS S F ANRS WS RT D S V V W L G
mCD1.2 T F R N L QTSSFANI SWSRT D S L I L L G
GROUP3 HCDIE |SJF R M tJQTS S F ANHS WAHS E G |s G |W L f]
SBU-T6 [sJf rli qi ssfanhswtktqg |s g |x l |g
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CHAPTER 5
PCR FOR THE GROUP 2 OVINE CD1 GENE(S)
5.1 Introduction
The results of the NH2-terminal sequencing described in Chapter 4 clearly
demonstrate the identification of a novel CD1 protein. The next step was to utilize
this information to obtain the sequence of the gene encoding this molecule. The most
logical way to achieve this was to convert an appropriate region of the amino acid
sequence into nucleotide sequence which could then be used as a 5' primer along
with a conserved 3' primer in a PCR to isolate the cDNA encoding this antigen.
The strong sequence conservation within the a3 region amongst the CD1 isotypes
(which is present even amongst the most divergent isotypes) was exploited to
generate a 3' primer capable of recognising all of the CD1 a3 regions described to
date.
5.2 Design of the 5' Degenerate Primers
Several factors were taken into account in the design of the 5' degenerate primers.
Where possible, stretches of protein sequence were chosen which contained the least
ambiguous amino acids in terms of codon usage. Where several possibilities for
codons existed, a combination of known ovine codon usage and conserved residues
within the CD1 gene family was used to establish the most likely sequence coding
for the amino acids in that region.
Figure 5.1 shows the region of amino acid sequence which was chosen for generation
of the 5' primers and the sequence of the resultant primers P10763 and P14365.
5.3 Results
5.3.1 Thymocyte RT-PCR
The conditions utilized for all PCR reactions described in this chapter are shown in




Design of 5' degenerate primers.
(a) Region of amino-acid sequence chosen for design of the 5' degenerate primers.
(b) Sequences of the two primers derived from this region as described in the text.
FIGURE5.1









Table outlining primer usage and cycle parameters for individual PCRs.
TABLE 5.1
SUBSTRATE
CDNA PCR (NESTED) PRIMERS CYCLE NO. CYCLE PARAMETERS EXTENSION
THYMOCYTE P14365
P9414

















35 94 - 0.5', 55 - 0.5',
68-3'
-
1|i\ G5936, API P9413
AP2
20 94 - 0.5', 66 - 3' 72- 10'
LYMPH NODE P9414
P14365





35 94- 1', 55- 1.5',
72 - 1.5'
72- 10'







35 94- 1', 55- 1.5',
72- 1.5'
72 - 10'
ljrl PCD1, P9414 PCD3
LN02
20 94-1', 57- 1',
72-1'
72 - 10'
l(il PCD1, P9414 PCD3
LN03




cDNA was synthesized using either oligo-dT or random hexanucleotide primers as
described in Chapter 2B. The cDNA was then analysed by PCR utilizing primers
specific for the ATPase gene (Woodall et al. 1994). The ATPase message should be
detectable in all tissues (Schull et al. 1985) and any samples which were negative for
this PCR product were not utilized further.
Primers P10763 and P14365 were used in conjunction with conserved a3 region
primers with the aim of obtaining clones specific for the the gene encoding the
molecule recognised by SBU-T6. In addition, and in order to increase the specificity
of the PCR reaction, a nested PCR was carried out utilizing alternative oc3 region
primers in conjunction with the degenerate 5' primers. The design of this nested PCR
is illustrated in Figure 5.2. No specific PCR products were generated using either of
these approaches.
5.3.2 'RACE' PCR
Having been unable to generate 5' degenerate primers capable of detecting the CD IE
gene, an alternative approach, still utilizing the PCR technique was adopted. If gene
specific primers could not be generated to detect the specific CD1 gene from a cell
population containing all the CD1 genes (i.e. thymocytes), then a logical alternative
would be to use primers from a 'conserved' region of the gene in a cell population
which should only contain the gene of interest. Hence, utilizing the data showing that
only the group 2 mAbs detect a percentage of peripheral blood mononuclear cells
(i.e. B cells and monocytes), cDNA from this source was used as a substrate for PCR
reactions to attempt to isolate the gene.
Generation ofAdaptor Ligated cDNA
Total and PolyA+ RNA was isolated as described in Chapter 2. The Clontech
'Marathon' cDNA kit was then used to generate double stranded cDNA which
subsequently had adapters ligated onto both ends. 10% of the cDNA synthesis
reaction was run on a gel alongside the manufacturers control and is shown in Figure
5.3. This demonstrates the presence of a wide size range of cDNAs. Preparation of a
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FIGURE 5.2
Diagram illustrating primer usage in nested PCRs using the degenerate 5' primers in
conjunction with conserved a3 region primers.
FIGURE 5.2




population of cDNA with adapters ligated at both ends was necessary as the a3
region was the only region for which a primer sequence was known. Hence an a3
specific primer could then be used as the gene specific primer in conjunction with the
supplied adapter primer in a 'RACE' PCR.
A diagrammatic representation of the 'RACE' PCR technique used is shown in
Figure 5.4. a3 primers were designed which were conserved across all known CD1
genes and utilised in both 3' and 5' PCR reactions.
This technique generated a product of the expected size following a nested PCR
reaction utilising two a3 gene specific primers and adapter primers 1 and 2 (Figure
5.5a). The product was purified using a spinbind column and cloned as before using
the TA cloning kit (Invitrogen). Sequencing of this insert revealed 90% homology to
the previously cloned ovine CD1 gene SCD1B-42. This result was unexpected in that
the earlier studies using mAbs to characterize CD 1 expression showed that the group
1 mAbs did not react with PBLs. Thus any cells expressing 'CDlb' (i.e. dendritic
cells) would be expected to be present in much smaller quantities than cells
expressing the CDle-like isotype recognised by SBU-T6.
5.3.3 Lymph node RT-PCR
For the work described in Chapter 6 to transfect cells with a cDNA library containing
the gene of interest, a lymph node library contained within the vector pcDNA3 was
obtained from Dr. Wayne Hein (Basel Institute for Immunology). A 1 TOO dilution of
this library was used as a substrate for PCR utilizing the degenerate 5' primers
described above in conjunction with a conserved a3 region primer. The results of
this PCR are shown in Figure 5.6a. The band which exists at approximately 700bp
was estimated to be the correct size and was found consistently on repeating this
PCR. A larger amount of the PCR product was therefore run on a gel and this band
excised and purified using a spin bind column. The purified fragment was run on a
gel to estimate quantity (Figure 5.6b) and was cloned using the TA cloning kit. 6
positive clones were analysed and restriction digests of the plasmid with EcoRI
revealed that each plasmid contained the correct sized insert and 5 of the inserts
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FIGURE 5.3
Agarose gel analysis of cDNA generated from mRNA using the 'Marathon cDNA kit'
(Clontech).
M - marker DNA
Lane 1 - control DNA.
Lane 2 - cDNA from PBL mRNA.
Figure 5.4
Diagram illustrating strategy for 'RACE' PCR utilising gene specific primers in






GSP1 > 4 API
GSP2 », 4 AP2
GSP1 - CD1«3 PRIMER G5936
GSP2 - CDla3 PRIMER P9413
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FIGURE 5.5
PCR and cloning ofDNA from RACE PCR utilising primers as in Figure 5.4.
(a) - Nested PCR on adapter ligated PBL cDNA.
M - Marker DNA.
Lane 1 - First round ofPCR (Primers G5936 and API).
Lane 2 - Second round of PCR (Primers P9413 and AP2).
(b) - Cloning of 700bp product.
M - Marker DNA.
Lanes 1-7 - EcoRI restriction digests of plasmid from seven clones showing





contained an internal EcoRI site (Figure 5.6c). Sequencing of the insert confirmed
that this was a CD1 gene which had closest homology to the CD ID genes and thus
will now be referred to as SCD1D.
5.3.4 PCR for 5' and 3' ends of SCD1D
Having obtained partial sequence for the SCD1D gene, it was necessary to obtain full
length sequence for this gene. The strategy adopted to perform this utilized the fact
that the original sequence was obtained from a cDNA library within the vector
pcDNA3. Primers were thus generated based on the sequence of this vector at both
ends of the multiple cloning site and internal gene specific primers were designed
based on the sequence of the segment of the SCD1D gene which was already cloned.
The location of these primers and demonstration of the PCR strategy is illustrated in
Figure 5.7.
Figure 5.8a shows the result of an anchored PCR for the 3' end of the gene. Lane 1
shows the products generated using primers LN01 and PCD2. Lane 2 shows the
more specific result obtained by performing an anchored PCR using primers P9413
and PCD2 in a second PCR utilising DNA from lane 1 as a substrate. Since the
primers used in the first and second rounds of PCR were 350bp apart, the product in
lane 2 was thus the expected size and was cloned. 8 positive clones were analysed
and restriction digests of the plasmid revealed that 5 contained an insert of the
correct size (Figure 5.8b). Sequencing confirmed this to be the 3' end of the SCD1D
gene.
Figure 5.9a shows the result of a nested PCR for the 5' end of the gene. The first
round of PCR used the primers PCD1 and P9414. This PCR did not generate a
specific product therefore 2 nested PCRs were subsequently carried out using this
DNA as a substrate. Lane 1 shows this nested reaction utilizing primers PCD3 and
LN03, lane 2 utilizing primers PCD3 and LN02. It is apparent that multiple bands
are present in both reactions therefore it was necessary to perform a Southern blot of
this gel and probe the DNA with internal oligonucleotides.
The result of the Southern blot is shown in figure 5.9b. This demonstrates
hybridization of the probes to virtually all the bands. However the probes did not
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hybridize to all the bands in lane 1 and those bands which are positive all show a size
reduction in lane 2 consistent with an internal primer which was 200bp closer to the
5' end. This suggested that these bands did represent varying amounts of the 5' end of
the LN1 gene. The largest band was therefore chosen for cloning. Restriction digests
of purified plasmid from 8 clones are shown in Figure 5.9c. 6 of the clones contained
inserts with internal EcoRI sites suggesting that this was indeed the 5' end of the
gene. Sequencing of the inserts confirmed this, however the sequence obtained for
the 5'UT region was not consistent with CD1 sequence and no methionine residue
was evident. It thus appeared that the library was truncated at the 5' end such that
sequence was only valid from residue 5 of the al domain (Figure 5.12).
Having obtained clones containing DNA for the majority of the gene, 4 clones for
each section of the gene were amplified and purified using Qiagen midiprep
columns. Sequencing of all four clones was then carried out and a consensus
sequence for the gene obtained. Where nucleotide ambiguities existed, three out of
four identical residues was taken as the consensus sequence.
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FIGURE 5.6
PCR and cloning using lymph node cDNA.
(a) PCR on lymph node cDNA.
M - Marker DNA.
Lane 1 - Multiple bands using primers PI4365 and P9414. The band at the
correct size (700bp) is indicated by an arrow.
(b) DNA used for cloning. This was obtained by running a larger amount of the
PCR product on a gel and excising the 700bp band from the gel. This was
then purified on a spin-bind column.
(c) EcoRI restriction digests of plasmids from six clones.
M - Marker DNA.
Lane 1 - Uncut plasmid.
Lanes 2-7 - EcoRI restriction digests of six clones showing 700bp inserts in




Diagram illustrating the primers used and PCR strategy employed to obtain the 5' and
3' ends of the SCD1D gene.
A- Initial PCR reaction
B- Nested PCR for 3' end.
































PCR and cloning of the 3' end of the SCD1D gene.
(a) Nested PCR for the 3' end.
M - Marker DNA.
Lane 1 - Multiple bands but large amounts of lOOObp product using primers
LN01 and PCD2.
Lane 2 - Anchored PCR using primers P9413 and PCD2. One specific 650bp
band is present.
(b) Cloning of 3' PCR product.
M - Marker DNA.
Lane 1 - Uncut plasmid.
Lanes 2-9 - EcoRI/Hindlll restriction digests of plasmid from positive clones.




PCR and cloning of the 5' end of the SCD1D gene.
(a) Nested PCR utilising DNA generated with primers PCD1 and P9414 as a
substrate.
M- Marker DNA.
Lane 1 - Multiple bands generated using primers PCD3 and LN03.
Lane 2 - Multiple bands generated using primers PCD3 and LN02.
(b) Southern blot of gel in Figure 5.9a probed with radiolabelled internal
oligonucleotides specific for the SCD1D gene. Lanes 1 and 2 correspond to
lanes 1 and 2 in Figure 5.9a.
(c) Cloning of the 1.2kb product in Figure 5.9a - lane 2.
M- Marker DNA
Lane 1 - Uncut plasmid.
Lanes 2-9 - EcoRI/Hindlll restriction digests of 7 positive clones. Lanes 2, 4,
5, 6, 8 and 9 contain inserts of the correct size and also demonstrate the
presence of an EcoRI site within the insert.
Figure 5.9
5.4 Sequence analysis
The SCD1D sequence was compared at the nucleotide and amino acid sequence level
to sheep, human, mouse and rat sequences using the GAP programme of UWGCG
8.0. GAP uses the algorithm ofNeedleman and Wunsch (1970) to find the alignment
of two sequences by maximizing the number of matches and minimizing the number
of gaps. Default settings for gap weight and gap length (5.0 and 3.0 for nucleotide
comparisons, 0.3 and 0.1 for amino acid comparisons respectively) were used.
Table 5.2 shows the percentage identity at both nucleotide and amino acid level
between SCD1D and known sheep, human, rat, mouse and rabbit sequences. The
sequence has closest homology to human CD ID (76.15% identity at the nucleotide
level, 63.8% identity at the amino-acid level) and has greater than 70% identity at the
nucleotide level with all the CD ID-like genes (with the exception of rat CD1 which
is 69.54% identical). Identity to the group 1 CD1 genes (i.e. CD1A, -B and -C and
the sheep CD1 genes) is less than 65% at the nucleotide level whilst identity to
HCD1E is 66.67%. This demonstrates that this sheep CD1 gene is most closely
related to the CD ID genes.
The PILEUP programme was used to compare SCD1D with the other sheep
sequences and with CD ID cDNAs in other species. PILEUP creates a multiple
sequence alignment using progressive pairwise alignments. Figure 5.10 shows
sequence comparisons between SCD1D and the sheep CD IB-like cDNAs.
Numbering is based on the full length sequence of SCD1A25 and SCD1B-42. A
similar comparison between this cDNA and cDNAs of the CD ID family (i.e. mouse
CD 1.1 and CD 1.2, ratCDl cotton-tail rabbit CD1 and human CD ID) are shown in
Figure 5.11. It is apparent from Figure 5.11 that identity in the 3' untranslated region
appears to be very low with few regions of identity existing across the six genes.
Table 5.3 shows the percentage identity between the domains of SCD1D and the
domains of the other CD ID-like genes. As expected, the highest degree of homology
exists in the a3 domain with the lowest homology in the 3' untranslated region when
compared to rodent CD1. It is notable however that SCD1D is 65.45% identical to
human CD ID in this region which is apparently higher than that shown in Figure
137
5.11 when sequences are aligned using PILEUP. Figure 5.12 resolves this
contradiction by demonstrating that the GAP programme (which can achieve an
optimal alignment of the two genes by introducing gaps into the sequence) shows
regions of considerable identity throughout the 3' untranslated region of SCD1D and
HCD1D.
The identity in the 3' untranslated regions of the CD1 genes is shown in Table 5.4.
This shows that SCD1D is more homologous to HCD1D in this region than any of
the rodent CD1D genes. SCD1B-42 and SCD1A25 show a similar percentage
identity when compare to HCD1B (63% and 65% respectively).
It is interesting that although mCDl.l and mCD1.2 are only 54% identical in this
region, RtCDl is 81% identical to mCDl.l. The only other genes which achieve this
level of identity are SCD1B-42 and SCD1T10 i.e. genes from one species. This may
have implications for the evolutionary relationship ofmCDl.l and RtCDl.
Interspecies comparisons of both groups of CD 1 amino acid sequences are shown in
Figure 5.13. Potential N-linked glycosylation sites are indicated by an asterisk. Class
specific CD1 residues for CDld-like proteins (as defined by Calabi et al. 1989b) are
indicated by boxed residues. SCDld has three potential N-linked glycosylation sites
compared to five in mCDld and four in human and rabbit CD Id. It can be seen that
SCDld shares the majority of class-specific CD Id residues in the al domain (11 out
of 12) and in the a2 domain shares 8 out of 13. Since SCDlb proteins do not contain
all the CDla-c class specific residues, it is apparent that as more CD1 genes and
proteins are identified in different species, so the original definition of these class
specific residues may have to be modified.
The cytoplasmic tail of SCDld contains a YXXZ motif (where Z is a hydrophobic
residue). It has recently been shown that CD lb localizes to an endocytic
compartment and that this localization is dependent upon the tyrosine-based motif in
the cytoplasmic tail (Sugita et al. 1996). This motif is shared by the all the other CD1
proteins with the exception of HCDla (and the predicted sequence ofHCD1E).
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TABLE 5.2
Table comparing percentage identity at nucleotide and amino-acid level between


















Alignment of ovine CD1 sequences using the PILEUP programme of UWGCG 8.
Domain boundaries were defined by the SCD1B sequences.
Dashes indicate identity to the SCD1D nucleotide sequence. Dots indicate gaps


















GAAGGAAGTC AGTACAGAGT ACTGAAAAAA .AAAAAAAAAG CTGAAATTAG
GGAGGAAGTC ACTATAGAGT ACTG...AGA AAAAGGTTTG CTGAAATTAG
51 5' Untranslated 100
CTCCGA GAGTCAGAAG TTCTACTTCC CAGTGAAATG
AGATCAAATA CCAGCTCCGA GAGTCAGAAA TTCTACTTTC CAGTGAAATG
AGATCAAATA CCAATTCTGA GAGTCAGAAG CTCTACTTCC CATTGAGATG
101 Leader 150
CTGCTTCTAC CACTTCTGTT ACTTGGAGTT ATCCTCCCAG GTGGTGACAA
CTGCTTCTAC CGCTTCTGTT ACTTGGAGTT ATCCTCCCAG GTGGTGACAA



























CC CCGCAAACGT CTTTCCCCTT CCGCTTCCTC CAGATCTCCT
TGAGGATGTG TTCC-GGG-C -AAC-T —ATC—AAG T—AA
TGAGGATGTG TTCC-GGG-C -AAC-T —ATC—AAG T—AA































































AGCATACATT TCAGGTTTAT CGCAGCAGCT TCACCAGGGA CATCCGGGAA
—G-C-TC— C-GA-CC—C TT—TTTT— TCA AG-G-A T
T-G-CCTC-- C-GA--C--C -T--TTG-A- TTC AG-G-A T

















































TTCGTGAAAA TGCTGCCTGG AGACT ATCCT TTTGAGATCC AGATATCTGG
CGA—C—TG A-T-C-AGTT A- -C--C T --G-CA-A-C
CGA--C--TG A-T-C-AGTT A- -C--C T --G-CATA-A
CAT—C-GTG AAT-C-AGCT G--A- -C--C T --GACATA-C



































































































































CAAGTGAAGC CAGAGGCTTG GCTTTCCAGT GGCCCCAGTC CTGGGCCTGA
751 800
CCGTCTGCTG CTGGGGTGCC ACGTCTCAGG ATTCTACCCA AAACCTGTGT
C—AT— TC -T T AC
801 850

































GACGTCATGC CCAATGCCGA CTCGACTTGG TATCTGCGAG TAACCCTGGA
A AA- T-G C C A--
A—A A- T T— T-G
. C
901 950
GGTGGCGGCT GGGGAGGCGG CTGGCTTGAG TTGCCGTGTG AAGCACAGCA
951




































































..CTC TCCTGCCCAC ACCTATCTGT CTGGACTTCA GGATCTCAGG
3CACT GA-C-TGTCT C-T-T—CA- T-T-GAA-A- -T CAG-T
C-CT GA-CATGTCT C-T-T—..A T-T-GAA-A- -T CAG-.
C-C. AT-ACTGTCT C-T-T—C.A T-T-GAA-A- -T-C-CAC-A
ITC-CT GA-CATGTCT C-.-T--CCA T-T-GAGCA- TT-C-CAG-A
1151 1200
SCD1D CCTTTAGCCC TCAGAATTTG AGGGTGAAAG AGAGCTACCT TGAAGAAGCA
SCD1B-52 A-CC-GAAA- AGT-G-C —CC-AGG— TC—TCT-A- CAT-TTTCAT
SCD1B42 AACC-GAAA- -T-AGT-G-C —CC-AGG— TC-ATCT-A- -AT-TTTCAT
SCD1A25 A-CCAGAAA- AGCGG-C —CCCAGT-- CC-AT-T-A- CAT-TTTCAT
SCD1T10 G-CCAGAAA- GT-GAC --CCCAGG-- TC-AT-T-AC -AT-TTTCAT
1201 1250
SCD1D GAGAAGAGGG AGCTCTTCTC ACACACTTTG AACATTTTAG CTAAGAGGAT
SCD1B-52 C-A-TA-TCA TCACA—TGA TC-A-.CA-T GTTCC-G G-TGT-A
SCD1B42 C-A-TA-TCA TCACA--TGA TC-A-TCA-T GTTCC-G G-TGT-A
SCD1A25 C-A-TA-TCA TCTGA-CAAA TC-A GTTCC-G A-TGC-A







TTAAGTTTAT TTTTTTCTTT TAGTATACTA CAAGTGTATA TGTCCAAGCA
AG-TCA-A— —A-AC-C-A GCAG-A—A- A—TGAA-AT TATTATG
AA-TCA-A— —A-ACTC-A GCAG-A--AT A—TGAA-AT TATTATG
CAG A-AC-G-A-T A GTGT-C ATATATTATG
AA-TCA-A-- —A-A-AC-G GT-G-A-AAT G-..-AA-GT GTA-ATTAT-
1^2
1301 1350
SCD1D GTTCTGTAAA AAAAGAAGTG CAAACTCAGA TACGTCTCAG GGACAAGCAG
SCD1B-52 AGA-CA--TC -CT—C—GA TCC -TTCATAG-T -TGATTTGT-
SCD1B42 AGA-AA--TC -CT—C—GA TCC -TTCATAG-T -TGATTTGT-
SCD1A25 AGA-AA—CT —T-TT—GA TCTG -TTC-TGG-T -TGGG-TGC-
SCD1T10 AGA-AA--TC -CT—T—AA TCC—A-G— -TTC..AGGT -TGA-GTGT-
1351 1400
SCD1D ATAAAGGTTG CAGTGTAAAA AAAAAAAAAA AAAAACCGGC GCTCGAGCAT
SCD1B-52 -G AA-A T-CCT-GG-- T TG T G-TGTA-ACA AAAAA-AAAA
SCD1B42 -G .A-A T-CCT-GG— T TG T G-TGTA-AC.
SCD1A25 GG AA— T-CCT-GT— T TG T G-TGTA-AC.
SCD1T10 -G AA— T-TCTC-G-C T TG T G-TGTG-A-G A—AA-TTG-
1401 1450




SCD1T10 -ACAT-CCTT TGG—TCTTA T-TTATAACA T-TTT-T-AC TCC—CTGAA
SCD1T10 ATATCATTTG TCAAAATGAG CTAATTGTAA TTATGTCAAG ATAATTGTAT
SCD1T10 TTGCAGAGAT GACCAGCATT TTAACTTAAT TTCATTGTAT CTGCTTGGAT
SCD1T10 GATTTTCTAT CTTGGAGAAA CTGAGCTCCT TCTTCTTCCA GGGAGCCTTC
SCD1T10 CTTGGTCCTA CAGTAGAAGT AACCATCCCT TGACTGATGT CATGCAGAGA
SCD1T10 TCTACTTTCC TCTTTACTCA GAACATTGCA GTTCTTTATG TTTTCTTTTC




Alignment of ovine CD1 sequences using the PILEUP programme of UWGCG 8.
Dashes indicate identity to the SCD1D nucleotide sequence. Dots indicate gaps














.CCCC GCAAACGTCT TTCCCCTTCC GCTTCCTCCA GATCTCCTCC
G-CT- C G G
A-AA- -A-A 1 G G— G--T
A-AA- -A-A G G— —CT— T
— ...A-AA- -A-A T G G— T
GAAG- G—T- ATGGA—G—
203 252
SCD1D TTTGCCAACC ACAGCTGGAC GCGCACGGAC GGCCTCATGT GGCTGGGGGA
HCD1D —C TA G C T-GGC—
MCD1D1 A A GA T- C A A—G-GG-C-
MCD1D2 T A TA T- C A A G—C- T
RATCD1D --C GA T- C A A-TG-GG-C-
CTRABCD1D T A G CA A A T—T-GGC—
253 302
SCD1D GCTGCAGCCC TATACTTGGC GCAATGAGTC GAGCACCATC CGCTTCCTGA
HCD1D A-G C-C-GC A C—C— -GA G— CT
MCD1D1 T A-T C-CCG A -T C— AGC A AC—
MCD1D2 T A-A C-CCG A -T C— AGC A AC—
RATCD1D T A-A C-CCG A -T C— AGA A ACA-
CTRABCD1D A-G C-C-G A C— AGA -A
303 352
SCD1D AGCATTGGTC TCAGGGCACA TTCAGCGACC AGCAGTGGGA GCAGCTGCAG
HCD1D C C G -AC
MCD1D1 CA C AG --G--TA -A--T
MCD1D2 CA C AG —G—TA -A—T
RATCD1D CG C A- TA -A--T
CTRABCD1D CC C A-TT-- G
353 402
SCD1D CATACATTTC AGGTTTATCG CAGCAGCTTC ACCAGGGACA TCCGGGAATT
HCD1D T G A G -GAA
MCD1D1 TG -A—C AGT T -A-A
MCD1D2 TG -A--C AGT T -A-A
RATCD1D TG -A—GC A-C T —AA A-


























- C A C G-G-
453 502
CTGGAGGATG TGAGTTACTC CCAAGGAATA TCTCAGAAAG CTTCTTACGT
-C-CT—C— G-G-A- --TG CG C A-T-A C-A-
CG--C-- AA-GTA- --TG G CT--G T AC
--ACC--C-- AA-GTA- --TG G CT--G T--T-A-
CT—C— AA-GTA- —TG G CT T AC
T--CT--C-- A-G-A- --TG-C C C-A-
503 552
SCD1D GCAGCGCTTC AAGAAAAGGA TGTCCTGAGT TTCCAAGGAA TGTCTTGGGT
HCD1D -T AT G A-- -A CT A
MCD1D1 -T AT G AT- G A TGG C C CA
MCD1D2 -T AT G AT- —C-G A GG CA CA
RATCD1D -T AT G-G-AT- G :-A T CA—C CA
CTRABCD1D -TG—CTA— G—T-C- TT G CT-TG A
553 602
SCD1D GTCAGCCCCA GATGCACCCC CTTGGAGCCA GGTGGTCTGC AAGGTGCTCA
HCD1D -C—A A- —G—C—A- T GTAA- CT C-ATT C-A
MCD1D1 -A T -GG—C—AT TTAG- CT—CC-AT- —A
MCD1D2 -AGG-T—T- -GG—C—AT TTAG- CT—CC-AT- —A
RATCD1D -AAG-T —G—C—AT TTAG- TT—CC-AT- --AA
CTRABCD1D -A T -GGA-T—G- -G-TTGTAA- -C-T—TGT- --A-A
603 652
SCD1D ATGAGGACCA AGGGACCAAG GAAACGGTGC ACTGGCTCCT CCATGACATC
HCD1D -CC A- GT G-G- A -G TA G--C-
MCD1D1 -C-CT--T-- A-GT -C C -GAT GA C-
MCD1D2 -C-CT—T— A-GT -C C -GAC GA C-
RATCD1D -C-CT--TG- A--G-GA A -GATA GA-C C-








TGCCCCGAGT TGGTCAAAGG CCTCATGCAG ACCGGGAAGT CCGAGCTGGA
C-A- -T GT— C-TG— T-A -G--A A-
CTAT -T CGT— T C-AG— G-A-—




-T CGT— C-AG-A G-A C -A—C--A--









TG AAGCCAGAGG CTTGGCTTTC CAGTGGCCCC AGTCCTGGGC
-A- T— -C T-G— T --CT CAG
-A- T— -C T-G— T --CT CA-
-A- T— -C T-A-- -C -AC CC-
753 802
SCD1D CTGACCGTCT GCTGCTGGGG TGCCACGTCT CAGGATTCTA CCCAAAACCT
HCD1D G T- T G
MCD1D1 A—G--A-AG --A T- --T—T -T--C
MCD1D2 A—G—A --A T- —T— T -T—C
RATCD1D A—G—A —A TA --T— T -T—C C- G
CTRABCD1D G A TA —C-GT -T—C G
803 852
SCD1D GTGTGGGTGA TGTGGATGAG GGGCGAGCAG GAGGAGCCTG GCACTCAACA
HCD1D —A A C- T C AG- G-C
MCD1D1 C C- T—C C-A-AG- -T CAG
MCD1D2 C- T--C C-A-AG- -T CAG
RATCD1D C- T—C C-AGGG- -T CAG
CTRABCD1D —ACA C- A--C C AC A G
853 902
SCD1D AGGAGACGTC ATGCCCAATG CCGACTCGAC TTGGTATCTG CGAGTAACCC
HCD1D G A— C -T GA A C C
MCD1D1 T—TT— C A -T— TGA A T -A--C
MCD1D2 T—TT— C A -T--TGA A T -A--C
RATCD1D T A— C A -G—TGA A T -A--C
CTRABCD1D T T— C TGG G C T
1^.5
903 952
SCD1D TGGAGGTGGC GGCTGGGGAG GCGGCTGGCT TGAGTTGCCG TGTGAAGCAC
HCD1D T T --A C — TCC—T— G
MCD1D1 T A A -AA C --GCC A- Q
MCD1D2 T A A -AA C —GCC A- G
RATCD1D T A A--C -A C --GCC A- G



















AGCAGTCTAG GAGACCAGGA CATC.ATCCT GTACTGGGAC GGGAAACGTG
AG-G .G C GT GCTACA
C GA T . C T -CC-GG-AA-
C GA T . C T -CC-GG-AA-
AG-GG . C GT --C-G--AA-
G T GT -A--.-A-GA
1003 1052
TCTCCAGGGG CTTGATTGTC GTCCTGGTAA TACTGGTGTT CGTCCTTCTG
c T c_ T-GGCA--CC -GGC-TGC-- GC-GT-C--C
CAC—GT -C C T—A-A C -GA-CA—C- A—GG-GG--
CAC—GT -C C T—A-A C —A-CA—C- A—GG-GG—
-A CC--T G CT-- T-GA-A G GCG-AC—G- TC-AG-GG--
A—GGG—TC -AG-C-G-AA A-GGGA-
1053 1102
TTTGTTGGAG GCTTAGTCTT CTGGTTTAGG AAGCACCGCC GCTATCAAGA
C-CA TG- TAC—C -C A- -G AACTT C G-G
GG—C—T— T—ACTAT.. .ATC-GG—A -G-AGAA—G CT
GG—C—T— T—ACTAT.. .ATC-GG--A -G-AGAA--G CT











1103 3' Untranslated 1152
TATCTCGTGA CTCTCCTGCC CACACCTATC TGTCTGGACT TCAGGATCTC
CG—CT G TG- T—G-G -C AC C C
C CG T-CTTA CTGCC— - C-T-A-AT--
C CG T-CTTA CTGCC— - C-T-A-AT—
C AT GAT-T..TTA -C-CTGCC— - C-T-A-GT--
1153 1202
AGGCCTT TAGC CCTCAGAATT TGAGGGTGAA AGAGAGCTAC
T--A-C-CAG GTTCCCA--A -T TCC- G-TCT-CTC- G--ATTGA-G
—A-T—CCA GGCTCTAG-A -T TCC- G-TCT-CTC- G--TCTGGGG
—A-T--CCA GGCTCTAG-A -T TCC- G-TCT-CTC- G—TCTGGGG
--A CCA GGTTCTAG-A -T TCCC --TCT-CTC- GA-ACTGAGG
1203
SCD1D CTTGAAG.AA GCAGAGAAGA GGGAGCTCTT CTCACACACT
HCD1D A-GT .G- ATT—AG-T-
MCD1D1 A-GA-G-AG- -G-ATCCT--







AAG- -G-ATCCT— A-A-ATGAAG AG—AC—G- ACACC-T
1253 1302
SCD1D TAGCTAAGAG GATTTAAGTT TATTTTTTTC TTTTAGTATA CTACAAGTGT
HCD1D -CATG-G-CA -C C-TCA C-CCC A ACA-TTATCT AA-AG-A-T-
MCD1D1 C-A-ATTA-T T—AAG-AA- --A--A G AG-.T—T-C G-CAGTT-CC
MCD1D2 A-AT - —GGAA-A-T AC—CC—AT TA-ATTAA-A
RATCD1D .-ATATTAAT T—AAG-AA- C-A—A A AA-GAT-T-T A--AGCT—G
I^
1303 1352
SCD1D ATATGTCCAA GCAGTTCTGT AAAAAAAGAA GTGCAAACTC AGATACGTCT
HCD1D -A—TCTTTT T—AAAA-TA C-CT-C-AGT T-AT—G-C- -A—GGC
MCD1D1 GT-TAG- A--AACACAA CTGC TGT -C-T-CCTG- CAGA-ACAAG
MCD1D2 TC-AT--A-- TT-CA-G-A- GTGCCGGAGT -A-GTGGGGG T-G....-G-
RATCD1D G—GT—AG- A--AACACAA CTGC-C-TGT -T-T-CCTG- CAGA-ACAAG
1353 1402
SCD1D CAGGGACAAG CAGATAAAGG TTGCAGTGTA AAAAAAAAAA AAAAAAAACC
HCD1D GT-AA-TC— A—TGC—A- G—TGCAAAC TTGT-TCTG- -G-CCT-C-A
MCD1D1 -T-TTGGC-- TGTT-T-T-- GATTT-CACT G--CT-G GC-T-CTT--
MCD1D2 -T-T-CTCTT G-ATACT—T GAT-TTAAA- GT-GG-G-GC CTGCGGTTT-
RATCD1D -T-TG-GC— TGTC-CGT— GATTT—ACT G—CT-G-CT GC-CGCTT—
1403 1452
SCD1D GGCGCTCGAG CATGCATCTA GAGGCCCTAT CCTATAGTGT CACCTAAATG
HCD1D --GA-AA-CA GG-AAGAGCT —T-TGAGTG TG-G-GA--G G-T--GT-A-
MCD1D1 T—C-AAACA G-C—TCTG- -GTTAGT-GG -AAG-GTAAA GT—A-C-CC
MCD1D2 CCT--AGCCG G-GTT--AGC CC-AG-AGGG TGATAT-GAC T-TAGG--CC
RATCD1D T—C-AAACA G-CA-T-TGG -G-TTGT-GG -AAG-GTAAA GT—AAC-CC
1453
SCD1D CTAGAGTAG
HCD1D GA-CT-G-AC ACACATGTCC TATCCAAAGG AATCAGCTGC AGCTGCTTGT
MCD1D1 AACCT-GCTG TACTCTGTAT TTTTCAAGGT GACTAGAAAA ATGGAT..T.
MCD1D2 AACTCTAGTC CTCTGCAAGG CCAGTGTGTG GTCTAAGGGA CTGAATCATC
RATCD1D AACAC-ACTG TACTCTGTAT TTTTCAAGAT AACGAGAAAA ATGGAT..TT
1*7
TABLE 5.3
Percentage identity at the nucleotide level between the domains of SCD1D and the
other CD ID sequences. These results were obtained using the GAP programme of
UWGCG 8.0.
TABLE 5.4
Percentage identity at the nucleotide level when the sequences of all CD1 3'
untranslated regions are compared. These results were obtained using the GAP
programme ofUWGCG 8.0.






































































































Pairwise comparison between the 3' untranslated regions of SCD1D and HCD1D.
Alignment was achieved using the GAP programme of UWGCG 8.0. Seven gaps
have been introduced into the SCD1D sequence to obtain maximum alignment.
FIGURE 5.12
948 CTCTCCTGCCCACACCTATCTGTCTGGA 975
II! III Mill II I I I I I I I I
1151 TTCCTATCAGGGCGTCCTGTGACTCGCCTTGCCACATCTGTGTCTCTGGA 1200
976 CTTCAGGATCTCAGGCCTTTAG CCCT 1001
I I I I I I I I I I I I I I II
1201 ACCCAGGACCTCTGGACCTCAGGTTCCCAAGACTTCAGTCCTGGTCTGCT 1250
1002 CAGAATTTGAGGGTGAAA GAGAGCTACCTTGAAGAA 1037
I I I I I I I I I II II II I II I I II I II I I I I
1251 CAGGAATTGAAGATGTAAGGAATTGAAGATAGGAGAGATACCTTGAAAAA 1300
1038 GCAGAGAA GAGGGAGCTCTTCTCACACACTTTGAACATTTTAG 1080
I I I I I I I I I I I I I I I I I I I I II I II I I I I I I I I I
1301 GTAGAGAACAGTCATGAGGCAGCTTTCATCACACCCTTTTAACA.TTTAT 1349
1081 CTAAGAGGATTTAAGTTTATTTTTTTCTTTTAGTATACTACAAGTGTATA 1130
I I I I II I I I II I I I I I I I II I II II I I I I I I I I I II
1350 CTAAAAGAATTTAAAT...TCTTTTTCAAAAATTACACTACAAGTTTATA 1396
1131 TGTCCAAGCAGTTCTGTAAAAAAAGAAGTGCAA A 1164
I I I I I I I I I II I I I I I I I I I II I I I
1397 AGCCCAAATGGCTCTGTGAAATCAGAAGTGCAAAGGTGTGCAAACTTGTA 1446
1165 CTCAGATACGTCTCAGGGACAAGCAGATAAAGGTTGCAGTGTAAAAAAAA 1214
I I I I I I I I I II I I I I I I I I I III III
1447 TCTGAAGACCTACCAGGGACAAGCAGGTAAGAGCTGATGTGAGTGTGTGT 1496
1215 AAAAAAAAAAACCGGCGCTCGAGCATGCATCTAGAGGCCCTATCCTATAG 1264
I I I I I I I I I I I I I I I II I I I
1497 GATGGGATCTGTAAG GAACTGGAACACACATGTCCTATCCAAAGG 1541
12 65 TGTCACCTAAATGCTAGAGTAG 12 8 6
I I I I I I III
1542 AATCAGCTGCAGCTGCTTGTTGTCAAGTATAAAGTCAGGACCTGGCTTGG 1591
FIGURE 5.13
Alignment of deduced amino-acid sequence of SCD1D with the CD Id sequences;
Human CD la, -b and -c; SCD1B-42 and the predicted sequence ofHCD1E.
Sequences were aligned using the PILEUP programme ofUWGCG 8.0.
Potential N-linked glycosylation sites are indicated by an asterisk.
Class specific residues for CD ld-like proteins (as defined by Calabi et al. 1989b) are
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-R R—L-S GQ V—A-
251
SCD1D TQQGDVMPNA DSTWYLRVTL EVAAGEAAGL
MCD1D1 -HR—FL -E QA-- D-E E
RATCD1 -HR—IL -E QA— D-E—DE
CTRABCD1D -R FL -G D D
HCD1D —P— IL -E A— D-V
HCD1E —R L -E A— D
SCD1B42 1 -W N
HCD1B —L—IL NW A— D—D
HCD1A —R—IL-S- -G A-- D_
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The inability of the degenerate 5' primers to detect the group 2 CD1 gene in
thymocyte DNA could have arisen for a variety of reasons. It is possible that the
cDNA substrate was not full length hence primers designed at the 5' end of the
sequence may have no template to bind. This would seem unlikely however as
primers based on the 5' end of known ovine CD1 genes amplified their target as
expected (data not shown).
It thus appears likely that the problem rests with the inability of the primers to bind
to their 'target' under the conditions used in the reactions described in this chapter.
Primers were designed based on the amino acid sequence obtained from the purified
protein recognised by SBU-T6. As discussed in Chapter 4 however, this sequence
may not be 100% accurate and it is obvious that a single amino acid alteration could
potentially result in 3 nucleotide errors in the primer sequence. Relevant to this point,
it has been stated that the NH2-terminal sequence can be 'unreliable' (Calabi et al,
1989b) as evidenced by the discrepancy between the reported NH2 terminal sequence
of rabbit CD1 with the subsequent predicted sequence from the gene.
With regard to the amplification of SCD1B-42 cDNA from PBM cDNA,
contamination with cloned SCD1B-42 was not possible since this product was
generated from cDNA which was adapter ligated and adapter specific primers were
used in the PCR reaction. Therefore assuming that this product did arise from PBM
cDNA, it raises the question as to why a3 region primers should preferentially detect
SCD1B-42 rather than a cDNA predicted to be present at much higher levels.
Previous results have shown that the only cell type likely to express the molecule
encoded by SCD1B-42 in the PBM compartment is the dendritic cell whereas the
molecule recognised by SBU-T6 is present on B cells and monocytes. In retrospect,
generation of the adapter ligated cDNA from a population of pure B cells and/or
monocytes may have provided a better source of cDNA substrate for this purpose.
Regardless of this, it is still surprising to amplify SCD1B-42 from this population
albeit that a nested PCR was required to generate the fragment. One explanation for
this result is that the group 2 gene(s) possess significant alterations in the sequence
152
of the a3 domain when compared to other CD1 isotypes or that alternative splicing
has deleted the a3 domain altogether. Significant differences within the a3 domain
would seem unlikely as all other CD1 genes isolated to date demonstrate marked
sequence conservation within this region and in addition, the a3 primers were chosen
in the regions of least variability.
This therefore leaves the possibility of alternative splicing resulting in deletion of
the a3 domain. As discussed in Chapter 7, the cDNA SCD1B-52 contains a precise
deletion of the a3 region. Although this may not necessarily be a feature of other
members of the ovine CD1 family, the fact that alternative splicing is known to be a
feature of the CD1 genes (Calabi et al. 1989; Bradbury et al. 1990; Woolfson and
Milstein, 1994) and that an ovine CD1 cDNA with an a3 deletion does exist would
be consistent with this theory. In addition, the fact that immunopurifled SBU-T6
antigen contains of a major antigen at 33kd would support, although by no means
confirm, this theory.
The identification of a sheep CD1 gene homologous to the CD ID group resulted
from a fortuitous binding of the degenerate 5' primer to a CD ID like sequence.
Although this sequence was obtained from lymph node cDNA by utilizing a PCR
primer designed on the basis of the NH2-terminal sequence of the antigen recognised
by SBU-T6, it is apparent that the protein encoded by the SCD1D gene does not
correspond to the SBU-T6 NH2-terminal sequence. Figure 5.14a compares the
amino-acid sequence of SCD1D with that of SBU-T6 and HCD1D and clearly shows
that in addition to greater identity to HCD1D, the SCD1D sequence also shares class
specific residues with HCD1D.
Figure 5.14b illustrates the relative homology of the 5' primer (P14365) to the
SCD1D, human CD ID and CD IE sequences demonstrating that despite being
designed on the basis of the SBU-T6 NH2-terminal sequence, the primer is a 100%
match to the sequence of the SCD1D gene. Thus although the SCD1D sequence has
closer overall homology to the CD ID gene, over short regions closer homology may
be found to other genes of the CD1 family. Relevant to this point is the possibility
that although the amino acid sequence of the SBU-T6 antigen has closest homology
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to the HCD1E predicted amino acid sequence, this homology is over a short amino
acid stretch which may not reflect homology along the entire length of the sequence.
However, as discussed in Chapter 4, the existence of class specific residues within
the SBU-T6 sequence which are closest to those of HCD1E, together with the overall
homology is highly suggestive that the SBU-T6 antigen is not encoded by the
SCD1D gene.
Further evidence for this is the work described in Chapter 8 where specific SCD1D
riboprobes do not detect those cells which are stained by the SBU-T6 mAb.
Previous work has shown that four CD IB homologues exist (Ferguson et al. 1996)
and the work described in this chapter demonstrates the existence of a CD ID
homologue. Combined with the evidence for a CDle-like protein (Chapter 4), this




(a) Amino acid sequence comparison of the SBU-T6 antigen, SCD1D and HCD1D.
Class specific residues are boxed.
(b) Comparison of the sequence of primer P14365 with SCD1D, HCD1D and
HCD1E.
FIGURE 5.14a
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GENERATION AND SCREENING OF A TRANSIENT EXPRESSION
LIBRARY
6.1 Introduction
Chapter 5 describes the identification of a new sheep CD1 gene which is shown to
have closest homology to the CD ID group of genes. As discussed in Chapter 5,
despite the fact that the degenerate primers used were designed on the basis of the
NH2-terminal sequence of the antigen recognised by SBU-T6, the PCR technique
failed to identify the sequence of the gene which encodes this CD1 molecule.
At this stage, an alternative approach was therefore adopted to establish the sequence
of this novel CD1 gene. The method used was based on the development of a cDNA
library within an expression vector. The vector containing the library was then used
to transfect COS cells and any cells expressing the molecule of interest were detected
using SBU-T6. In this way, the mAb could be used to identify directly the cells
containing the gene encoding the molecule of interest i.e. the SBU-T6 antigen.
6.1.1 Transient expression systems
Transient expression systems were initially used extensively to clone cytokine and
growth factor genes. These genes are particularly suitable for this system because
they are encoded by small mRNAs which are present in high abundance. The
original transient expression systems for cytokines involved analysing supernatants
from small numbers of transfected COS cells followed by rescreening of positive
groups of cells (Simmons, 1993). These techniques are suitable for such molecules
which are in high abundance and are likely to have cDNAs well represented in
cDNA libraries. However, these systems are less suitable for cell surface molecules
encoded by genes which are not abundantly expressed and are generally over lkb in
length. In order to modify the system to improve cloning of cell surface molecules,
high efficiency transient expression vector systems have been developed (see below).
Utilizing such modified techniques whereby a transient expression system is used
followed by antibody mediated selection of the desired cells, it has now been
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possible to clone a number of other cell surface molecules including CD2 (Seed and
Aruffo, 1987) and CD28 (Aruffo and Seed, 1987) demonstrating the suitability of
this system for cloning cell surface molecules. More recently, and relevant to the
work carried out in this section, Aruffo and Seed (1989) have utilized this system to
isolate and characterise cDNA clones encoding CD la, CD lb and CDlc.
The method used in this case was based on that of Simmons (1993) with several
modifications. The cDNA library was transfected into COS cells by DEAE-dextran
facilitated transfection. This efficient method of introduction of DNA into the cells
allows the cDNA library to be represented maximally within the cell population (an
estimated 103-104 different cDNA clones can be taken up into the COS cells by this
method- Simmons, 1993). Following this initial transfection and subsequent
selection using the mAb SBU-T6 to detect positive CD1 expressing cells, subsequent
rounds of transfection were carried out using the technique of spheroplast fusion as
described in section 2B.12.4. This is a much less efficient technique when compared
to DEAE-Dextran transfection and since only a small number of spheroplasts will
actually fuse with each COS cell and each spheroplast only contains one cDNA
clone, over several rounds, it provides a means whereby enrichment for the clone of
interest occurs. This strategy for identifying and enriching for cells expressing the
CD1 molecule is illustrated in Figure 6.1.
6.1.2 Vectors
SV40 based plasmids replicate to very high copy numbers per cell (103-105) and thus
result in high expression of specific molecules. The vector pCDM8 (Aruffo and
Seed, 1987), has been used to clone the genes encoding several cell surface
molecules. The salient features of this vector are illustrated in Figure 6.2a. These
features include:
• CMV enhancer and promoter
• Polylinker cloning site flanked by nonpalindromic BstXI sites
• SV40 and polyoma origin of replication
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FIGURE 6.1
Diagram illustrating the method for transient expression of a cDNA library in COS
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• Suppressor tRNA (supF) which suppresses amber stop codons in ampicillin and
tetracycline resistance genes which are carried on a stable episome (p3) in the
E.coli strain MC1061/p3.
The vector chosen to contain the library in this study was pcDNA3. This vector is a
modification of the original pCDM8 vector and is illustrated in Figure 6.2b. pcDNA3
shares several features with pCDM8 however, notably it contains an ampicillin
resistance gene which avoids the requirement for growth in bacteria containing p3
which is required when using the vector pCDM8.
6.2 Results
6.2.1 cDNA library generation and analysis
cDNA library generation was carried out as described in Chapter 2. RNA was
isolated from thymocytes using the RNAzol method. Prior to selection of polyA
RNA, total RNA was run on a denaturing formaldehyde gel to confirm that the RNA
was not degraded and was suitable for downstream manipulations. Figure 6.3 shows
this RNA demonstrating intact 28s and 18s bands with no evidence of RNA
degradation. PolyA RNA was therefore isolated from this preparation and cDNA
synthesized. Following ligation of adapters to the cDNA and its insertion into the
pcDNA3 vector, test transformations were carried out to enable an estimation of the
size range of the cDNA population. Twenty-four colonies were selected, grown in
liquid culture overnight and plasmid DNA isolated. Restriction digests of purified
plasmids were carried out and typical results shown in Figure 6.4. This illustrates the
range of insert sizes present and indicates that the cDNAs that are present are not
representative of those found in the tissue as they are all less than 1.2kb in length.
Repeating the mRNA isolation, cDNA synthesis and transformation gave a similar
result.
At this stage, a commercial cDNA library (Clontech) was obtained as a gift from Dr.
W. Hein and this library was used in transfection of the COS cells. The library had
been made from sheep lymph node.
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FIGURE 6.2
(a) Diagram of the vector pCDM8 showing relevant features.
CMV - enhancer-promoter sequences from the immediate early gene of human
cytomegalovirus (CMV).
MCS - multiple cloning site.
POLYOMA ori and SV40 ori - polyoma and SV40 origins of replication for
episomal replication in cells expressing the SV40 large T antigen or latently infected
with polyoma virus.
ColEl - origin for growth in E.coli.
supF - suppresser tRNA for maintenance in E.coli strains which carry the p3
episome.
(b) Diagram of the vector pcDNA3 showing relevant features.
CMV - as above.
MCS - as above.
AMP - ampicillin resistance gene for selection.
FIGURE 6.2
FIGURE 6.3
Denaturing formaldehyde gel analysis ofRNA preparations used for selection of
polyA RNA. 18s and 28s bands are marked.
Lane 1 - PBL RNA.
Lane 2 - Thymocyte RNA.
FIGURE 6.4
Agarose gel analysis of inserts obtained following restriction digests ofpcDNA3
from 19 clones.
M - marker DNA.
Lane 1 - uncut pcDNA3.
Lanes 2-20 - pcDNA3 digested with XHOI and BamHI.
FIGURE 6.3
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6.2.2 Screening of the transfected cells
Following transfection of the library into the COS cells, the cells were left for 48
hours before being screened for CD1 expression. Several methods may be used to
select cells which are expressing the molecule of interest. Original protocols describe
the use of the 'panning' technique whereby Petri dishes are pre-coated with affinity
purified goat anti-mouse IgG then cells which have been incubated with the specific
mAb are applied to the dishes and allowed to adhere (or 'pan') for 2-3 hours. An
alternative technique, and that which was used in this case, was to incubate harvested
cells with mAb in the same way but subsequently select the cells using Dynabeads
(Dynal) coated with anti-mouse IgG.
This procedure was carried out over 3 cycles of spheroplast fusion and selection
however no apparent increase in the number of cells selected was apparent following
each successive round. E.Coli colonies did grow following transfection with Hirt
DNA prepared following each fusion however analysis of these colonies after the
three cycles revealed a lack of plasmid. The possible reasons for these results are
discussed in Section 6.3.
6.3 Discussion
The reason why colonies were found to exist without apparently containing plasmid
is difficult to explain. The logical conclusion is that either the ampicillin on the
plates was degraded or not at the correct concentration or that a small number of the
bacteria had developed ampicillin resistance.
Despite the reported success of the transient expression cloning system for cloning
cDNAs such as CD2 and CD28, there are several major disadvantages of the
technique. Multicomponent glycoprotein complexes i.e. those which require
expression of other molecules cannot be cloned using this technique unless there is
co-transfection of an existing cDNA for other members of the complex. An example
of molecules falling into this category are the integrins. CD1 is known to associate
non-covalently with P2m although as discussed in Chapter 7, this does not appear to
be analogous to the MHC class I/p2m association and P2m may not be an absolute
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requirement for CD1 expression. Nevertheless, assuming that P2m is required for
CD1 cell surface expression in some situations (suggested by the
immunoprecipitation data), it is obviously important to ensure that a source of (32m
is available in any experiments involving expression of a CD1 molecule. Human
CD1 molecules have been successfully cloned using the technique of transient
expression in COS cells (Aruffo and Seed, 1989) however the similarity between
monkey p2m and human p2m is likely to be closer than between monkey and sheep
P2m. Despite this, however, it has been shown that bovine p2m in tissue culture
supernatant can exchange with P2m on the cell surface of the human cell line
MOLT-4 (Bernabeu et al. 1984). Hence it is probably safe to assume that monkey
P2m can associate with sheep CD1. Thus if the CD1 cDNA is represented in the
library, it would be expected that the CD1 molecule could be expressed at the cell
surface in association with P2m.
Perhaps the major drawback of this technique is the number of stages to proceed
through before being able to analyse colonies for correct sized inserts. If the
technique is proceeding according to plan, it is expected that after each round of
spheroplast fusion and selection, an increased number of positively selected cells
should be apparent. Although positive cells were apparent following the first round
of selection (subsequent to the DEAE-dextran transfection), there was no apparent
increase in selected cell numbers as each round of spheroplast fusion was carried out.
It is therefore likely that the failure of this technique to identify the cDNA encoding
the SBU-T6 antigen was the result of a problem at the spheroplast fusion stage. It
may also be relevant that in the work described in Chapter 5 in which the SCD1D
gene was identified, the SCD1D gene in the pcDNA3 library was found to be
truncated at the 5' end. If the gene encoding the molecule recognised by SBU-T6 is
similarly truncated in this library then the failure of the technique may have occurred
as a result of a lack of full length mRNA within the transfected cells.
Further work will be aimed at optimising this technique such that this cDNA can be
isolated as this remains the most rational approach to identify the gene encoding the
molecule that this mAb recognises.
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CHAPTER 7
ANALYSIS OF THE a3 DELETION MUTANT SCD1B-52
7.1 Introduction
7.1.1 Alternative splicing
Alternative splicing of genes results in the formation of protein isoforms which share
extensive regions of identity and vary only in specific domains. The consequences of
alternative splicing are many and varied but include alteration in cellular or
subcellular protein localization, modification of enzyme activity and, by giving rise
to prematurely truncated open reading frames, can result in quantitative regulation of
gene expression (Smith et al. 1989).
Alternative splicing is known to occur in several genes encoding human HLA
molecules one example of which is HLA-DQ (Briata et al. 1989). Alternative
splicing in this gene can result in the production of secretory isoforms of the protein
as a result of deletion of the TM exon. Alternative splicing of the gene encoding the
human NCCI molecule HLA-G has also been shown both in vivo and in HLA-G
transfected cell lines (Ishitani et al. 1992; Kirszenbaum et al. 1994). Two splice
variants named G2 and G3 lacked the a2 domain and the a2 and a3 domains
respectively. The murine NCCI gene Qa-2 also exhibits alternative splicing
demonstrated by the expression of soluble Qa-2 molecules resulting from alternative
splicing of exon 5 (Tabaczewski et al. 1994). In the mouse, it has been shown that
most CD1 mRNA in the thymus is incompletely spliced (Bradbury et al. 1990).
In humans, Northern blots utilizing probes from the 3' UT region have shown that all
the CD1 genes (with the exception of CD ID) produce several transcripts ranging
from 1.2 - 3kb. In addition, cDNA sequence analysis demonstrates the existence, in
CD IB and CD IE cDNA, of cryptic splice sites within the a3 domain which splice to
the TM/C exon (Calabi et al. 1989a).
Woolfson and Milstein (1994) provide evidence for the TM/C exon of CD1 genes
being under alternative splicing control. Both CD1A and CD1C demonstrate
transcripts with a truncated or absent TM domain. Using mouse myeloma cells
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transfected with CD1A, the major protein is shown to be a secretory form arising
from an unspliced transcript. An additional intracellular form of CD la also arises as
a result of usage of a cryptic splice acceptor site within the TM/C exon. Within the
thymus, the CD1C and CD IE genes also possess complex splicing patterns.
Alternative splicing of the CD ID gene resulting in a variety of transcripts, including
an a3 deletion, has been cited as unpublished data in Blumberg et al. (1995).
Thus it would appear that the alternative splicing which occurs in both classical and
non-classical MHC molecules is also a feature of the CD1 family. It is possible that
alternatively spliced transcripts may serve a specific purpose e.g. allowing the
molecule to perform its 'function' in a non-cell associated manner.
7.1.2 The Ovine a3 deletion mutant, SCD1B-52
The cDNA clone SCD1B-52 contains a precise a3 deletion (Ferguson et al. 1996).
SCD1B-52 was isolated from lamb thymocyte cDNA and sequence analysis reveals
96% identity at the nucleotide level between SCD1B-52 and the equivalent domains
of the SCD1B-42 clone implying that SCD1B-52 may be an allele of SCD1B-42
(Ferguson et al. 1996).
As described above, alternative splicing would appear to be a feature of the CD1
genes. Although there is no reported evidence for precise a3 deletions in CD1 genes
in other species, it is interesting that the transmembrane protein, endothelial cell
protein C receptor (EPCR- a type 1 transmembrane glycoprotein with 28% identity to
CDld), has al and a2 domains followed by the TM domain (Fukudome and Esmon,
1994; 1995). In addition, a study on the evolution of CD1 genes (Hughes, 1991),
suggests that the evolutionary history of the a3 domain of human CD1 genes may
differ significantly from that of the al and a2 domains, based on the demonstration
that the a3 region does not contain isotype specific sequences (as is the case for the
al and a2 regions - Section IB.2) but is highly conserved across the CD1 isotypes.
In view of this evidence and the existence of the SCD1B-52 clone, it was decided to
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undertake studies to investigate whether the protein encoded by the SCD1B-52 gene
is expressed, either intracellular^ or as a membrane bound form.
7.2 Results
7.2.1 PCR to confirm the presence of SCD1B-52
Due to the precise nature of the oc3 deletion, the SCD1B-52 sequence was unlikely
to have arisen due to sequencing or cloning error. However, to ensure that this gene
was present in a cDNA population derived from thymocyte mRNA, a 3' PCR primer
(P10435) was designed which spanned the deletion region (Figure 7.1). This primer
was used in conjunction with a 5' primer specific for both SCD1B-42 and SCD1B-52
(P14388) to amplify the sequence of interest from thymocyte cDNA. Although the 3'
primer would also be complementary to SCD1B-42 cDNA in the a2 and TM/CYT
domains, the annealing temperature used in the PCR reaction (60°C) would not allow
this primer to bind to SCD1B-42.
This PCR produced a product of the expected size from thymocyte cDNA (488bp) -
Figure 7.2 (arrowhead). The PCR product was cloned using the TA cloning kit and
one of the positive clones sequenced. This confirmed that the product was part of the
SCD1B-52 gene. Hence SCD1B-52 is not a cloning artefact but represents mRNA
present in more than one sheep.
7.2.2 Insertion of SCD1B-52 into the expression vector pCDNA3
The SCD1B-52 cDNA had been previously cloned into the vector pBluescript
(Stratagene). This is not an expression vector thus it was necessary to subclone the
gene into an alternative vector to allow investigation of gene expression. The stocks
were amplified and the orientation of the gene established by sequencing. The gene
was found to be present in the reverse orientation to that required, therefore
restriction sites were chosen to allow the insert to be subcloned into pCDNA3
(Invitrogen) such that it was in the correct orientation to be transcribed under the
influence of the CMV promoter contained within this vector (Figure 7.3). Figure 7.4
shows the vectors following overnight digestion at 37°C with the enzymes Hindlll
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FIGURE 7.1
Diagram of the exon structure of SCD1B-52 showing the location of the primers used
to detect the SCD1B-52 gene in thymocyte cDNA.
FIGURE 7.2
Photograph ofPCR amplification of SCD1B-52 from thymocyte cDNA.
M - marker DNA
Lane 1 - negative.
Lane 2 - 488bp product generated by primers P10448 and P10435 (arrowhead).
FIGURE 7.1












and Xbal. The digests were then purified as follows. pCDNA3 was purified using
Geneclean and resuspended in 30 |Ltl SDW. The digest containing SCD1B-52 was
ethanol precipitated, run on a gel and the SCD1B-52 band excised and purified using
a spin-bind column. Subsequently, SCD1B-52 was ligated into pCDNA3 overnight
at 12°C. After ligation, 2pl of the ligation reaction was used to transform INVaF
E.coli.
Figure 7.5 demonstrates restriction digests of 4 clones resulting from the transfection.
This illustrates the successful transfer of SCD1B-52 into PCDNA3.
7.2.3 Transfection of cells and selection of transfectants
CI27 cells were transfected using DOTAP transfection reagent as described in
Chapter 2. Positive clones were identified as those which appeared as slow growing
colonies at the highest dilution when grown in the presence of the selecting agent, the
aminoglycoside antibiotic, G418. The identification of positive clones took several
days as cells are known to divide once or twice in the presence of lethal doses of
G418. Positive clones were isolated then grown up over several weeks until confluent
in a T175 flask. G418 selection was maintained at all times.
7.2.4 Analysis of positive clones
Positive clones were analysed for expression of SCD1B-52 at the cell surface and
also for mRNA expression.
7.2.4.1 Protein expression
Cells for FACS analysis and cytosmears were harvested by incubating in EDTA at
37°C for 15 minutes. A panel of CD1 mAbs was used to screen transfected cells for
CD1 expression using flow cytometry. Four clones were analysed by these methods
and the results of one such experiment are shown in Figure 7.6 demonstrating the
lack of significant staining by any of the mAbs. Immunostaining of cytospins of




Agarose gel analysis of restriction digests ofpcDNA3 and pBluescript
M - marker DNA.
Lane 1 - pcDNA3 uncut.
Lane 2 - pcDNA3 following overnight digestion with Hindlll and Xbal.
Lane 3 - pBluescript uncut.
Lane 4 - pBluescript following overnight digestion with Hind III and Xbal
FIGURE 7.5
Agarose gel analysis of four clones obtained by transforming InvaF' E.coli with
pcDNA3 containing SCD1B-52.
M - marker DNA.
Lane 1 - pcDNA3 uncut.





Flow cytometry analysis ofCI27 cells.
(a) Forward and side scatter profile of transfected CI27 cells showing analytical
region.
(b) Frequency histograms of transfected cells stained with negative control
(VPM53-top left histogram) and a range of anti CD1 mAbs. The mAb used and








Western blotting was carried out by incubating cells in EDTA at 37°C as above
followed by TNT lysis, fractionation of proteins by SDS-PAGE and blotting onto
nitrocellulose. Non transfected CI27 cells were used as a control. Strips of the blot
were incubated either in normal rabbit serum or polyclonal rabbit CD1 anti-serum
(R-179: this serum had been obtained by immunizing rabbits with SBU-T6 antigen
and was shown to recognise CD1 antigen on Western blots). Figure 7.7a shows the
results of a blot of lysate from transfected cells incubated with either normal rabbit
serum (lane 1) or R179 (lane 2). No positive control was available due to the lack of
cells transfected with a full length sheep CD1 clone. Although bands are present at
46kd and 14kd in lane 2 but not in lane 1 (arrowheads), Figure 7.7b shows that this
reactivity is also observed using R-179 on untransfected lysate. Deletion of the a3
domain would predict that the size of the a chain in SCD1B-52 would be
approximately 30-35kd. No reactivity against a protein of this size was observed
using the CD1 antiserum. It is possible that the antiserum is cross reacting with MHC
class I and (32m resulting in the bands at 46kd and 14kd which are present in both the
transfected and non-transfected cells. Thus there is no evidence for recognition of
CD1 antigen in the transfected cells by the polyclonal anti-CD 1 rabbit serum.
7.2.4.2 mRNA expression
RNA was also isolated from the cells - in this case, cells were lysed by adding
RNAzol (Biogenesis) directly to the flask and gently shaking for 1 minute. The lysate
was removed and processed as described in Chapter 2B. RT-PCR was then carried
out using this RNA as a substrate and utilizing primers P6087 and P6086 (Appendix
II-specific for sequences in the al region and 3'UT region ofB52 respectively).
Figure 7.8 shows the results of RT-PCR on RNA isolated from the individual clones.
Lane 1 is marker DNA. Each PCR was carried out on a sample of RNA which had
not received treatment with reverse transcriptase (lanes 2, 4, 6 and 8) in addition to
the cDNA from each clone (lanes 3, 5, 7 and 9). This rules out contamination of the
RNA sample with original plasmid DNA. Positive and negative controls for the PCR
are shown in lanes 10 and 11 respectively. The positive control utilized plasmid
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FIGURE 7.7
Western blot analysis of lysate from transfected cells (A) and control nontransfected
cells (B).
Lane 1 - normal rabbit serum.
Lane 2 - polyclonal rabbit CD1 antiserum.
The 46kd and 14kd bands are indicated by arrowheads.
FIGURE 7.8
Photograph ofRT-PCR analysis from four transfected clones.
M - marker DNA
Lanes 1, 3, 5, 7 - no reverse transcriptase negative control for clones 1-4.
Lanes 2, 4, 6, 8 - RT-PCR utilizing primers P6086 and P6087 on cDNA from
transfected clones.
Lane 9 - positive control.
Lane 10 - negative control.
FIGURE 7.7
P3
containing the gene as a substrate and the negative control utilized sterile water as a
substrate. A band of the expected size was obtained with the positive control whilst
no product was generated in the negative control.
7.3 Discussion
The aim of the work carried out in this chapter was to establish whether the CD1
molecule encoded by the SCD1B-52 gene could be expressed in the absence of the
a3 domain. When considering the potential consequences of the lack of an a3
domain, the major feature to consider is the effect of the inability of the molecule to
bind (32m.
Studies using (32m knockout mice show little if any surface expression ofMHC class
I molecules confirming the necessity for a trimolecular MHC/peptide/(32m complex
for stable surface expression ofMHC class I molecules. Although the a3 region has a
critical role in MHC class I molecules in the non-covalent association of the
molecule with (32-microglobulin, there is evidence that the requirement for [32m and
therefore the a3 domain in CD1 molecules may not be so stringent. Co-capping
experiments demonstrated that CD la and CD lb can exist in isolation from (32m
(Kahn-Perles et al. 1985). In addition, it has recently been shown that CD Id can exist
on human intestinal epithelial cells in a (32m independent manner (Balk et al. 1994).
Residues within the a.3 domain (together with residues in the a2 domain) are
involved in the association of the a chain with (32m in MHC class I molecules and
similar predictions have been made for CD1 molecules although folding differences
in the al and a2 domains indicate that the binding may have different characteristics
(Tysoe-Calnon et al. 1991). Analysis of potential (32m contact residues in ovine CD1
a chains has been carried out (Ferguson et al. 1996) and demonstrates that of the nine
contact residues located within the a3 domain, only two are conserved in the ovine
sequences.These data imply that ovine CD1 a chains interact with (32m in a manner
different from classical MHC class 1/ (32m association and raises the possibility that
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[32m association may not have the same significance for CD 1 molecules as for MHC
class I molecules. If this is the case, then the lack of an a3 region and possible
inability of [32m to bind to the a chain may still be consistent with a 'functional'
molecule.
Although RT-PCR demonstrated successful transfection of cells with the SCD1B-52
construct, no intracellular or membrane bound protein was detectable using the
methods described above. Despite the lack of evidence for either intracellular or
expressed protein, the assumption cannot be made that such protein does not exist. It
is possible that the mAbs used either recognise a conformational epitope which is
lost with the change in conformation of the protein which will obviously occur as a
result of the a3 deletion, or that a mAb is not available for the protein encoded by
this gene whether complete or lacking the a3 region. The polyclonal antiserum
which was used on the Western blots would perhaps have been expected to be more
likely to recognise CD1 protein in the clones, however this antiserum was made
against purified SBU-T6 antigen at a stage when this mAb was thought to represent a
pan-CD 1 mAb. The data presented in Chapter 4 argues against this, hence this
antiserum may in actual fact be less likely to detect SCD1B-52 protein as it is
apparently directed against a novel CD1 isotype. Despite this however, the ELISA
data described in Chapter 4 clearly show that SBU-T6 does recognise purified group
1 antigen. In addition, the identity which exists between all CD 1 proteins may allow
an antiserum generated against one isotype to cross-react with other isotypes.
Although SCD1B-52 was detected by PCR from thymocyte cDNA, there is no
evidence of immunoprecipitation of a 30-35kd band by CC14 (a mAb shown to
recognise an NH2-terminal sequence identical to that of SCD1B-52 and SCD1B-42 -
Chapter 4). Whilst this may reflect only relative amounts of specific gene products, it
would also be consistent with lack of cell surface expression or loss of the epitope
recognised by the mAb. As discussed previously, although it is possible that the lack
of an a3 domain may result in loss of conformational epitopes recognised by mAbs,
it is unlikely that the mAb CC14 specifically recognises an epitope within the a3
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domain as a3 domains are highly conserved across the CD1 groups and CC14 is
CD lb specific.
In hindsight, the use of a control i.e. transfection of the cells with SCD1B-42 would
have been beneficial to prove that ovine CD1 can be expressed in this system. As
described in Chapter 4, immunopurified CC14 antigen has an NH2-terminal sequence
identical to that of SCD1B-42. It would thus be expected that CC14 would recognise
SCD1B-42 at the cell surface in this system therefore providing a suitable positive
control.
In conclusion, it has been shown that the transfected SCD1B-52 gene is transcribed
in this system but translation could not be detected. However, this inability to detect
protein may be due to a lack of suitable reagents. An alternative approach which
could be adopted is to raise antiserum to a peptide which is common to both
SCD1B-42 and SCD1B-52. This could then be used as a specific reagent to detect the
proteins both in vivo and in vitro.
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CHAPTER 8
ANALYSIS OF OVINE CD1 GENES IN TISSUES
8.1 Introduction
The mAbs which recognise CD1 in sheep form two distinct clusters. The majority of
these mAbs recognise a molecule with a similar distribution to human CD lb whilst
SBU-T6, CC43 and CC118 recognise a molecule with a much wider tissue
distribution. Comparing the pattern of reactivity of these mAbs to the known
expression pattern of CD Id in humans and mice suggests that they do not recognise
the sheep CD Id molecule. This is supported by the NH2-terminal sequence of the
antigen recognised by SBU-T6 which is clearly more similar to the CDle sequence
than the CD Id sequences (Chapter 4). These data imply that sheep express at least
three CD1 isotypes i.e. CD lb, CDle and CD Id with mAbs only available against the
CDle and CD lb isotypes.
In order to localize the cells and tissues expressing CD ID, it was therefore necessary
to employ molecular techniques. RT-PCR and subsequent Southern hybridization
using labelled internal oligonucleotides were used to identify the distribution of the
CD1 transcripts in various cells and tissues. In situ hybridization was also used to
identify more precisely those cell types expressing CD 1 mRNA.
8.1.1 RT-PCR
PCR reactions were carried out using primers specific for SCD1D and SCD1B-42/
SCD1B-52. Internal primers for SCD1D and SCD1B-42/SCD1B-52 were labelled
and used as internal probes to confirm the identity of the PCR product. The primer
sequences are listed in Appendix II and conditions for the PCR reactions used to
generate these fragments (and the fragments used for riboprobe generation) are
shown in Table 8.1.
As described above, PCR for the SCD1D gene allowed identification of those cells
and tissues expressing SCD1D mRNA. Performing a similar experiment using
primers specific for SCD1B-42/ SCD1B-52 allowed confirmation of results
obtained using immunochemistry both in normal cells and tissues and in intestinal
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TABLE 8.1
PCR primers and conditions used to detect ATPase, SCD1D, SCD1B-42/SCD1B-52







PRIMERS CYCLE NO. CYCLE PARAMETERS EXTENSION
SCD1T10 G5936
G5935





35 94-1', 55-1', 72-1' II








35 94-1', 55-1', 72-1' ll
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tissue infected with M. paratuberculosis. The results of immunostaining illustrated
in Chapter 3 suggest that up-regulation of CD lb occurs in association with this
disease. This may be a result of either a specific role for CD1 in the presentation of
mycobacterial mycolic acids and LAM (Beckman et al. 1994, Seiling et al. 1995), or
more simply may occur as a result of the elaboration of pro-inflammatory cytokines
by activated T cells. This latter hypothesis is suggested by the fact that cytokines
(GM-CSF, IL-1, IL-6 and TNFa) have been shown to up-regulate CD1 (Walsh et al.
1986, Ishii et al. 1990, Porcelli et al. 1992, Kasinrerk et al. 1993).
8.1.2 In situ hybridization
In situ hybridization has been used in the mouse to investigate the expression ofCD 1
genes in the intestine. A radiolabelled probe spanning the a3 region of the murine
mCD 1.1 gene was used in the hybridization experiments and the results showed that,
within the small intestine, only Paneth cells at the base of the crypts expressed CD1
mRNA (Lacasse and Martin. 1992). This result was unexpected as immunostaining
shows expression of murine CD1 on gastrointestinal epithelium (Bleicher et al.
1990).
Flaving shown expression of ovine CD1 on intestinal epithelium and also discovered
a different pattern of CD 1 expression in the intestine with the group 1 and group 2
mAbs, a similar approach was taken to establish the pattern of CD1 mRNA
expression in sheep intestine using a riboprobe derived from the conserved a3
region. This riboprobe was also used to examine CD1 mRNA expression in thymus
and lymph node.
Subsequently, a riboprobe specific for the SCD1D gene was generated in order to
localize SCD1D mRNA specifically. Having established that this gene possesed an
a3 domain with 90% identity to the a3 region generated from the SCD1T10 clone
(used in generation of a3 riboprobes), it was predicted that cells which are positive
for the SCD1D transcript would also be positive for the a3 region. Logically
however, it was possible that the a3 probe would generate a positive signal in cells
lacking SCD1D mRNA .
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8.2 Results
8.2.1 RT-PCR and Southern blotting
RT-PCR was carried out on RNA from thymus, liver, lymph node, PBLs and
intestine (normal and infected with M. paratuberculosis). Total or mRNA was
reverse transcribed into cDNA using random hexanucleotide primers. This cDNA
was used as a substrate in the PCR. ATPase was used as a control for the cDNA from
each source.
The results of this experiment are shown in Figure 8.1. Figure 8.1a shows the signal
generated by the ATPase internal probe, Figure 8.1b by the SCD1D probe and Figure
8.1c by the SCD1B-42/SCD1B-52 probe. In each case, lane 7 represents a negative
control in which SDW was used in place of cDNA.
This PCR was not designed to be quantitative and was carried out purely to ascertain
whether CD1 mRNA was present in each particular tissue. The signal generated by
the ATPase was similar in all samples implying that similar amounts of substrate
cDNA were being analysed in each sample. All the tissues examined showed a
positive result for the SCD1D gene (Figure 8.1b lanes 1-6). For the SCD1B-42 gene,
only lane 1 (thymus), lane 3 (M.paratuberculosis infected ileum) and lane 6 (PBL)
showed a positive signal.
8.2.2 In situ hybridization
In situ hybridization was carried out using riboprobes designed on the conserved a3
region and also on the al/a2 region of the SCD1D gene. Both sets of riboprobes
(sense and antisense for each gene) were approximately 300 base pairs in length. The
regions of the CD1 genes represented by these probes are illustrated in Figure 8.2a.
8.2.2.1 Riboprobe generation
Generation of a3 riboprobes
The PCR technique was used to amplify the a3 region from the ovine CD1 clone
SCD1T10 using primers G5935 and G5936. The resulting 290bp PCR product was
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FIGURE 8.1
Southern hybridization of PCR products generated utilizing primers specific for
ATPase (a), SCD1D (b) and SCD1B-42/ SCD1B-52 (c).
The source of the cDNA in each lane was as follows:
Lane 1 - thymus.
Lane 2 - intestine (normal).
Lane 3 - intestine (Johne's disease).
Lane 4 - liver.
Lane 5 - lymph node.
Lane 6 - PBLs.




cloned using the TA cloning kit (Invitrogen). The orientation of the insert was
established by sequencing on an automatic sequencer.
The sense riboprobe was generated by cleaving the plasmid with Hindlll followed by
RNA synthesis using T7 polymerase. The antisense riboprobe was generated by
cleaving with NotI followed by RNA synthesis using Sp6 polymerase (Illustrated in
Figure 8.2b).
Generation of SCD1D riboprobes
PCR was used to generate a 300bp fragment using primers LN01 and LN03. Within
this region, sequence homology to the previously described ovine CD1 genes
(SCD1A25, SCD1T10, SCD1B-42, SCD1B-52) was less than 50% thus probes
generated from this region were considered highly specific with minimal likelihood
of cross-reactivity with other CD1 isotypes. The PCR product was cloned as for the




Initial experiments were carried out using the a3 riboprobes on sections of thymus in
order to validate the probes. Thymus was chosen as a tissue which expresses high
levels ofCD1 and the results of hybridization on this tissue are illustrated in Figure
8.3. Figure 8.3a clearly demonstrates the detection of CD1 mRNA in the thymic
cortex but not in the medulla detected by the antisense riboprobe. This contrasts with
results using the sense riboprobe which did not give a significant signal (Figure
8.3b). Using the antisense SCD1D riboprobe in the thymus (Figure 8.3c and 8.3d), a
strong signal was also detected in the thymic cortex.
Lymph Node
Hybridization using both the a3 and SCD1D riboprobes revealed a similar pattern of
staining within the lymph node. Figure 8.4a and 8.4b show results of hybridization
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FIGURE 8.2
Generation of riboprobes for in situ hybridization.
(a) Regions utilized for generation of the oc3 and SCD1D specific riboprobes.
(b) Strategy for generation of the a3 riboprobes.
FIGURE 8.2
a
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using an a3 probe (no counterstain). Strongly positive cells are evident within the
paracortex and in the follicle centre. Figure 8.4c reveals a similar pattern of reactivity
with the SCD1D antisense riboprobe. Cells within the centre of the follicle and
scattered cells beneath the capsule are stained. Figure 8.4d shows the sense riboprobe
negative control.
Intestine
Figure 8.5 shows the results of hybridization on intestinal tissue (ileum). 8.5a shows
intense staining which appears superficial on the cells lining the intestinal crypts
with an a3 antisense riboprobe. Figure 8.5b and 8.5c show staining of isolated cells
within the intestinal epithelium with the SCD1D antisense riboprobe (b) and the a3




In situ hybridization on paraformaldehyde fixed sections of sheep thymus.
Development was carried out using an alkaline phosphatase system with no
counterstain.
(a) - a3 antisense riboprobe. Signal in thymic cortex.
(b) - a3 sense riboprobe. Background signal only.
(c), (d) - SCD1D antisense riboprobe. Signal in thymic cortex.
Magnification - a, c x250.






In situ hybridization on paraformaldehyde fixed sections of sheep lymph node.
Development was carried out using an alkaline phosphatase system.
(a) and (b) - a3 antisense riboprobe. Positive paracortical dendritic cells (a) and cells
within the follicle centre (b) are shown. No counterstain.
(c) - SCD1D antisense riboprobe. Positive cells within the follicle centre and beneath
the capsule. Counterstain - methyl green.
(d) - SCD1D sense riboprobe. No positive cells. Counterstain - methyl green.
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In situ hybridization on paraformaldehyde fixed sections of sheep intestine.
Development was carried out using an alkaline phosphatase system.
(a) - a3 antisense riboprobe. Superficial staining of cells lining the crypts. No
counterstain.
(b) - a3 antisense riboprobe. Isolated positive cells within the intestinal epithelium.
Counterstain - methyl green.
(c) - SCD1D antisense riboprobe. Isolated positive cells within the intestinal
epithelium. Counterstain - methyl green.
(d) - SCD1D sense riboprobe. Background staining only. Counterstain - methyl
green.
Magnification (a) x400.




RT-PCR for the SCD1D gene showed that this gene is present in all the tissues tested
i.e thymus, intestine, liver, PBLs and lymph node. Table 8.2 compares published
data on expression of members of the CD ID group of CD1 genes across the species
using molecular techniques. Black boxes indicate that there is no published data for
that particular tissue, shaded boxes indicate that the tissue is positive by the
technique listed. This table presents published data of studies using molecular
techniques only. This demonstrates that although there are individual variations in
expression, CD ID genes are characterised by expression in thymus, intestine and
liver. One exception is the cotton-tail rabbit CD1 which is not detectable by Northern
hybridization in the liver or spleen. It is possible however that a more sensitive
technique e.g. RNase protection or RT-PCR may detect RNA in this tissue.
The results shown in Figure 8.1b show that the SCD1D gene is found in the same
group of tissues as other members of the CD ID family.
RT-PCR for the SCD1B-42/SCD1B-52 gene is shown in Figure 8.1c. The positive
tissues are thymus, PBLs and M. paratuberculosis infected intestine. Notable points
about this result are the positive signal with PBL RNA consistent with the isolation
of the SCD1B-42 gene from the adaptor ligated PBL cDNA (Chapter 5) and the
identification of two positive bands consistent with the labelled internal
oligonucleotide recognising both SCD1B42 and SCD1B52. Most significantly
however, is the demonstration of SCD1B-42/ SCD1B-52 in diseased intestine but not
in control intestine confirming induction/up-regulation of this isotype as a
consequence of infection. This result is consistent with the immunostaining results
using CC14 on M. paratuberculosis infected tissue (Chapter 3 - Figures 3.10 and
3.11). This showed induction of CD lb expression in clusters of cells within
lymphoid aggregates and also within intestinal epithelial cells. These findings
suggest that in this disease, CD1 may have a role in presenting mycobacterial
antigens to T cells as has been shown in vitro (Beckman et al. 1994, Sieling et al.
1995). This disease may therefore provide a useful in vivo model for the study of
CD1 - T cell interactions.
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TABLE 8.2
Comparison of published data on expression of members of the CD ID group of
genes with SCD1D. Black boxes indicate no published data for that particular tissue.
Shaded boxes indicate that the tissue is positive by the technique listed according to
the appropriate reference. The abbreviations are as follows:
RPA ribonuclease protection assay.
N Northern hybridization.
RT RT-PCR.
ISH In situ hybridization.
Table 8.2
THYMUS PBL INTESTINE LIVER SPLEEN
mCDl.l rpa1 ish2 rpa1 ,n6 rpa1
mCD1.2 rpa' ish2 rpa1 rpa1
RtCDl n3 rt3 n3'6 n3
CtRabCDl n4 -ve4 -ve4
HCD1D n5
SCD1D rt, ish rt rt,1sh rt
1. Bradbury et al. 1988.
2. Lacasse and Martin 1992.
3. Ichimaya et al. 1994.
4. Calabi et al. 1989b.
5. Balk et al. 1989.
6. Burke et al. 1994.
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8.3.2 In situ hybridization
In situ hybridization in the thymus demonstrated CD1 mRNA in cortical thymocytes
using both the a3 and SCD ID-specific riboprobes (Figure 8.3). CD ID mRNA has
been detected in the thymus in other species by various molecular techniques (Table
8.2) and the positive results obtained in this work show that SCD ID mRNA is
similarly expressed in the thymus.
Hybridization in lymph node revealed a similar pattern with both a3 and SCD ID
riboprobes i.e. signal was detected in paracortical and subcapsular dendritic cells and
in cells in the centre of follicles (Figure 8.4). When this pattern of staining is
compared to the results of immunostaining using the group 2 mAbs (Chapter 3 -
Figure 3.4), it is apparent that the strong staining of mantle zone lymphocytes is not
mirrored by a similar pattern of staining using in situ hybridization as the strongest
signal is generated by cells within the follicle centre.
The results of hybridization in the intestine are somewhat confusing and their
interpretation is to a certain extent speculative. The strong signal detected
superficially within the intestinal crypts does not appear to be intracellular and may
therefore represent an artefact. However, it is notable that the group 1 mAbs
recognise cells lining the crypts (Chapter 3 -Figure 3.6) and the pattern of staining by
the two methods is similar. In addition, isolated cells within the intestinal epithelium
are detected with both the a3 and SCD1D specific probes (Figure 8.5b and 8.5c) and
this pattern appears highly specific. This is another surprising finding as it indicates
that IELs may contain CD1 mRNA. Both human CD Id and murine CD1 antigens
have been detected on intestinal epithelial cells by immunochemical techniques
(Bleicher et al. 1990, Blumberg et al. 1991). In contrast to these earlier studies,
Sydora and colleagues (1996) demonstrated low levels ofmCDl expression on IELs
using 3 different anti-CDl mAbs (including the mAb 3C11 used by Bleicher et al.,
1990) but were unable to to detect expression on epithelial cells. These data support
the hybridization results described above in which SCD ID mRNA appears to be
expressed in IELs.
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Neither the a3 or the SCD1D probe detects those cells within the lamina propria
which are strongly stained by the mAbs CC118 and SBU-T6. Whilst not an
unexpected result for the SCD1D probe, it is surprising that an a3 probe (which
should in theory detect all CD1 isotypes) clearly does not detect cells which express
high levels of CD1 as detected by the group 2 mAbs.
The logical conclusion to make from this is that an a3 probe does not detect mRNA
which encodes group 2 molecules raising the possibility that the group 2 mAbs
recognise a CD1 molecule which lacks an a3 region. This would also explain the
discrepancy between the hybridization results in lymph node compared to results
obtained using immunostaining.
The SCD1B-52 gene lacks an a3 region and alternative splicing is a recognised
feature of the CD1 genes (Calabi et al. 1989, Bradbury et al. 1990). CD Id in humans
has been reported to be expressed by intestinal epithelium in a lower molecular
weight (32m independent manner (Balk et al. 1994). Although the reduction in size is
attributed to altered glycosylation of the molecule rather than any specific alterations
in splicing, the fact that CD Id exists in this way independent of (32m would imply
that an a3 deleted CD1 molecule with its associated lack of (32m may also exist.
Whilst SBU-T6 immunoprecipitates a 46kd protein from the thymus, following
affinity purification of the antigen, a 33kd protein in dimeric and monomeric form
exist in apparently much greater levels than the 46kd protein (see Chapter 4). Again
this would be consistent with an a3 deletion although there is no evidence for this
assumption.
The only other report of in situ hybridization using CD1 specific riboprobes which
was carried out in the mouse. These studies utilized an a3 riboprobe to localize
mCDl gene expression within the intestine (Lacasse and Martin. 1992).
Discrepancies between the results of immunohistological analysis of CD1 expression
in the intestine and Western blotting on antigen from the same tissue (Bleicher et al.
1990, Mosser et al. 1991) led to the utilization of this technique to attempt to clarify
the situation (Lacasse and Martin. 1992). It was shown that only Paneth cells at the
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base of the intestinal crypts express CD1 genes - there was no detectable CD1
mRNA in the extrusion zone of the intestinal villi. This study highlighted a
discrepancy between results obtained using mAbs to detect CD Id antigen and
molecular probes to detect CD ID mRNA. It is clear that a similar discrepancy has
also been shown in this study. Resolution of this conflict between immunostaining
and in situ hybridization results will require isolation of the cDNA encoding the




The CD1 family is a group ofMHC related molecules, members ofwhich have been
described in a number of species. Humans possess five different CD1 genes each of
which encodes a separate CD1 isotype. In contrast, mice only possess two CD1
genes each encoding a CD1 molecule of the same isotype i.e. CD Id.
Previous molecular studies have identified four ovine CD1 genes all of which have
closest homology to CD IB (Ferguson et al. 1996). The results of the work carried
out in this thesis now indicate that in addition to CD IB homologues, sheep also
possess a CD 1D-like gene and are also likely to possess a CD 1E like gene although
the sequence of this gene has yet to be ascertained. This information renders the
sheep an intriguing model for study of the CD1 family in that multiple isotypes exist
(as in humans and rabbits), multiple genes encoding molecules belonging to the
same isotype exist (as in mouse) and a novel CD1 protein has been demonstrated
with closest homology to the predicted amino-acid sequence of human CD IE.
9.1 Groups of CD1 genes and proteins
The original grouping of CD1 molecules by Calabi and colleagues (1991b) allowed
division of CD1 molecules into 'classic' CD1 i.e. CDla-c and the CD Id group on the
basis of conserved sequences within the leader, al and a2 domains. These two
classes are now referred to as group 1 (CDla-c) and group 2 (CDId) (Porcelli, 1995).
The human CD IE gene remains 'unclassified' and in an intermediate position as a
protein product has yet to be identified.
The studies described in Chapter 3 investigating expression of ovine CD1 using
mAbs revealed 2 distinct patterns of expression. The mAbs which revealed a pattern
of staining consistent with recognition of a CD lb like molecule were classed as
group 1. The mAbs that recognise a molecule with a wider distribution i.e. SBU-T6,
CC43 and CC118 were classed as group 2. It is apparent that a distinction must be
made between the group 1 and group 2 'classes' as defined above and this grouping
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of mAbs according to staining pattern. As a result of the NH2-terminal sequencing
data presented in Chapter 4, it appears that at least one member of the group 2 mAbs
(SBU-T6) recognises the product of an intermediate/unclassified CD IE-like gene.
Thus it is proposed that, as illustrated in Table 9.1, any CD IE gene products will
form group 3. Since SBU-T6, CC43 and CC118 cluster together (Chapter 3), these
three mAbs will be considered to recognise a group 3 molecule to make the
important distinction between mAbs which may recognise a CDle homologue and
group 2 CD1 i.e. CD Id. This nomenclature will be adopted throughout the remainder
of this discussion.
9.2 Interspecies isotype comparison
9.2.1 CD1 evolution
Two alternative theories have been proposed to explain the origin of the CD1 family
and its relationship to the MHC. Since CD1 is approximately equally related to both
MHC class I as MHC class II, this implies that CD1 diverged from the MHC at the
same time as MHC class I diverged from MHC class II. An alternative theory is that
MHC class I was the first to diverge from the common ancestor followed by
divergence ofMHC class II and CD1 at a later time (Calabi et al. 1991).
Regardless of the origin of the CD 1 family, it is apparent that throughout the process
of evolution, different species have retained or acquired different CD1 isotypes.
Table 9.2 shows the variation in numbers and classes of CD1 genes between species.
It is tempting to assume that the patterns of CD1 expression observed in different
species together with retention of members of the different CD 1 classes in some but
not all species has some functional significance for, or has conferred some selective
advantage on that particular species. It is generally accepted that the two groups of
CD1 genes diverged prior to the radiation of the placental orders (Calabi et al.
1989c). The lack of group 1 CD1 genes in rodents implies partial deletion of the
CD1 gene cluster during rodent speciation (Calabi et al. 1989b).
A number of studies have been carried out on the evolution of the CD1 family.
Phylogenetic trees have been constructed based either on the number of
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TABLE 9.1
Table demonstrating division of the CD1 genes into three groups. The sheep CD1
genes are highlighted by shading.
TABLE 9.2
Interspecies comparison ofCD1 genes.
TABLE 9.1









SPECIES NUMBER OF CD1
GENES
KNOWN GENES OTHER GENES
HUMAN 5 CD1A-E No
MOUSE 2 MCD1.1, MCD1.2 No
RAT 1 RtCDl No
RABBIT Up to 8 CtRabCDl, DoRabCDl Yes






non-synonymous (i.e.amino acid altering) nucleotide substitutions (dN) in the al and
a2 domains (Hughes, 1991) or on alignments of full-length CD1 protein sequences
(Porcelli, 1995). Using the former method, Hughes (1990) showed that the mouse
and cotton-tail rabbit CD1 genes, HCD1D and HCD1E cluster together and are
separated significantly from the other CD1 genes. In addition, a close relationship of
HCD1A and HCD1C is shown and HCD1B is shown to represent a separate lineage
that diverged prior to HCD1A and HCD1C. This separation of HCD1B is not
however shown in the phylogenetic trees (based on amino-acid sequences)
constructed by Porcelli (1995). Phylogeny based on the full length sequence or on
the a2 domain sequence clearly shows the two groups of CD1 antigens (i.e. CD Id
and CDla-c) with CDle being significantly separated. Phylogeny based on the al
domain amino acid sequences however shows CD la to be the most divergent. It is
evident therefore that no consistent evolutionary relationships are demonstrated by
these various methods.
Functional divisions within the CD1 family may also relate to the evolutionary
history. CD lb is known to present mycolic acids and LAM to T cells (Beckman et al.
1994, Sieling et al. 1995) and whilst not necessarily being significant in vivo, mouse
CD1 has been shown to bind peptides. This represents the first functional division
i.e. on the basis of antigen binding.
A second functional division is suggested following analysis of the CD1 cytoplasmic
tails. CDlb, -c and -d all share an endosomal targeting motif in the cytoplasmic tail.
CD la differs in that it has a shorter cytoplasmic tail which may be involved in
interactions with tyrosine kinases (Porcelli, 1995). The recent demonstration by
Sugita and colleagues (1996) that localization ofCDlb to an endocytic compartment
is dependant on the tyrosine-based motif in the cytoplasmic tail further supports the
functional division between CD la and CDlb-d.
The absence of members of the CDla-c group in rodents is considered to result from
a deletion occurring after the separation between rodent and the rabbit/human lineage
(Calabi et al. 1989b). It has been suggested that the TL antigens in mice perform the
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function of the missing group 1 CD1 antigens in this species (Bradbury et al. 1988)
and whilst this is a possibility, it may also be that rodents do not require the 'function'
of the group 1 CD1 antigens and thus they have not been retained.
Another interesting feature of the CD1 family when comparisons are made across the
species is the observation that in the mouse and sheep, two or more genes encode
molecules of the same isotype. This may also be the case in the rabbit as up to eight
genes have been shown to exist by Southern blot (Calabi et al. 1989b). Of these
potential eight genes, however, only one group 2 (CD 1D) gene was shown to exist as
demonstrated by hybridization with an al probe from the CtRabCDl gene. Hence if
multiple genes do exist encoding CD1 antigens of the same isotype in the rabbit,
they are likely to be group 1 CD1 as in sheep. The fact that this is a feature of the
CD1 family in at least two (i.e. sheep and mice) and probably three (i.e. rabbit) of the
species in which the CD 1 family has been studied would suggest that this feature is
of some functional significance to the animal. What could be the benefit to a species
of retaining different genes that apparently encode highly similar molecules with no
(or limited) allelic variants? There is now compelling evidence that group 1 CD1
molecules act as restriction elements for non-protein antigens and two of these
reports have specifically shown that CD lb restricts the response ofT cells to mycolic
acids and LAM (Beckman et al. 1994, Sieling et al. 1995). Hence the existence in the
sheep of multiple CD lb-like isotypes may imply a greater need or reliance upon this
type of antigen presentation. It is important to note that this presentation of
'alternative' non-protein antigen has thus far only been shown to be a feature of
CD lb. With the lack of polymorphism which is a feature of the CD1 molecules, a
larger number of genes of one particular isotype capable of performing a similar
function but with differences, e.g. in the particular range of lipid that may be
presented, could conceivably enhance the ability of this species to deal with
antigenic challenge of this nature by increasing the range of antigens which may be
recognised and presented.
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9.2.2 CD1D - an isotype common across the species
Previous studies on CD1 have shown that all species studied to date possess at least
one member of the CD Id group of CD1 molecules i.e. man, mouse, rat, rabbit. The
identification of an ovine CD ID gene (Chapter 5) shows that, in addition to the
multiple CD 1 b-like isotypes, a member of the CD 1 d group has also been retained in
this species. CD Id is the only isotype which appears in all species in which the CD1
family has been studied. This suggests that functionally, this isotype is required in all
these species as there would appear to have been evolutionary pressure to retain it.
At the functional level, as discussed in Chapter 1, there is evidence that members of
the group 1 family may differ from group 2 i.e. CD Id molecules. The demonstration
of peptide binding by mouse CD1 in a manner which differs from, yet has
similarities to, both MHC class I and MHC class II peptide binding (Castano et al.
1995) suggests that group 2 CD1 may present antigen in a more 'conventional' sense
than group 1 CD1 i.e. presentation of short peptides. Although it is by no means
certain, if it is assumed that group 2 CD1 molecules do bind and present peptides in
vivo then the key to the specific role and requirement for a molecule of this nature
may lie in its unusual tissue distribution. Although there are species variations, a
general feature of the group 2 CD1 molecules is high levels of expression on
gastrointestinal epithelium and hepatocytes. It is therefore tempting to speculate that
there may be a role for group 2 CD1 molecules in mucosal immunity within the
intestine. Although not reported in any other species, also relevant to this discussion
is the apparent induction of ovine CD lb on intestinal epithelial cells in
M.paratuberculosis infection and also in neonatal lambs. It is intriguing that the rat
neonatal receptor for Ig (FcRn), in addition to being expressed in the intestine is also
expressed outside the neonatal period on the canalicular surface of adult hepatocytes
(Blumberg et al. 1995). Whilst there is no suggestion that FcRn and CD1 have any
precise functional similarities, a more general role in immunosurveillance of
epithelial surfaces may be a shared feature of the two classes ofmolecule.
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9.2.3 Group 3 CD1/ CD1E
Although the phylogenetic trees constructed by Porcelli (1995) indicate that the
predicted protein product of the HCD1E gene is significantly separated from the
group 1 and group 2 CD1 proteins, sequence analysis of the 5'UT, leader, al and a2
domains show that in terms of sequence, CD IE is in an intermediate position
between the group 1 and group 2 genes (Calabi et al. 1989c). Notably, in the 5'
region, there are specific blocks of sequence conservation (including two heptamers)
which are conserved between all the human CD1 genes with the exception of
HCD1D (Calabi et al. 1989b).
Man is the only species to date in which a CD IE gene has been described. Despite
indications that the gene is transcriptionally active (), no protein product has yet been
described. Thus the identification of a NH2-terminal sequence of a protein which has
closest homology to the predicted product of this gene represents a significant
finding as this is the first description in any species of a CDle-like protein. The fact
that SBU-T6 apparently recognises a protein encoded by a novel CD1 gene is
perhaps not surprising considering the pattern of expression observed using this mAb
(Chapter 3) which clearly does not resemble that of any recognised CD1 isotype. The
mAbs CC43 and CC118 exhibit a similar but not identical pattern of reactivity when
compared to SBU-T6. The data presented in Chapter 3 showed that CC43 and
CC118 do not stain epidermal Langerhans' cells (which are stained by SBU-T6) and
they stain thymocytes and DCs with lower intensity. In cattle, CC43 and CC118
exhibit similar reactivity to SBU-T6 in Bos taurus with the exception of weak
staining of small intraepithelial cells (Howard et al. 1993a). These minor differences
in reactivity between the group 2a (SBU-T6) and group 2b (CC43 and CC118) mAbs
in both cattle and sheep suggest that more than one CD1 antigen of the group 3 class
is being recognised.
With the recent interest in the functional properties of members of the CD1 family
and the apparent dichotomy which exists between group 1 and group 2 CD1
molecules in terms of antigens which they are capable of presenting, a CD1 molecule
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which is, at least in terms of sequence, in an intermediate position between the two
groups would be an intriguing molecule to study in terms of function.
Once the sequence of the gene encoding this molecule is identified, it may also be of
interest to ascertain if this isotype is present in other related species (e.g. cattle) as is
suggested by mAb studies (Howard et al. 1993a, 1993b). Assuming that both cattle
and sheep do possess a group 3 gene(s) it is possible that the retention of this isotype
represents a functional requirement for a CD1 molecule in ruminants which does not
exist in other species.
9.3 Summary and conclusions
The work described in this thesis has demonstrated that the ovine CD1 family
appears to be one of the most complex studied to date. In conjunction with the
previously described sheep CD IB genes (Ferguson et al. 1996), the demonstration of
a sheep CD ID gene and identification of an antigen which is likely to be encoded by
a CD IE like gene renders the sheep an intriguing model for the study of CD1.
Although no specific functional questions were asked in this work, the identification
of CD1 expression in cells and tissues in which CD1 molecules have not been
described in other species may have some functional relevance. In particular, the
identification of constitutive CD1 expression (group 3) by tissue macrophages, all B
cells, monocytes and microglial cells in the CNS demonstrates that sheep possess
isotypes with a wider tissue distribution than those in man and mice. Notably, this is
the first description ofCD1 expression within the CNS.
Expression of CD1 as recognised by the group 1 i.e. CDlb-like mAbs was shown in
normal tissue to resemble expression of CD lb in man with the exception of the
expression on intestinal epithelial cells in neonates and following infection with M.
paratuberculosis. This in vivo up-regulation of CD1 in association with
mycobacterial disease is consistent with a role for CD1 in presentation of
mycobacterial antigens to T cells.
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9.4 Future work
Future work will focus on the isolation and subsequent characterisation of the gene
encoding the molecule recognised by SBU-T6. This will then allow detailed
comparison at the molecular level of genes belonging to each of the three CD1
classes.
Further studies on the SCD1D gene product would be facilitated by the generation of
antipeptide antiserum specific for the SCDld molecule.
Further investigation of the mRNA splicing complexity of the ovine CD1 family
would also be interesting in view of the presence of the SCD1B-52 gene which
contains a precise a3 deletion and also the indirect evidence that the antigen
recognised by the group 3 mAbs may lack an a3 region. If this is a general feature of
ovine CD1 (as has been shown for human CD1 - Woolfson and Milstein, 1994), then
it may have functional relevance as a result of the generation of alternative CD1
isoforms.
In view of the current interest in the role of CD lb as a molecule capable of
presenting lipid antigen to T cells, the demonstration of CD1 up-regulation in a
naturally occurring mycobacterial disease of sheep may provide a useful model to
study presentation of lipid antigen by members of the CD1 family.
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APPENDIX I













0.5% Triton X 100
pH8
LB Broth TYM media
1%(w/v) tryptone 2%(w/v) tryptone
0.5%(w/v) yeast extract 0.5%(w/v) yeast extract
0.17M NaCl O.lMNaCl
pH7 10mMMgSO4
TE buffer (Tris-EDTA) TAE buffer (Tris-acetate-EDTA)
lOmM TrisCl pH8 40mM Tris






















G5936 TGAAGCCTGGCTGTCCAGT a3 5
G5935 CCAGTACAGGATGATATCC a3 3
G4252 TACCAGGCTGCTCCTGCTCA a3 3
P10763 GCCAACCACASCTGGACWAARAC Degen. 5'
P14365 TCCTTTGCCAACCACASCTGGAC Degen. 5!
P6087 TCCTGAAGCCCTGGTCC B52 al 5'
P6086 TGACTCCTAGGCTGACAAC B52 3TJT 3'
PI 0448 GTCAACAGCACATGGGCTC B52 al 5'
P10435 TGTGGGGTGTCCTTGCCTCTG B52 TM/CYT 3'
LN01 CAGGGCACRTTCAGCGACC LN1 al 5'
LN02 GTCCCTGGTGAAGCTGCTKCG LN1 a2 3'
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